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Abstract 
 
Toxoplasma gondii is a polyxenous parasite of the phylum Apicomplexa and the 
etiological agent of the coccidian disease Toxoplasmosis. Toxoplasma gondii is 
characterized by its unique gliding motility as well as its ability to infect virtually all 
nucleated cells. The micronemes are a group of secretory organelles that contribute to 
the ability of the parasite to recognize the surface of the host-cell prior to parasite 
invasion via the secretion of adhesive protein complexes. 
 
Previous attempts at obtaining structural data for several microneme proteins from 
Toxoplasma gondii such as microneme protein TgMIC 2, 3 and 4 have so far been 
unsuccessful due to the inability to produce soluble protein samples using the 
prokaryotic expression system, Escherichia coli. This work is focussed upon the 
adaptation of a eukaryotic expression system, Pichia pastoris, to producing 
Apicomplexan microneme proteins which can cause problems in prokaryotic 
expression systems due to its eukaryotic origin as well as its high cysteine content.  
 
Modifications to the fermenter medium and standard screening protocols allowed for 
the expression of microneme protein domain constructs in Pichia pastoris with yields 
ranging from 0.1 to 1.2 mg/L in fermenter culture. Soluble protein samples were 
produced for several constructs expressed in Pichia pastoris including full length 
samples of TgMIC3 and TgMIC4 as well as the TSR56 pair in TgMIC2. In addition, 
isotopically enriched soluble and folded protein samples were successfully produced 
with a yield of 0.02 to 0.12 mg/L and were successfully subjected to analysis via 2D 
NMR. Full length TgMIC4 was also successfully crystallized and resulted in crystals 
which diffracted to 8.0Å.  
 
Pichia pastoris has been successful in producing soluble microneme protein samples 
and has the potential to alleviate the long-standing bottleneck in our efforts to 
understand the mechanisms involved in Toxoplasma gondii host-cell invasion.  
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1.1 Phylum Apicomplexa 
 
The Apicomplexa are a group of eukaryotic unicellular spore-forming microorganisms 
that are characterised by the common presence of a unique organelle known as the 
apicoplast and an apical complex structure involved in host cell invasion (Levine 1988). 
All members of the phylum are parasites that infect both invertebrates and vertebrates. 
They have been known to cause various diseases such as Malaria (Plasmodium sp.), 
Babesiosis (Babesia sp.) and Toxoplasmosis (Toxoplasma gondii).  
 
The apicoplast is a nonphotosynthetic plastid essential to parasite survival. Its function 
is still unclear, but it been postulated to be involved in the synthesis of various 
biomolecules such as fatty acids, isoprenoids or iron-sulphur clusters (Fichera and Roos 
1997).  
 
The apical complex is a collection of three distinct structures involved in host cell 
invasion. First, the conoid, a series of microtubules arranged in a spiral formation. 
Second, the rhoptry, club-shaped organelles that are heavily involved in the penetration 
process and third, the micronemes, specialised secretory organelles heavily involved in 
gliding motility.  
 
1.1.1 Toxoplasma gondii 
 
Toxoplasma gondii is a ubiquitous intracellular coccidan parasite of the phylum 
Apicomplexa. The genus Toxoplasma was named for its bow-like structure (Greek : 
toxo- = bow/arc, -plasma = creature). It is a remarkably successful parasite, having been 
estimated to infect up to one third of the world’s population (Montoya and Liesenfeld 
2004).  Its remarkable success can be attributed to its distribution of resistant oocytes 
throughout different environments via its primary host, felids, as well as further 
propagation through carnivorous or omnivorous feeding behaviour. The parasite also 
has the ability to penetrate and grow in virtually all warm-blooded animals as well as a 
diverse variety of cell types (Black and Boothroyd 2000; Carruthers 2002). In addition, 
the tissue cysts produced by the parasite are remarkably resistant to immunological 
challenges, persisting in a dormant stage throughout the rest of the host’s lifespan.  
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1.1.2 Life Cycle of Toxoplasma gondii 
 
The life cycle of T. gondii can be broken down into two phases, the sexual phase and 
the asexual phase (Fig. 1.1).  The sexual phase takes place only in members of the 
family Felidae (Comstock and Ganley 1973), whilst the asexual phase can take place 
in intermediate hosts such as humans, mice and birds (Dubey, Gendron-Fitzpatrick et 
al. 1988).  
 
Ingestion of tissue-cysts by intermediate hosts initiates the asexual phase. In the asexual 
phase, tachyzoites multiply rapidly via endodyogeny within different types of host cells 
(Skariah, McIntyre et al. 2010). The tachyzoites form tissue cysts, primarily within 
neural and muscular tissues such as the central nervous system, the eyes and the skeletal 
and cardiac muscles. Bradyzoites multiply within these tissue cysts. These bradyzoite 
tissue cysts can persist for the life of the host causing a chronic asymptomatic infection. 
 
Upon ingestion by a definitive host, such as the aforementioned members of the family 
Felidae, the bradyzoites initiate another phase of multiplication via endodyogeny 
followed by several phases of multiplication via endopolygeny within the epithelial 
cells of the small intestine(Tenter, Heckeroth et al. 2000; Torda 2001). This initiates 
the sexual phase of the T. gondii life cycle. In the intestinal enterocytes the parasites 
differentiate into two varieties of gametocytes, microgametocytes and 
macrogametocytes. These then fuse to form an oocyst.  Unsporulated oocysts are passed 
into the environment within faeces between three to ten days post-ingestion (Dubey, 
Gendron-Fitzpatrick et al. 1988). Oocysts sporulate and become infectious within one 
to five days outside the host (Hill, Chirukandoth et al. 2005).  
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Figure 1.1: The 2 phases of the Toxoplasma gondii life cycle. The T. gondii life cycle has two phases, 
the asexual phase and the sexual phase. The asexual phase takes place within intermediate hosts and can 
cause chronic infection after initial acute infection. Encystation within neuromuscular tissues is the 
primary cause of the most severe symptoms of toxoplasmosis. If the host’s immune system is 
compromised in the future, the reactivation of latent infections can result. The sexual cycle takes place 
entirely within the definitive hosts and results in the spread of toxoplasmosis via the release of 
environmental oocysts.  
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1.2 Toxoplasmosis 
 
Toxoplasmosis is an infection caused by the parasite T. gondii. It is an extremely 
widespread infection with estimated seroprevalence levels worldwide of 30% to 50%. 
It is relatively harmless for healthy adults but can cause severe complications in 
immuno-compromised individuals. Toxoplasmosis has also been postulated to have a 
wide-ranging psychological impact in addition to its physiological effects.  
 
1.2.1 Symptoms  
 
Toxoplasmosis can present with mild-flu like symptoms during the first few weeks of 
infection, after which the patient reverts to an asymptomatic condition (Carruthers 
2002).  Small numbers of acute infections can result in Chorioretinitis, encephalitis or 
neurological damage. However, if the patients' immune system is compromised due to 
factors such as HIV infection, pregnancy or a course of immunosuppressant drugs as a 
part of treatment, a reactivation of chronic infection can occur and cause severe 
symptoms such as brain inflammation, encephalitis and neurological damage which can 
prove to be fatal (Montoya and Liesenfeld 2004). A study has shown that up to 40% of 
AIDS patients suffer from encephalitis due to toxoplasmosis (Rousseau, Pueyo et al. 
1997).  
 
Whilst dormant chronic infection with T. gondii cannot be transmitted through the 
placenta, acute infection with T. gondii during pregnancy or reactivation of a chronic 
infection can result in congenital infection of the foetus (Rorman, Zamir et al. 2006). 
Congenitally infected individuals may present with no symptoms immediately after 
birth however up to 75% exhibit developmental retardation and hearing loss in later life 
with up to 90% suffering ocular damage. In addition, acute infection during pregnancy 
can also result in spontaneous abortion (Jones, Sever et al. 1969).  
 
In addition to the physical symptoms of toxoplasmosis, there are indications that 
infection with T. gondii can have effects upon the personality of the host (Flegr, Zitkova 
et al. 1996; Flegr 2007). There is also a negative correlation between neuropathic T. 
gondii infection and novelty-seeking behaviour (Novotna, Hanusova et al. 2005). Due 
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to the variation in eating habits and climate between countries, the seroprevalance of T. 
gondii varies accordingly. This and the tendency for T. gondii infections to trigger 
personality changes have led Lafferty to postulate that the differing rates of infection 
could influence personality trends and cultural tendencies in different countries 
(Lafferty 2006). This variation in T. gondii seroprevalance has also shown an effect on 
the differing rates of adult brain cancer between countries (Thomas, Lafferty et al. 
2012). 
 
1.2.2 Epidemiology 
 
T. gondii has three main avenues of human infection, the oral ingestion of bradyzoite 
tissue cysts, the ingestion of oocysts containing sporozoites in cat intestines and the 
consumption of waterborne parasites (Dubey 1998). The primary cause of T. gondii 
infection in humans is the consumption of undercooked and improperly prepared meat, 
especially pork and lamb. As such, seroprevalance varies greatly between different 
nations, with 20% of the population estimated to be seropositive in the USA, whilst up 
to 75-80% of the population in countries such as El Salvador, Brazil and France being 
estimated to be seropositive (Tenter, Heckeroth et al. 2000). However, improvements 
in animal husbandry and a greater awareness of proper food preparation methods have 
decreased the worldwide prevalence of toxoplasmosis in recent years.  
 
Although infection with T. gondii most often manifests itself asymptomatically, its 
impact on the healthcare system cannot be underestimated. A recent study has shown 
that the annual cost of toxoplasmosis in the USA is estimated to be around US$7 billion 
(Miller, Boulter et al. 2009). In addition, toxoplasmosis is the third leading cause of 
death due to food-borne pathogens in the USA.  
1.2.3 Treatment  
 
Due to the similarity of T. gondii and the Plasmodium falciparum (the etiological agent 
of malaria), the primary drugs of choice for the treatment of toxoplasmosis are anti-
malarial drugs such as quinine and pyrimethamine (Chirgwin, Hafner et al. 2002). 
Pyrimethiamine is commonly administered in conjunction with sulfadiazine, a 
 22 
 
sulphonamide antiobiotic. These drugs are mainly used to control the disease during the 
acute stage when the active multiplication of the parasite causes distress, however, these 
drugs generally do not eradicate the infection.  
 
Pyrimethiamine is a folic acid antagonist which interferes with the enzyme 
dihydrofolate reductase. This inhibits the formation of tetrafolic acid, an important 
precurser in the synthesis of DNA, RNA and certain amino acids (Nduati, Diriye et al. 
2008). Sulfadiazine is a sulphonamide antibiotic that inhibits dihydropteroate 
synthetase and interferes with the synthesis of dihydropteroate, an important 
intermediate in the formation for folic acid (McCullough and Maren 1974). For the 
treatment of pregnant women, treatment with pyrimethiamine and sulfadiazine is 
accompanied with folic acid supplementation. Alternative treatment options include the 
macrolide antibiotics spiramycin or azithromycin (Chang and Pechere 1988). 
 
For the control of chronic toxoplasmosis in immune compromised patients such as HIV 
positive individuals and organ transplant patients the common treatment is antibiotics 
such as atovaquone and clindamycin (Katlama, De Wit et al. 1996; Sackoff, McFarland 
et al. 1998) 
 
1.2.4 Prevention 
 
Due to the lack of treatment options for chronic toxoplasmosis, prevention of infection 
is the key to controlling its spread. Prevention of cross-contamination can be achieved 
by undertaking basic food hygiene such as the washing of hands and materials in 
contact with uncooked meat with soap and water. All stages of T. gondii in meat are 
killed by contact with soap and water (Dubey 1998). 
 
Tissue cysts in meat can also be killed by extreme heat (67C) or cold (-13C) (Dubey, 
Kotula et al. 1990; Dubey 1996).  As such, all meat should be cooked thoroughly prior 
to consumption. In addition, due to their vulnerability and the possibility of harm to the 
foetus, pregnant women should avoid contact with cats, soil and raw meat (Foulon, 
Naessens et al. 1994; Cook, Gilbert et al. 2000). 
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1.2.5 Vaccination 
 
There is currently no effective vaccine for toxoplasmosis in humans. Current efforts 
towards vaccine development have focussed on the prevention of host-cell invasion, 
prevention of tissue cyst formation and the prevention of zoonotic transmission by 
limiting the exposure to oocysts and tissue cysts (Innes and Vermeulen 2006). 
 
Protection against toxoplasmosis is mediated by CD4+ and CD8+ IFN-γ producing T-
cells (Jongert, Lemiere et al. 2010). DNA vaccines been shown to have the potential to 
induce T-cell responses against the antigen of interest. Plasmid vaccines coding for 
SAG1, GRA1, GRA7 and ROP2 have all conferred partial protection against T. gondii 
infection (Vercammen, Scorza et al. 2000; Couper, Nielsen et al. 2003). In addition, 
vaccination with plasmids coding for microneme protein regions from MIC2, MIC3, 
MIC4, M2AP and AMA1 have resulted up to 84% reduction in cyst loads in affected 
individuals(Beghetto, Nielsen et al. 2005; Rosenberg, De Craeye et al. 2009). 
 
A live attenuated vaccine S28 (Toxovax®) has been used successfully for vaccination 
in sheep, but has also been shown to inhibit the sexual development of T. gondii in 
felines (Wastling, Harkins et al. 1994; Innes, Bartley et al. 2009). Other potential 
attenuated, live T. gondii vaccines include the oocyst deficient T263 strain and a mic1 
and mic3 knockout T. gondii strain (Frenkel, Pfefferkorn et al. 1991; Ismael, Dimier-
Poisson et al. 2006).  
 
Antigen vaccines such as intranasally delivered SAG1 and MIC3 and MIC4 protein 
extracts have been shown to provide limited protection when challenged with T. gondii 
isolates (Wang, He et al. 2009; Fang, Feng et al. 2012). When intranasal SAG1 was 
administered with QuilA or cholera toxin as an adjuvant, a 90% survival rate with no 
brain cysts or a 85% reduction in brain cyst load was reported in murine species (Khan, 
Ely et al. 1991; Debard, Buzoni-Gatel et al. 1996; Velge-Roussel, Marcelo et al. 2000). 
Mic1 and mic4 purified protein from protein extracts have shown to produce an 80% 
survival rate and a 68% reduction in brain cyst load in C57BL/6 mice (Lourenco, 
Bernardes et al. 2006). In addition, intranasally administered purified rhoptry protein 
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extracts provided immunity to oocyst shedding in feline species (Zulpo, Headley et al. 
2012). 
1.3 Cell ultrastructure and Key organelles 
 
The phylum Apicomplexa is defined by the presence of several unique organelles which 
contribute to their parasitic lifestyle; these comprise the micronemes, rhoptries and 
dense granules (Dubremetz and Schwartzman 1993; Carruthers and Sibley 1997). 
These secretory organelles have been implicated at various stages of host cell invasion 
(Striepen, Soldati et al. 2001).  
 
The secretory organelles are polarised towards one end of the cell and culminate in a 
cone –shaped projection of the cell membrane known as the apical complex (Fig. 1.2). 
The apical complex consists of a microtubular spiral (conoid), two ring-like structures 
(preconoidal ring and the polar ring) which span the subpellicular microtubules and the 
associated secretory organelles the micronemes and rhoptries (Hu, Johnson et al. 2006). 
The extrusion and retraction of the conoid region suggests a mechanical role whilst 
molecules secreted for host cell attachment from associated organelles have been shown 
to be essential for attachment, invasion and the formation of the parasitophorus vacuole 
(PV) (Monteiro, de Melo et al. 2001; Del Carmen, Mondragon et al. 2009). The conoid 
extrusion has been shown to be Ca2+ dependent (Mondragon and Frixione 1996). 
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Figure 1.2:  Schematic of the cell ultrastructure of Toxoplasma gondii. This schematic shows the 
location and polarization of the cell organelles in a T. gondii tachyzoite. The secretory organelles are the 
rhoptries (red, neck region coloured light blue), micronemes (pink) and the dense granules (black dots). 
The apical complex is comprised of the conoid (brown), the apical polar ring (purple) and the 
subpellicular microtubules (black). The molecular machinery facilitating gliding motility is found 
between the inner membrane complex and the plasma membrane (see section 1.4 and figure 1.3). The 
apicoplast is an essential plastid that currently has no confirmed function (Waller and McFadden 2005). 
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1.3.1 Microneme organelles 
 
The micronemes are small (160nm X 65nm) membrane-bound cigar shaped organelles 
(Carruthers and Sibley 1997). The micronemes are oriented primarily around the 
conoidal channel but randomly oriented micronemes have also been observed. As 
aligned micronemes are exocytosed, randomly oriented micronemes dock at the level 
of the posterior polar ring (Paredes-Santos, de Souza et al. 2012). Secretion of the 
microneme proteins is triggered by a rise in intracellular calcium that occurs during 
gliding motility and contact of the apical end of the parasite with the host cell surface 
(Carruthers, Moreno et al. 1999; Carruthers and Sibley 1999; Wetzel, Chen et al. 2004). 
Secretion of the microneme proteins takes place during recognition and adhesion by the 
T. gondii tachyzoites.  
1.3.2 Rhoptry organelles 
 
Rhoptry secretion takes place after micronemes secretion. The rhoptry organelles are 
large (100nm X 2500 nm) club-shaped organelles with a bulbous body and a narrow 
electron dense neck that extends to the conoid (Opitz and Soldati 2002; Dubremetz 
2007). There can be anywhere from 6-14 rhoptries per cell. Field Emission Scanning 
Electron Microscopy (FESEM) has revealed the existence of a porosome-like structure 
at the probable point of rhoptry docking (Paredes-Santos, de Souza et al. 2012).   These 
porosomes have been identified in other specialized secretory cells and could offer a 
clue as to the exact position and trigger for rhoptry secretion (Jena 2009).  
 
The interior of the rhoptries are acidic (Shaw, Roos et al. 1998) and contain both lipid 
and protein contents. The rhoptry proteins consist of RONs (Rhoptry Neck Proteins) 
and ROPs (Rhoptry Bulb Proteins). The RONs are responsible for the assembly of the 
moving junction during host cell invasion and PV formation (Alexander, Mital et al. 
2005) and the ROP proteins are primarily parasite virulence factors (Bradley and Sibley 
2007). 
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1.3.3 Dense granules 
 
The dense granules are named for their density in transmission electron micrographs 
and are more dispersed throughout the cell when compared to micronemes or rhoptries 
(Blackman and Bannister 2001). There are typically about twenty dense granules in a 
single T. gondii cell. They are constitutively secreting organelles and continually 
secrete their contents into the PV (Leriche and Dubremetz 1990; Chaturvedi, Qi et al. 
1999). These secretory products have been postulated to form the intravacuolar network 
which acts as a mechanical support for the PV (Cortez, Stumbo et al. 2008). The 
secretory proteins of the dense granules primarily consist of the dense granule antigen 
(GRA) proteins and nucleoside triphosphate hydrolases (NTPases) (Mercier, Adjogble 
et al. 2005). 
 
1.4 Molecular Basis of Parasite Invasion  
 
Members of the phylum Apicomplexa are characterized by the lack of common motile 
structures such as flagella or pseudopodia, instead using a form of gliding motility to 
achieve host cell invasion and egress (Keeley and Soldati 2004). This gliding 
mechanism is comparatively fast (5.0 µm/s) compared to the host-cell invasion 
processes employed by bacteria or viruses (Soldati and Meissner 2004).  The nature of 
T. gondii’s gliding mechanism is different from other gliding mechanisms found in 
bacteria which rely upon surface appendages such as type IV pili (Sibley 2004). The 
active nature of the gliding mechanism allows T. gondii the ability to pass through 
normally non-permissible biological barriers such as the blood-brain barrier, the 
intestinal epithelium and the placenta, thus causing many of its most severe conditions 
such as neurological complications, congenital infections and ocular pathology 
(Barragan and Sibley 2003).  
 
This gliding mechanism involves the apical secretion of adhesions followed by the 
translocation of the adhesion-receptor complexes along the cell surface to the back of 
the parasite. This process is reliant upon the sequential release of microneme and 
rhoptry proteins for the adhesion and maintenance of the PV.  
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The adhesion-complex is collectively known as the glideosome (Fig. 1.3). These 
secretory adhesins are coupled to the intracellular components of the glideosome via 
the transmembrane thrombospondin-related adhesive protein (TRAP) in plasmodium 
(Kappes, Doerig et al. 1999) or TRAP-like proteins such as Toxoplasma gondii 
microneme protein 2 (TgMIC2) (Barragan, Brossier et al. 2005).   
 
TgMIC2 is delivered to the apical end of the parasite via constitutive secretion that is 
strongly upregulated upon contact with the host cell. Inhibition of TgMIC2 via 
conditional suppression using a tetracycline-regulated system (tTA-dhfr) causes the 
impairment of helical gliding motility and host cell attachment and attenuated parasite 
virulence (Huynh and Carruthers 2006).  Both TgMIC2 and TgMIC6 been shown to 
interact with aldolase, which is an actin binding protein that directly associates with 
actin microfilaments in the actin-myosin motor (Dobrowolski, Carruthers et al. 1997; 
Zheng, He et al. 2009). The C-terminal tryptophan residue of TRAP and Trp767 in 
TgMIC2 have subsequently been identified as the key residues involved in interactions 
with aldolase and is essential for the efficient invasion of host cells (Buscaglia, Coppens 
et al. 2003; Jewett and Sibley 2004; Starnes, Jewett et al. 2006).  
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Figure 1.3: The molecular machinery of gliding motility. Gliding motility is driven by a molecular 
motor. This molecular motor consists of an intracellular actin-myosin network coupled to an extracellular 
parasite adhesion/host cell receptor complex. The parasite is coupled to the host-cell via the cell-surface 
TRAP-like protein, TgMIC2. TgMIC2 recognizes and binds an as-yet unidentified host-cell receptor. 
TgMIC2 is in turn coupled to the actin-myosin network via the glycolytic enzyme aldolase. TgMIC2 is 
translocated towards the posterior end of the parasite through the action of the intracellular actin-myosin 
network thereby driving the parasite forward. TgMIC2 is subsequently proteolytically processed and 
shed via the action of rhomboid proteases localized to the posterior end of the parasite.  
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Invasion of the host cell proceeds via seven major phases (Fig. 1.4). The initial 
reversible attachment is mediated via glycosylphosphatidylinositol (GPI) - anchored 
surface antigens (SAGs) (Mineo and Kasper 1994). The parasite is reorientated and 
apical attachment is driven by the migration of a variety of microneme proteins to the 
apical end. This microneme release is dependent upon the release of intracellular 
calcium and chelation of calcium prevents attachment and the subsequent invasion of 
host cells (Carruthers and Sibley 1999). The essential role of Toxoplasma gondii apical 
membrane antigen-1 (TgAMA1) and Toxoplasma gondii Microneme protein 8 
(TgMIC8) in apical attachment and signalling rhoptry secretion has been determined 
via reverse genetic studies (Mital, Meissner et al. 2005; Kessler, Herm-Gotz et al. 
2008). 
 
Next, calcium mediated conoid extrusion is postulated to accompany the subsequent 
release of apical membrane antigen (AMA1) as well as the rhoptry neck proteins 
(RON). AMA1 complexes with several RON proteins (RON2/RON4/RON5/RON8) to 
form a complex called the moving junction (Alexander, Mital et al. 2005). All of the 
RON proteins (RON4/RON5/RON8) are also inserted directly into the host cell 
membrane with AMA-1 being localised to the parasite membrane and 
RON4/RON5/RON8 being associated with the cytoplasmic side of the host cell 
membrane (Besteiro, Michelin et al. 2009). This allows the moving junction to interact 
intimately (<6nm) with the host cell surface, migrating from the anterior to the posterior 
end of the parasite as invasion progresses. The translocation of the MJ coincides with 
the formation of a membrane-bound compartment, the parasitophorus vacuole, due to 
the invagination of the host cell membrane (Martin, Liu et al. 2007).   
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Figure 1.4: The seven stages of parasite invasion. Invasion of the host-cell by T. gondii can be 
separated into seven major stages. Initial attachment is mediated by GPI-anchored SAGs. The release of 
intracellular Ca2+ causes the localization of MICs to the apical end of the parasite and subsequent apical 
attachment. The Moving Junction is created by the formation of a complex between AMA-1 at the 
parasite membrane and the RONs at the host-cell membrane. The RONs are released from the neck 
region of the rhoptries (light blue). This is followed by the release of the ROPs (red) and the invagination 
of the host-cell membrane to form the parasitophorus vacuole. The MICs are translocated to the posterior 
end of the parasite and proteolytically processed by ROMs localised at the posterior end of the parasite.  
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As the moving junction migrates, it acts to remove many host and parasite proteins. 
GPI-anchored SAGs as well as AMA1 are unaffected by the moving junction, however, 
all known microneme proteins are excluded by it. The cleavage of TgMIC2 is required 
for the release of the parasite from the host cell membrane (Brossier, Starnes et al. 
2008). A group of proteases known as the rhomboid proteases (ROM) have been found 
to be responsible for the proteolytic removal of adhesin-receptor complexes from the 
posterior of the cell (Buguliskis, Brossier et al. 2010).  
 
TgROM1, TgROM4 and TgROM5 were identified as being expressed in tachyzoites. 
TgROM1 was colocalised with TgMIC2 in the micronemes, TgROM4 was uniformly 
distributed at the surface of the parasite and TgROM5 was primarily localised to the 
posterior of the parasite. Studies have also shown that TgROM5 was capable of 
cleaving TgMIC2 and the transmembrane domains (TMDs) of MIC6 and MIC12. This 
points to the probable role of TgROM5 as the protease responsible for the processing 
of the micronemes TMDs during invasion (Brossier, Jewett et al. 2005). 
 
TgROM4 has also been postulated to perform the role of a sheddase, removing 
unnecessary adhesions that would otherwise accumulate on the cell surface. In addition 
TgROM4 has also been shown to affect the efficiency of processing of cell surface 
adhesins such as MIC2, MIC3 and AMA1 (Dowse, Koussis et al. 2008; Buguliskis, 
Brossier et al. 2010). 
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1.4.1 Structural Organization of Microneme Proteins 
 
No less than twenty-nine genes for apicomplexan microneme proteins have been 
identified. Eleven microneme proteins have been confirmed and a further nine have 
been identified based on their secretion properties.  These proteins were predicted to be 
type 1 membrane proteins with a transmembrane domain towards their C-terminus 
(Tomley and Soldati 2001).  
 
Microneme proteins have a modular architecture made up of combinations of these 
conserved structural domains (Soldati, Dubremetz et al. 2001) (Fig. 1.5). Several 
potential adhesive domains have also been identified in various micronemal proteins 
such as the van Willebrand A-like/integrin-like I domain (A/I domain) (Harper, Hoff et 
al. 2004), thrombospondin type 1-like (TSP-1) repeats (TSR) (Kawase, Nishikawa et 
al. 2010), the chitin binding like (CBL) domain (Garcia-Reguet, Lebrun et al. 2000) 
and epidermal growth factor (EGF)-like domains in TgMIC3 (Meissner, Reiss et al. 
2002) as well as the apple domains in TgMIC4 (Marchant, Sawmynaden et al. 2008).  
These domains show similarities with adhesive domains in proteins from higher 
eukaryotes (Sheiner, Santos et al. 2010).  
 
These multiple adhesive domains, if not engaged in host cell receptor binding, can 
interact with other microneme proteins to form stable adhesive complexes. These 
complexes work synergistically to facilitate host cell binding, often consisting of one 
or multiple adhesins and one or more transmembrane escorter proteins (Meissner, Reiss 
et al. 2002). TgMIC6, TgMIC8 and TgM2AP are escorters for the TgMIC1/MIC4, 
TgMIC3 and TgMIC2 adhesins respectively. Hence, it can be seen that there are three 
primary microneme protein complexes in T. gondii, the TgMIC1-MIC4-TgMIC6 
complex, the TgMIC2-TgM2AP complex and the TgMIC3-TgMIC8 complex (Cerede, 
Dubremetz et al. 2005). These complexes of micronemes are synthesized in the ER and 
travel through the secretory pathway until they are secreted.  
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Figure 1.5: Schematic representation of the three major microneme complexes in Toxoplasma 
gondii. Microneme proteins have a modular architecture made up of combinations of several common 
structural domains. These are the currently postulated compositions as reported in Harper et al. (2006) 
and Liu et al (2009) for TgMIC2/M2AP, Meissner et al (2002) and Cerede et al (2005) for 
TgMIC3/TgMIC8 and Meissner et al (2002), Opitz et al (2002) and Sawmynaden et al (2008) for 
TgMIC1/TgMIC4/TgMIC6.  
  
 35 
 
1.4.2 TgMIC2-TgM2AP complex 
 
It has been postulated that TRAP and homologues of TRAP like TgMIC2 in T. gondii 
play an instrumental role in invasion (Matuschewski, Nunes et al. 2002). The TgMIC2-
TgM2AP complex is highly conserved in apicomplexan parasites and is present during 
all stages of the Toxoplasma life-cycle. Along with TgMIC3 and TgMIC8, TgMIC2 is 
expressed at the tachyzoite stage in the T. gondii life-cycle (Garcia-Reguet, Lebrun et 
al. 2000; Cerede, Dubremetz et al. 2002). Knockout of TgMIC2 is lethal for T. gondii, 
and reduced expression results in misrecognition of host-cell receptors and attenuated 
invasion. This indicates that TgMIC2 has an important role to play in facilitating 
parasite motility and virulence (Huynh and Carruthers 2004).  
 
TgMIC2 is a 769 amino-acid TRAP-like protein with two extracellular domains, a von 
Willebrand Factor A-Integrin like A/I domain and one degenerate and five conserved 
TSP-1 repeats, a transmembrane domain and a short cytoplasmic tail (Brossier and 
David Sibley 2005). It is likely that TgMIC2 adopts a rod like structure with the A/I 
domain capping the rod formed by the six TSR domains. The cytoplasmic Carboxyl-
Terminal Domain (CTD) of TgMIC2 contains 2 motifs essential for the targeting of 
TgMIC2 to the micronemes, SYHYY and EIEYE (di Cristina et al. 2000). Mutation of 
Lysine 692, eleven amino acids upstream of the TgMIC2 TMD, inhibits the cleavage 
of TgMIC2 by a rhomboid protease (Carruthers, Sherman et al. 2000; Brossier, Jewett 
et al. 2003; Starnes, Jewett et al. 2006).  
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Figure 1.6:  Crystal structure of TgMIC2 A/I domain. The crystal structure of TgMIC2 A/I domain 
was solved by X-Ray crystallography to a resolution of 2.05Å. TgMIC2 A/I domain exhibits a typical 
Rossman fold with a central twisted beta sheet arrangement flanked by five α-helixes. The conserved 
MIDAS domain is made up of five residues, Asp 82, Ser 84, Ser 86, Thr 155, and Asp 188 (red). The 
protein samples were produced via expression in insect cells. PDB accession number: 2XGG 
 
 
 
 
 
 
Figure 1.7: Crystal structure of human TSP-1. There is currently no structure available for a TSP-1 
like domain from toxoplasma. However, the structure for human TSP-1 has been solved via X-ray 
crystallography to a resolution of 1.90Å. The core of the structure of TSP-1 made up of three strands 
with two of the strands forming well-ordered β-strands. The other strand adopts a rippled conformation. 
The protein samples were produced via expression in insect cells. PDB accession number: 1LSL 
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Both the A/I domain and the TSR-1 region have been implicated in adhesion, however, 
the relative contribution from the two domains remains unknown (Liu, Sawmynaden et 
al. 2009). TgMIC2 interacts with TgMIC2-associated protein (TgM2AP) to form a 
complex. It has been postulated that TgMIC2 and TgM2AP form a hexameric complex 
with 3  dimers (Jewett and Sibley 2004). Data also suggests that this association is 
necessary for the correct delivery of TgMIC2 to the micronemes.  
 
The A/I domain in other proteins such as integrin  subunits and von Willebrand Factor 
(vWF A) has been shown to bind to substrates such as collagens, laminins and 
fibrionectins. In addition, the A/I domain also contains a cation binding site known as 
the  metal ion independent adhesion site (MIDAS) motif which consists of 5 conserved 
residues Asp-X-Ser-X-Ser. However it has been postulated that cation-binding to the 
MIDAS domain is non-essential for adhesive interactions.  Structural studies (Fig. 1.6) 
have revealed that the TgMIC2A/I domain has a unique Gly185 residue that could 
stabilize the conformation of the nonfunctional MIDAS domain and cause it to lose its 
cation-binding capacity (Tonkin, Grujic et al. 2010).   
 
Conversely, multimerization of the A/I domain has been demonstrated to be required 
for binding to heparin and human fibroblast cells (Harper, Hoff et al. 2004). The 
analysis of the crystal structure of the A/I domain (Fig. 1.6) has shown that there is a 
small basic patch formed from helices 3,4 and5 on the TgMIC2A/I surface that could 
be a putative heparin binding site, however no heparin binding was observed with 
monomeric or dimeric TgMIC2A/I (Tonkin, Grujic et al. 2010).  
 
The TSP repeats have been shown to interact with several ligands, including gags and 
HIV gp120. The crystal structure has been solved from human TSP-1 (Fig. 1.7) and 
contains 3 anti-parallel strands with two of the strands forming well-ordered β-strands 
and the other adopting a rippled conformation (Tan, Duquette et al. 2002). 
 
1.4.3 TgMIC3-TgMIC8 Complex 
 
Individual knockout of TgMIC1 and TgMIC3 only slightly decreased parasite 
infectivity whilst double knockout of both genes severely attenuated the ability of the 
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parasite to infect mice (Cerede, Dubremetz et al. 2005). These findings support the 
hypothesis that T. gondii has evolved multiple routes of host-cell attachment and that 
multiple proteins play a synergistic role in the polyxenous infectivity of T. gondii.  
 
TgMIC3 is an 37.9kDa protein with an N-terminal chitin-binding-like domain with 
three tandem repeated EGF domains (EGF234),  with two degenerate EGF domains 
(EGF1, EGF5)  that overlap with the others as well as a dimerization domain within the 
C-terminal 66 residues (Achbarou, Mercereau-Puijalon et al. 1991; Garcia-Reguet, 
Lebrun et al. 2000). The CBL has been found in lectins and plant chitinases and has 
been known to take part in both protein-protein and protein-carbohydrate interactions. 
The CBL has been shown to be involved in binding to host cells and the EGF domains 
have been shown to play an important role in the targeting of TgMIC3 to the 
micronemes (El Hajj, Papoin et al. 2008). In-depth analysis of TgMIC3 has been carried 
out, however the domain boundaries remain unclear (Cerede, Dubremetz et al. 2005). 
 
Dimerization of TgMIC3 is required for it to function as an adhesin (Cerede, Dubremetz 
et al. 2002) in addition, dimerization has been shown to involve protein-protein 
interaction rather than inter-chain disulphide links or common protein-protein 
dimerization motifs i.e.  leucine-zipper.  
 
TgMIC3 has been shown to interact with TgMIC8 and similarly to the 
TgMIC2/TgM2AP complex, TgMIC8 was postulated to be an escorter for the TgMIC3 
adhesin (Meissner, Reiss et al. 2002). However, recent studies have indicated that 
TgMIC3 does not exhibit mistargeting in the absence of TgMIC8 and no build-up of 
TgMIC3 was found in early endosomes in strains with overexpressing TgMIC8. 
Although the exact function and mechanism of action of TgMIC8 remains inconclusive, 
TgMIC8 has been shown to play an essential step in the formation of the MJ and has 
been postulated to be involved in a signalling cascade that leads to both RON and ROP 
secretion (Kessler, Herm-Gotz et al. 2008). Structural information has not been 
available for the TgMIC3/TgMIC8 complex.  
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1.4.4 TgMic1-TgMic4-TgMic6 Complex 
 
In T. gondii, TgMIC4 (63kDa) is known to form a complex with TgMIC1 (48.7kDa) 
and TgMIC6 (36.7kDa) which is important in host-cell invasion (Ferguson, Brecht et 
al. 2000; Cerede, Dubremetz et al. 2005). Co-immunoprecipitation and western blot 
analyses have indicated that TgMIC1 interacts with both TgMIC4 and TgMIC6, 
TgMIC4 and TgMIC6 do not directly interact with each other (Reiss, Viebig et al. 
2001). TgMIC6 interacts with aldolase and couples the cell surface adhesins with the 
parasite actin-myosin motor (Zheng, He et al. 2009). 
 
TgMIC1 has been identified as an important host-cell binding protein The N-terminal 
Micronemal Adhesive Repeat (MAR) -Regions from TgMIC1 have been shown to bind 
to a wide variety of sialylated oligosaccharides.  In addition, TgMIC1 is also able to 
differentiate between different oligosaccharide linkages, which could possibly explain 
both its polyxenous nature as well as its varying virulence in distinct host species 
(Blumenschein, Friedrich et al. 2007; Garnett, Liu et al. 2009).  
 
TgMIC4 consists of six Apple domains. The Apple domain is a subdomain of the 
PAN_Ap family of domains, which contain four conserved cysteines giving rise to two 
internal disulphide bridges. In Apple domains, two additional cysteine residues flanking 
the four found in PAN domains form a further disulphide bridge. It is known that C-
terminal domains bind the host-cell (Reiss, Viebig et al. 2001) and the N-terminal 
domains bind to the 2 MAR domains of MIC1. The first and second apple domains of 
TgMIC4 have been assigned via NMR as a pair (Fig. 1.8B) whilst apple-5 has been 
assigned as a single domain (Fig. 1.8A). The apple-5 domain from TgMIC4 has been 
shown to bind galactose strongly. It has been proposed that the galactose binding could 
possibly help in the evasion of the galectin-activated host immune system (Marchant, 
Cowper et al. 2012).   
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Figure 1.8: Structure of the apple domains from TgMIC4. A: This shows the NMR structure of the 
apple-5 domain from TgMIC4. PDB accession number 2LL3. B: This shows the NMR structure of the 
apple-1 and apple-2 domain pair from TgMIC4. PDB accession number 4A5V.  The apple domain is a 
subdomain of the PAN_Ap family of domains and has been predicted to have protein/carbohydrate 
binding capabilities. The apple-5 domain from TgMIC4 has recently been shown to bind galactose.  The 
protein sample was produced using an E.coli expression system.  
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1.5 Aims of Project 
 
Toxoplasmosis is a wide-ranging and pervasive pathogen with a large socioeconomic 
cost. T. gondii micronemes and rhoptry proteins play a pivotal role in host-cell 
attachment and invasion and serve as a tempting target for therapeutic solutions. In 
addition, T. gondii is phylogenically interesting and would serve as an ideal basis to 
understand other apicomplexan microorganisms. There is still a distinct lack of 
structural data for these proteins and the biological processes that they facilitate and 
information regarding these topics would be invaluable for the understanding of 
Toxoplasmosis.  
 
Our lab has focused upon the investigation of adhesins from T. gondii via both NMR 
and X-ray crystallography. Due to the highly cysteine-rich nature of the proteins of 
interest, specialized methods were needed for the production of suitable material such 
as the use of thioredoxin tags, extensive refolding and specialized E. coli strains 
(Saouros, Blumenschein et al. 2007). We have achieved some success utilizing E. coli 
as our primary expression system to obtain isotopically enriched protein samples for 
structural studies for various proteins and protein domains such as TgM2AP, TgMIC4 
apple domains, TSR12 domain pairs from MIC2 as well as MIC1 (Marchant, 
Sawmynaden et al. 2008; Saouros, Sawmynaden et al. 2008; Sawmynaden, Saouros et 
al. 2008; Liu, Sawmynaden et al. 2009).  
 
However, many of the most interesting proteins such as the ROMs, RONs as well as 
other microneme proteins such as TgMIC3 and TgMIC4 have not been expressed 
successfully in E. coli. The binding of TgM2AP to TgMIC2 is a key determinant for 
the correct targeting of TgMIC2 to the parasite surface and subsequent successful 
invasion, however, the exact location and nature of the interacting surfaces between the 
two proteins are currently unknown. The dimerization of TgMIC3 is required for its 
biological function and involves a novel dimerization domain. Our lab has produced 
resonance assignments for single and paired apple domains from TgMIC4, however, it 
is still unclear as to the exact overall configuration of the apple domains. Attempts at 
generating soluble, folded proteins samples for these projects have so far been 
unsuccessful even after extensive screening of experimental parameters, host cells, tags 
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and purification conditions. The generation and use of pure, folded, monodisperse, 
soluble protein samples presents a significant roadblock in the effort to understand the 
invasion mechanisms of T. gondii.  
 
We believe that the use of E. coli as an expression system for the production of adhesins 
from T. gondii has reached the extent of its capabilities and other alternative expression 
systems such as P. pastoris, insect cells or mammalian cell expression should be 
investigated. Due to the relatively similar molecular biological techniques needed for 
E. coli and P. pastoris, P. pastoris was seen as the natural step to take to expand the 
range of techniques available for protein production within the lab.   
 
Using P. pastoris, a eukaryotic microorganism, as the primary expression system, this 
project aims to generate suitable protein samples for the structural determination of 
Apicomplexan microneme proteins. The protocol developed should be adaptable for 
both isotopic enrichment for NMR as well as heavy metal labeling (i.e. 
selenomethionine labelling) for X-Ray crystallography. As a first step, we aim to 
produce folded samples of TgMIC3 and TgMIC4 for structural study via either NMR 
or X-Ray Crystallography.  
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Chapter 2  
Cloning and construct design  
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2.1 Introduction 
 
The generation of a viable protein sample for structural analysis begins with the cloning 
of a set of constructs that aims to encompass the scientifically interesting domains of 
the protein in questions. This is usually achieved through the use of prior research as 
well as bioinformatics prediction tools to identify areas of significant secondary 
structure or areas of significant homology to domains of other proteins.   
 
As explained in section 1.4.1, Microneme proteins from T. gondii are modular and 
typically made up of well-defined domains with significant structural homology to the 
same domains in other proteins. These are used in our laboratory as convenient initial 
domain boundaries for cloning and subsequent structural study via NMR as full length 
proteins are typically too large for structural elucidation via NMR.  
 
Prior work on TgMIC2 has been on the escorter of TgMIC2, the TRAP homologue, 
M2AP. The location and nature of the interaction between M2AP and TgMIC2 is the 
current focus of our studies and as such, the TSP-1 pairs within the TSR region of 
TgMIC2 is the current focus of our work. Work on the TSR56 pair has revealed that 
the pair exhibits significant flexibility and variations of the boundaries specified in 
literature were explored to attempt to find a structured construct.  
 
Previous work on TgMIC3 in E. coli has been unsuccessful in producing a structured 
protein sample. TgMIC3 has several scientifically interesting domains, including the 
CBL domain which could be the primary domain involved in cell-surface recognition 
and adhesion as well as a putative dimerization domain which has no structural 
homologue and is postulated to exhibit a novel dimerization mechanism. However, the 
process of domain scanning is complicated by the degenerate EGF1 and EGF5 domains 
which flank the EGF core. The degenerate EGF domains overlap with EGF2 and EGF4, 
are not perfect homologues of an EGF domain and have unclear domain boundaries.  
 
Our lab has conducted extensive work on TgMIC4 and the structure of several of the 
apple domains have been solved successfully through NMR. However, the overall 
conformation of the apple domains remains unknown and a full length protein sample 
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was sought to resolve this. Prior trials in E. coli have not resulted in a viable protein 
sample.   
 
Cloning into E. coli is relatively straightforward, with a large number of commercially 
available kits to suit a variety of purposes. Cloning into E. coli in this project was 
simplified by the use of the Ligation Independent Cloning (LIC) system in the 
commercially available pET32-Xa/LIC kit. This allows for the addition of a thioredoxin 
tag which has been shown to help in the production of structured microneme protein 
samples which have high cysteine contents (Saouros, Blumenschein et al. 2007). 
Cloning into P. pastoris is conversely more limited in its scope, with a limited selection 
of plasmids and kits for cloning. Cloning into P. pastoris in this project made use of 
traditional cloning techniques, without the use of the LIC system.  
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2.2 Materials and Methods 
 
2.2.1 Chemicals and laboratory substances  
 
Chemicals and materials used were obtained from Invitrogen, Merck, Fisher Scientific 
and Sigma-Aldrich. Buffers were prepared with deionised water passed through a 
Millipore automated water purification system.  
 
2.2.2 Media 
 
All liquid media was autoclaved before use and stored at room temperature. Agar plates 
were stored at 4°C. Luria-Bertani (LB) broth was made up of 1% (w/v) tryptone, 0.5% 
(w/v) yeast extract, and 0.5% (w/v) NaCl in distilled water. LB agar was was made up 
of 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1.0% (w/v) NaCl and 2% agar in 
distilled water. Antibiotics were added as needed to a final concentration of 50 mg/ml 
(Carbenecillin), 15 mg/ml (Kanamycin), 12.5 mg/ml (Tetracyclin). Concentrations for 
Zeocin™ and Geneticin® varied depending on the experimental parameters desired.  
 
2.2.3 Escherichia coli Strains 
 
Novablue (DE3) were used primarily for cloning and plasmid purification due to its 
high transformation efficiency and production of high quality plasmids. The Novablue 
(DE3) strain contains mutations in the genes endA and recA which eliminates 
endonuclease I activity and eliminates general recombinase activity and hence reduced 
the chance of plasmid multimer formation respectively.  
 
Novablue (DE3) also contains a λ prophage carrying the T7 RNA polymerase gene and 
lacIq. This allows for the repression of plasmid-carried T7 promoter driven expression 
until induction with isopropyl β-D-1-thiogalactopyranoside (IPTG).  
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2.2.4 Construct Design 
 
Ligation-Independent Cloning (LIC) was used throughout the cloning process for 
expression in E. coli and thus all primers were designed to result in short LIC 
compatible overhangs and obtained from Invitrogen. The LIC system allows for cloning 
without the need for ligation or restriction enzymes, instead replacing them with the the 
3’  5’ exonuclease activity of T4 DNA polymerase. Polymerase Chain Reaction 
(PCR) products were obtained via PCR with a TgMIC2 cDNA template and the 
respective LIC compatible primers.  
 
For expression into P. pastoris oligonucleotides were designed to incorporate a 5’ ClaI 
site and a 3’ XbaI site for restriction enzyme cloning into pPICZa . The oligonucleotides 
add 8 amino acid residues between the tag and the gene-of-interest.  
 
PCR was conducted using either Pfu (Qiagen) or KOD (Novagen) DNA P and carried 
out as per manufacturer’s protocols for the relevant enzymes and desired insert lengths. 
50 μl PCR reactions were performed in a Mastercycler Gradient (Eppendorf) using the 
thermal cycling conditions summarized in Table 2.1. 
 
cDNA for TgMIC2 were obtained from Liu Bing (Imperial College London) in pGEM 
vectors. cDNA for TgMIC3, TgROM1, TgROM4 and TgROM5 were obtained from 
Dominique Soldati (Imperial College London) in pGEM vectors. cDNA for TgMIC4 
was obtained from Ben Cowper (Imperial College London).  
  
2.2.5 Agarose gel electrophoresis 
 
The purity and concentration of the PCR product was assessed via electrophoresis using 
a 1% agarose gel. 1% (w/v) agarose powder was added to 100 ml of 1X TAE buffer 
(0.484% (w/v) Tris-base, 1.142% (v/v) glacial acetic acid, and 0.029224% (w/v) 
EDTA) and dissolved by heating in a microwave oven for 3 minutes with periodic 
agitation every 30 seconds in a 250 ml  glass flask. When the agarose gel solution was 
cooled to 50 °C, 10 µl of SYBR® Safe DNA gel stain (Invitrogen) was added to the 
agarose gel solution and the mixture poured into a gel caster. 5 µl of the PCR products 
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were loaded into each well and run at 25 V until the dye front has migrated the length 
of the gel. Agarose gels were visualised using a UV Transilluminator (Syngene).   The 
PCR products were purified using a QIAquick Gel Extraction kit (Qiagen) to remove 
the excess dNTPs and the original pGEM vector. Quantification of purified DNA 
samples was conducted sing a NanoDrop 3300 (Thermo Scientific). 
 
The PCR product was then prepared as per manufacturers protocols for the respective 
Xa/LIC kit to generate LIC compatible overhangs.  
 
2.2.6 Plasmids  
 
2.2.6.1 Expression in Escherichia coli 
 
The pET vector series (Merck) for cloning was extensively used throughout the cloning 
process. The two major vectors used were the pET-32 Xa/LIC vector and the pET-30 
Xa/LIC vector (Fig 2.1). The pET-32 Xa/LIC vector fuses the target protein with a 
109aa thioredoxin (trx.tag) fusion partner. The vector also contains a His-tag and an S-
tag to facilitate purification. The thioredoxin fusion partner has been proven to enhance 
the proper formation of disulphide bonds in cysteines-rich proteins. The vector also 
contains a Factor Xa cleavage site (ile-glu/asp-gly-arg) for the easy removal of the 
fusion partner and His-tag from the target protein.  
 
The pET-30 Xa/LIC vector contains a His-tag and an S-tag without the thioredoxin 
fusion partner. It is primarily used for the expression of the target protein when the 
action of thioredoxin would be undesirable. The pET-30 Xa/LIC vector also has a 
Factor Xa Cleavage site which allows for the removal of the His-tag and S-tags.  
 49 
 
 
Step Pfu KOD  
Temperature (°C) Time No. of Cycles Temperature (°C) Time No. of Cycles 
Initial Denaturation 94 2 min 1 94 2 min 1 
Denaturation 94 1 min 30 94 15 sec 30 
Annealing 55 30 sec 60 30 sec 
Extension 72 2 min 72 1 min 
Final Extension 72 5 min 1 72 5 min 1 
Soak 4 indefinite 1 4 indefinite 1 
 
Table 2.1: Temperature cycling conditions for PCR. PCR reactions were conducted in 50µl volumes using either Pfu or KOD polymerase. Initial annealing temperature was 
set at 55 °C but varied if the PCR reaction was problematic according to the theoretical Tm of the primer pair. 
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Figure 2.1: Cloning/expression region of pET-30 Xa/LIC and pET-32 Xa/LIC (Novagen). The 
plasmids pET-30 Xa/LIC and pET-32 Xa/LIC were used to reduce process error due to ligation. pET-32 
Xa/LIC allows for the production of a thioredoxin fusion protein with a Factor Xa cleavage site that 
allows for removal of the thioredoxin tag. Thioredoxin aids in the proper folding of cysteine-rich proteins. 
Use of the lac operator in both plasmids allow for highly-regulated inducible expression using IPTG in 
E. coli. Figure adapted from Novagen manual for pET-30 Xa/LIC and pET-32 Xa/LIC kits.  
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2.2.6.2 Expression in Pichia pastoris 
 
For expression in P. pastoris, the pPICZα A vector (Invitrogen) and the pPIC9k vector 
(Invitrogen) were used (Fig 2.2).  
 
The pPICZα A vector contains the S. cerevisiae α-factor secretion signa (Fig 2.3). This 
allows for the secretion of folded proteins from P. pastoris. The vector also contains a 
C-terminal myc epitope tag that allows for detection of low levels of protein expression 
through western blot. The presence of a C-terminal polyhistidine tag also allows for 
purification of the target protein through metal affinity chromatography. SacI and PmeI 
restriction sites are also present at the aox1 locus to allow for linearization of the 
plasmid and integration by homologous integration. The pPICZα A vector also contains 
the Zeocin™ resistance (Sh ble) gene which can be used to select for transformants.  
 
The pPIC9k vector also contains the S. cerevisiae α-factor secretion signal (Fig 2.4). 
The presence of a C-terminal polyhistidine tag also allows for purification of the target 
protein through metal affinity chromatography. SacI, SalI and BglII restriction sites are 
also present at the aox1 locus to allow for linearization of the plasmid and integration 
by homologous integration. The pPIC9k vector contains the kanamycin resistance gene, 
which results in low expression levels and hence results in the need for multicopy 
integrants.  Resistance to Geneticin® (G418) conferred on the strain is dose-dependent 
and allows for selection of multicopy integrants based on the concentration that strains 
are resistant towards.   
 
Choice of SacI, SalI and BglII restriction sites allows for directed integration of the 
gene into specific loci (i.e. within the AOX1 or HIS4 genes) in the yeast genome to 
generate different phenotypes in the yeast cell strains.  
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Figure 2.2: cloning/expression region of pPICZα and pPIC9k. Use of both the pPICZα and the 
pPIC9k plasmid allow for pAOX1 regulated expression of heterologous protein. The pPICZα plasmid 
confers Zeocin™ resistance to successful transformants via the sh ble gene whereas the pPIC9k plasmid 
confers geneticin® (G418) resistance to successful transformants via the kanR gene. The addition of the 
α-factor signal sequence allows for secreted expression and the Kex2 cleavage site allows for proper 
post-production processing of the signal sequence in both plasmids. pPICZα also encodes a c-myc 
epitope and a his-tag to allow for verification and purification through western blot and IMAC. Plasmid 
diagrams adapted from plasmid manuals (Invitrogen) 
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Figure 2.3: Multiple Cloning Site of pPICZα A: The pPICZα A plasmid allows for soluble expression 
in P. pastoris. Constructs should be designed so that it is in frame and downstream of the α-factor signal 
sequence as well as with the C-terminal peptide. Alternative plasmids pPICZα B and C are available with 
+1 and +2 frame shifts to allow for flexibility in cloning. AT-rich regions can cause premature 
termination, as such, if AT-rich regions are present in the gene-of interest, changing the sequence to 
make it more amenable for expression in P. pastoris might be required for successful expression (Scorer, 
Buckholz et al. 1993). Plasmid diagrams adapted from plasmid manuals (Invitrogen) 
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Figure 2.4: Multiple Cloning Site of pPIC9k: The pPIC9k plasmid allows for soluble expression in P. 
pastoris. Constructs should be designed so that it is in frame and downstream of the α-factor signal 
sequence. AT-rich regions can cause premature termination, as such, if AT-rich regions are present in 
the gene-of interest, changing the sequence to make it more amenable for expression in P. pastoris might 
be required for successful expression (Scorer, Buckholz et al. 1993). Plasmid diagrams adapted from 
plasmid manuals (Invitrogen) 
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2.2.7 Plasmid sequencing 
 
Plasmids created were purified from 5 ml overnight LB cultures using a miniprep kit 
(Qiagen).  Samples were then sent for sequencing at Cogenics (UK).  
 
Plasmid DNA needed for P. pastoris transformation was purified from 100 ml 
overnight low-salt LB cultures using a midiprep kit (Qiagen). DNA was purified and 
desalted via isopropanol precipitation both prior to and after linearization with SacI. 10 
µl of 3 M Sodium Acetate solution was added to 50 µl of DNA sample followed by 40 
µl of isopropanol. The mixture was incubated for 1 hour at -80°C and centrifuged at 
15000 rpm (SS-34, Sorvall) for 30 minutes. The supernatant was removed,  the pellet 
washed with 70% ethanol and centrifuged at 15000 rpm (SS-34, Sorvall) for 30 
minutes. The DNA pellet was then resuspended in 10 µl sterile water. 
 
2.2.8 Competent cells and transformation 
 
2.2.8.1 Expression in Escherichia coli 
 
A 50 μl aliquot of purchased competent cells was thawed on ice. 100 ng of purified 
plasmid was added and mixed by flicking gently. Vials were incubated on ice for 30 
minutes with occasional agitation. Cells were then heat-shocked at 42 °C for 70 s and 
then incubated on ice for 2 minutes. 50 μl of the reaction mixture were spread onto LB 
agar plates containing appropriate antibiotics and incubated at 37 °C overnight.  
 
2.2.8.2 Expression in Pichia pastoris 
 
Competent cells for P. pastoris transformation were made fresh for every round of 
transformations. A single aliquot of the frozen stock was thawed on ice and used to 
inoculate 10 ml of YPD media and incubated overnight at 30 °C with constant agitation. 
100 µl of the overnight culture was then used to inoculate 500 ml of YPD media in an 
unbaffled flask and grown overnight (16-18 hours) to an OD600 of 1.3-1.5. Cells were 
pelleted by centrifugation at 1500 rpm (SLA-3000, Sorvall) for 5 minutes and 
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resuspended in 500 ml of sterile ice-cold water twice and finally in 20 ml of sterile ice-
cold 1 M sorbitol. The cells were centrifuged once more at 1500 rpm (SLA-3000, 
Sorvall) for 5 minutes and resuspended in 1ml of sterile ice-cold 1 M sorbitol.  
 
An 80 µl aliquot of competent cells were then mixed with 10 µg of linearized plasmid 
DNA in 10 µl of sterile water and transferred to a pre-chilled 0.2 cm electroporation 
cuvette (Bio-rad). The cells were then pulsed in a Bio-Rad Gene-Pulser II according to 
the manufacturer's recommended settings for yeast. 1 ml of 1 M sorbitol was 
immediately added to the electroporated cells and the cells incubated at 28 °C for 1 
hour without shaking. 1 ml of YPD media was then added to the cells and the cells 
incubated at 28 °C for 1 hour with shaking. 200 µl of transformed cells were then plated 
on 4 different plates containing 4 concentrations of Zeocin™, 100 mg/ml, 500 mg/ml, 
1000 mg/ml and 2000 mg/ml. The plates were then incubated at 28 °C for 3-6 days until 
colonies formed.  
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2.3 Results 
 
2.3.1 Construct Design for TgMIC2  
 
The full length TgMIC2 protein is a 769 amino acid protein made up of one vWF A 
domain, and five TSP-1 like domains with one less conserved TSP-1 like domain. 
TgMIC2 contains a 70 amino acid pro-peptide upstream of the A domain which is 
cleaved by a putative membrane-bound protease.  The boundaries of the first five TSP-
1 domains are relatively well delineated, however, TSR6 is less conserved than the 
other five and might not be a typical TSP-1 like domain.  
 
A typical TSP-1 domain contains six cysteine residues, however primary analysis of 
the existing clones of TSR5 shows that they only contain four cysteine residues. In 
addition, two cysteine residues were found a short distance from the starting residue 
532 of TSR5.  As for TSR6, the existing clone encompasses the predicted TSP-1 like 
region (598 to 648) whereas the cytoplasmic tail of TgMIC2 starts from residue 699. In 
an effort to produce suitable protein samples, new constructs encompassing the two 
cysteine residues and the extra residues to the start of the cytoplasmic tail were designed 
and produced. These new contracts were designated TSR5n, TSR6n, TSR5n6, 
TSR56_long and TSR5n6n (Table 2.2).  
 
After the successful expression of full-length extracellular domain constructs of MIC3 
and MIC4 in P. pastoris, it was thought that expression of longer domain constructs 
could be more amenable for success. These longer constructs were based upon the 
original domain boundaries and incorporated the entire TSP repeat region as well as the 
entire extracellular domain of TgMIC2. 
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Constructs Start end MW (kDa) pI Extinction coefficient (M-1 cm-1) 
A 73 270 21.706 6.07 17335 
12 271 402 14.018 4.60 29740 
56 532 648 13.182 5.48 30075 
123456 271 648 40.971 4.92 87940 
A 1,2 73 402 35.705 5.25 47075 
5n6 522 648 14.211 5.23 30200 
5n6n 522 698 19.253 4.70 29825 
56_long 532 698 18.224 4.76 30075 
 
Table 2.2: Table showing key parameters of newly constructed TgMIC2 constructs. Potential constructs were identified from secondary structure prediction and sequence 
analysis of the TgMIC2 protein. All constructs were cloned into pET32 Xa/LIC for expression in E. coli and selected constructs were cloned into both pPICZα A and pPIC9k 
for expression in P. pastoris. 
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Primer Name  Sequence 5’ - 3' 
AI_073F_MIC2_pET32Xa/LIC 1 GGTATTGAGGGTCGCAACCAGCTGGACATTTGCTT 
T1_271F_MIC2_pET32Xa/LIC 2 GGTATTGAGGGTCGCGCCATTTGCTCGGATTGG 
T5_532F_MIC2_pET32Xa/LIC 3 GGTATTGAGGGTCGCGAACGACCGGGGGAGTGG 
T5_522F_MIC2_pET32Xa/LIC 4 GGTATTGAGGGTCGCACTTGCAATCCTCAAGCGTG 
AI_270R_MIC2_pET32Xa/LIC 5 AGAGGAGAGTTAGAGCCTTAAATCCTGGGGGAGTGTCTTACA 
T2_402R_MIC2_pET32Xa/LIC 6 AGAGGAGAGTTAGAGCCTTAATATAGTTATGCAAGGAGCAAGAGTTG 
T6_648R_MIC2_pET32Xa/LIC 7 AGAGGAGAGTTAGAGCCTTAAATTTGTCTCGCCGCAGCT 
T6_698R_MIC2_pET32Xa/LIC 8 AGAGGAGAGTTAGAGCCTTAAGCCACTGCCTGACTCTTTCT 
S186F_MIC3_ekLIC 9 GACGACGACAAGATCTCCGAGGATCCTTGTTCAAAAAGAGGGAACGCGAAGTG 
G236R_MIC3_ekLIC 10 GAGGAGAAGCCCGGTAATCCAGTCCTCTTGCATCCTTGTC 
E294F_MIC3_ekLIC 11 GACGACGACAAGATGGAATTCGGCATCAGCGCGTCATCCTGCAAATGCGATAAC 
Q359R_MIC3_ekLIC 12 GAGGAGAAGCCCGGTAACTGCTTAATTTTCTCACACGTCACGGTGTGGGCATG 
 
Table 2.3: Table showing primers used for cloning in Escherichia coli. Sequences highlighted in red are sequences required for cloning using the LIC system. Sequences in 
black are sequences corresponding to the gene of interest.  
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2.3.2 Construct Design for TgMIC3 
 
TgMIC3 is part of an adhesive complex with TgMIC8 which is localized at the parasite 
surface during attachment and invasion. TgMIC3 is a 37.9 kDa protein with 359 amino 
acid residues consisting of an N-terminal chitin binding-like domain (CBL) and five 
putative overlapping epidermal growth factor-like (EGF) domains and a predicted pI of 
6.01 (Fig 2.5). The predominant amino acids are serine (12.5%), glycine (11.4%) and 
cysteine (9.5%). A C-terminal domain has also been identified as being critical for the 
dimerization of TgMIC3 termed the dimerization domain (DD) (El Hajj, Papoin et al. 
2008). Its secondary structure has been predicted to be comprised primarily of β-sheets 
which is consistent with the predicted presence of EGF domains (Reiss, Viebig et al. 
2001). A domain analysis of TgMIC3 has been conducted (Cerede, Dubremetz et al. 
2005), however domain boundaries remain unclear as it has been postulated that EGF1 
and EGF5 overlap with the CBL/EGF2 and EGF4/DD flanking domains respectively.  
 
TgMIC4 forms a complex with TgMIC1 and TgMIC6. TgMIC4 is a 63.1 kDa protein 
with 580 amino acid residues with a pI of 5.04 (Fig. 2.6). It adopts the modular structure 
common to most microneme proteins, made up of six apple domains. Cysteine residues 
make up 6.6% of its amino acid content. Each apple domain contains three conserved 
disulphide bonds that are a major contributor to the stabilization of its tertiary structure.  
 
Construct design for TgMIC3 was based upon the secondary structure prediction and 
location of cysteine residues whilst taking into account the overlapping domain 
boundaries and published analysis. In addition to the constructs for the single domain 
of CBL and the EGF234 core, a CBL/EGF2 construct that encompasses the possible 
overlapping EGF1 and an EGF234DD that encompasses the possible overlapping 
EGF5 were constructed in addition to a full length construct.  
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Figure 2.5: Secondary structure prediction and domain schematic of TgMIC3. This diagram shows 
the three predicted core EGF domains within TgMIC3 and its β-sheet composition. The core EGF 
domains are flanked by two degenerate EGF domains and cause some uncertainty as to the exact domain 
boundaries within the protein. Results shown were generated from InterProScan (Quevillon, Silventoinen 
et al. 2005) and the PSIPRED server (Buchan, Ward et al. 2010). The predicted N-glycosylation site is 
highlighted on the sequence in red (See Fig 2.7). 
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Figure 2.6: Secondary structure prediction and domain schematic of TgMIC4. This diagram shows 
the six predicted apple domains within TgMIC4. The apple domains have five β-strands neighboring a 
single helix. Results shown were generated from InterProScan (Quevillon, Silventoinen et al. 2005) and 
the PSIPRED server (Buchan, Ward et al. 2010). The predicted N-glycosylation site is highlighted on 
the sequence in red (See Fig 2.8)
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Table 2.4: Pichia pastoris constructs. This table shows the constructs tested for expression in P. pastoris along with the starting and ending residues of each construct. 
Constructs were designed from TgMIC2 and TgMIC3, TgMIC6 and were cloned into both pPICZα A and pPIC9k. TgMIC4 was supplied as a pPIC9k plasmid. Domain 
boundaries were identified from sequence analysis, secondary structure prediction and existing studies.  
  
Protein name Start end MW (kDa) pI Extinction coefficient (M-1 cm-1) 
TgMIC3-CBL 67 146 8.512 7.45 10595 
TgMIC3-CBL/EGF2 (CE2) 67 189 13.006 6.03 10970 
TgMIC3-EGF234 146 290 15.200 4.97 5595 
TgMIC3-EGF234/DD 146 359 22.422 5.72 10315 
TgMIC3-Full Length 67 359 30.828 6.00 20910 
TgMIC4-Full Length 26 580 60.355 4.94 47060 
TSR56_long (TgMIC2) 522 698 19.253 4.70 30200 
TSR56_short (TgMIC2) 529 698 18.535 4.70 30075 
TgMIC2-TR (271-648) 271 648 40.971 4.92 86940 
TgMIC2-TR (271-698) 271 698 46.014 4.74 86940 
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Primer Name  Sequence 5’ - 3' 
CBLD_067F_MIC3_ pPICZa 1 GTCAATATCGATATCCCCCAGCAAGCAGGAGACGCAACTCTGTG 
EGF1_146F_MIC3_ pPICZa 2 GACATAATCGATCAGCTGTGAAAAGCAGGGCCATCGGTGCGAC 
CBLD_146R_MIC3_pPICZa_ext1 3 GTCATCGTCATCGGAACCGCTGCAGTCTCCTCCATAGCTTTTGTCAGGATGGTAG 
CBLD_146R_ MIC3_pPICZa_ext2  4 GTGACTTCTAGACCCTTGTCATCGTCATCGGAACCGCTGCAGTCTC 
EGF2_189R_MIC3_pPICZa_ext1 5 GTCATCGTCATCGGAACCAGGATCCTCGGAGCAAGTCAACCCAGTGCCGACGAAG 
EGF2_189R_MIC3_pPICZa_ext2 6 GTCACTTCTAGACCCTTGTCATCGTCATCGGAACCAGGATCCTC 
EGF5_290R_MIC3_pPICZa_ext1 7 GTCATCGTCATCGGAACCTTTCTCAGCCAGCGTGACTTCGACTC 
EGF5_290R_ MIC3_pPICZa_ext2  8 GTCACTTCTAGACCCTTGTCATCGTCATCGGAACCTTTCTCAGCCAG 
DD_359R_MIC3_pPICZa_ext1  9 GTCATCGTCATCGGAACCCTGCTTAATTTTCTCACACGTCACGGTGTGGGCAT 
DD_359R_ MIC3_pPICZa_ext2 10 GTCACTTCTAGACCCTTGTCATCGTCATCGGAACCCTGCTTAATTTTCTC 
TR_271F_MIC2_ pPICZa 11 GTCAATATCGATGCCATTTGCTCGGATTGGTCCGCATGGAGCCCC 
TR_648R_MIC2_pPICZa_ext1 12 GTCATCGTCATCGGAACCATTTGTCTCGCCGCAGCTGCATGCTTTCGTTTCAAA 
TR_648R_MIC2_pPICZa_ext2 13 GTGACTTCTAGACCCTTGTCATCGTCATCGGAACCATTTGTCTCGC 
TR_698R_MIC2_pPICZa_ext1 14 GTCATCGTCATCGGAACCGCCACTGCCTGACTCTTTCTTGGACTGTTCTCCCTC 
TR_698R_MIC2_pPICZa_ext2 15 GTGACTTCTAGACCCTTGTCATCGTCATCGGAACCGCCACTGCCTGACT 
 
 
Table 2.5: Table showing primers used for cloning in Pichia pastoris. Sequences highlighted in red are restriction enzyme sequences required for cloning (ClaI for forward 
primers and.XhoI for reverse primers). Sequences highlighted in yellow correspond to the gene of interest.  
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Figure 2.7: N- and O- glycosylation site prediction of TgMIC3. This is a graphical representation of 
the predicted N- and O- glycosylation sites within TgMIC3. The presence of N-glycosylation sites can 
indicate the potential for hyperglycosylation. There is one predicted N-glycosylation site at N202 within 
TgMIC3. The diagram was generated through the use of the NetOGlyc 3.1 Server and the NetNGlyc 1.0 
Server (Julenius, Molgaard et al. 2005). 
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Figure 2.8: N- and O- glycosylation site prediction of TgMIC4. This is a graphical representation of 
the predicted N- and O- glycosylation sites within TgMIC4. The presence of N-glycosylation sites can 
indicate the potential for hyperglycosylation. There is one predicted N-glycosylation site at N55 within 
TgMIC4. The diagram was generated through the use of the NetOGlyc 3.1 Server and the NetNGlyc 1.0 
Server (Julenius, Molgaard et al. 2005). 
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Glycosylation prediction software has determined that there is an N-glycosylation site 
(NGTC) starting from N202 which would affect the TgMIC3-EGF234, TgMIC3-
EGF234/DD or the full length TgMIC3 constructs. In addition, there is an N-
glycosylation site (NVTS) within the TgMIC4 full length construct. This could result 
in possible hyperglycosylation of the protein sample. Conversely, glycosylation of the 
protein could be required for its proper folding and could increase the thermostability 
of the protein sample.  
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Chapter 3 
The expression of microneme proteins 
in Escherichia coli and Pichia pastoris 
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3.1 Introduction 
 
The very first consideration for a high-quality protein sample is the ability for a 
substantial amount of purified homogenous material to be produced and purified in a 
single batch. E. coli has been the primary expression system of choice for structural 
biology due to its ease of use, familiarity and the presence of an extensive body of 
knowledge regarding its biological processes.  
 
TgMIC2 is one of the central proteins involved in parasite invasion. It has been 
implicated in host-cell recognition as well as interactions with the intracellular action-
myosin motor. However, only limited structural information regarding its interactions 
are available. The A domain of TgMIC2 has been solved via X-Ray crystallography to 
a resolution of 2.05 Å but the structure of the TSP-repeat region (TSR) of TgMIC2 
remains unresolved. The crystal structure of human Trombospondin-1 (TSP1) has been 
solved to a resolution of 1.90 Å. The A-domain has been postulated to bind the host-
cell whilst the C-terminal TSR domains have been implicated in binding to its 
postulated escorter protein, TgM2AP.  
 
Previous work in the group was focused on obtaining a high-quality structure of 
TgM2AP (Liu Bing et al.). The project then moved on to the binding partner of 
TgM2AP, TgMIC2. According to our collaborators, the primary domains involved in 
binding TgM2AP were the TSR56 pair. In addition, TSR 6 was noted to be a degenerate 
TSP-1 domain.  The initial primary focus of our work on TgMIC2 was to obtain 
structural data for the TSP-1 domains as well as to identify and characterize the nature 
and location of the interactions with its exporter TgM2AP.   
 
Apicomplexan microneme proteins such as TgMIC2, TgMIC3 and TgMIC4 pose some 
unique problems during the generation of protein samples. Microneme proteins in 
general have a higher proportion of cysteine residues and disulphide bonds and require 
additional processing and/or co-expression of chaperones for production of folded 
protein. Using a eukaryotic expression system like P. pastoris has the potential to 
eliminate these needs.  
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However, adoption of eukaryotic expression systems can be slow due to the longer 
experimental time frame, unfamiliarity with the more complex protocol optimisation 
process, the lack of information regarding the protein production processes and the 
relative paucity of mutant expression strains for specialised applications. Although P. 
pastoris has been used as an expression system for the last decade, it has never been 
investigated for its suitability for Apicomplexan microneme proteins.  
 
This chapter describes the initial work done to characterize the role of TSR pairs in 
binding to M2AP as well as the attempts to produce a folded homogenous sample that 
would yield high-quality NMR spectra that could be used for resonance assignments. 
This chapter also illustrates the primary reasons for the shift to a eukaryotic expression 
system and the application of the improved protocol to the original TgMIC2 constructs.  
 
This chapter describes the expression of the various constructs for protein expression 
in both P. pastoris and E. coli expression systems to produce stable, pure, homogenous 
protein samples in quantities sufficient for structural analysis via both NMR and X-ray 
crystallography.  
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3.2 The Pichia pastoris expression system 
 
3.2.1 History of Pichia pastoris 
 
The first discovery of yeast species that utilised methanol as a sole carbon and energy 
source was by Koichi Ogata in 1969 (Ogata, Nishikawa et al. 1969). In the early 1970s, 
taking advantage of the relatively low cost of synthesizing methanol from natural gas, 
the Phillips Petroleum Company developed the media and methods for the production 
of single cell protein for use in low-cost animal feed (Buckholz and Gleeson 1991).  
However, due to the increasing cost of natural gas in the late 1970s, the focus eventually 
shifted to the development of Pichia pastoris as a new expression system for the 
production of heterologous recombinant protein using the newly isolated AOX1 
promoter.  
 
The origin of the P. pastoris expression system as an industrial system for protein 
production at high cell densities as well as the similarity of its handling techniques to 
those of Saccharomyces cerevisiae has allowed for its increasing popularity as the 
lower eukaryotic host for the production of heterologous recombinant proteins.  
 
3.2.2 Physiology of Pichia pastoris  
 
P. pastoris is a single-celled eukaryotic organism. It is a methylotrophic organism, 
allowing the use of methanol as the sole carbon and energy source. Its eukaryotic nature 
also allows it to undertake many post-translational modifications such as proteolytic 
processing, folding, disulphide bond formation and glycosylation (Cregg, Cereghino et 
al. 2000). Since the early 1990s, P. pastoris has been experiencing an increase in 
popularity as an expression system with over 1000 recombinant proteins reported to 
have been expressed (Cereghino and Cregg 2000; Lin-Cereghino and Lin-Cereghino 
2007) with expression levels as high as 80% total secreted protein or 30% total cell 
protein (Cregg, Vedvick et al. 1993).  
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3.2.2.1 Metabolism of methanol by Pichia pastoris  
 
P. pastoris can be cultured in cell suspensions with methanol concentrations that would 
prove toxic to most other microorganisms. The metabolism of methanol takes place in 
the peroxisome and starts with the oxidisation of methanol to formaldehyde using 
molecular oxygen by alcohol oxidase (AOX). Alcohol oxidase is a 600kDa peroxisomal 
flavoprotein with 8 subunits, these subunits each are non-covalently associated with 
one FAD or modified FAD group (van der Klei, Harder et al. 1991).  P. pastoris has 
been known to adjust the number and volume fraction of peroxisomes in response to 
changes in external conditions. The conversion of methanol to formaldehyde is the rate-
limited step in the utilization of methanol. AOX has a low affinity for molecular 
oxygen, and large amounts of the enzyme are produced by P. pastoris to compensate. 
The formaldehyde produced is shunted into one of 2 possible pathways, the methanol 
assimilatory pathway and the dissimilatory pathway (Duff and Murray 1988; Hartner 
and Glieder 2006; Sola, Jouhten et al. 2007; Vanz, Lunsdorf et al. 2012) (Fig 3.1).  
 
The assimilatory pathway allows for the generation of biomass and is catalysed by the 
activation of peroxisomal dihydroxyacetone synthease (DHAS). DHAS allows for the 
conversion of formaldehyde and D-xylulose 5-phosphate into dihydroxyacetone (DHA) 
and glyceraldehyde-3-phosphate (GAP). Dihydroxyacetone synthase (DHAS) and 
triose phosphate isomerase (TPI1) convert DHA and GAP respectively into 
dihydroxyacetone phosphate (DHAP). DHAP is converted into GAP through the action 
of fructose 1, 6 bisphosphate aldolase 1 and 2 (FBA1, 2) and fructose-1,6-
bisphosphatase (FBP1). In contrast, the dissimilatory pathway allows for the generation 
of energy. In the dissimilatory pathway, formaldehyde is converted into formate by 
formaldehyde dehydrogenase (FLD) and from formate to carbon dioxide by formate 
dehydrogenase (FDH1) and formylglutathione hydrolase (FGH1) (Krainer, Dietzsch et 
al. 2012).  
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Figure 3.1: The methanol metabolism pathway of Pichia pastoris. The initial metabolization of 
methanol (CH3OH) into formaldehyde (HCHO) takes place in the peroxisome. The formaldehyde then 
enters either the assimilatory pathway (blue) to produce biomass or the dissimilatory pathway (red) to 
produce energy. The dissimilatory pathway begins with the reduction of formaldehyde by gluthathione 
(GSH) whilst the assimilatory pathway begins by the conversion of formaldehyde and D-xylulose 5-
phosphate (Xu5P) into dihydroxyacetone (DHA) and glyceraldehyde-3-phosphate (GAP) via the action 
of dihydroxyacetone synthease (DHAS) Adapted from Hartner and Glieder 2006.  
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3.2.2.2 AOX1 and AOX2 
 
Two genes, aox1 and aox2, code for AOX in P. pastoris. aox1 is the primary gene 
responsible for the majority of AOX activity, accounting for up to 95% of total 
expressed alcohol oxidase (Koutz, Davis et al. 1989). aox2 is 97% homologous to aox1; 
however, loss of the aox1 results in a dramatic reduction in the ability of the cell to 
utilise methanol (Cregg, Madden et al. 1989). There are 3 methanol utilization 
phenotypes in Pichia, mut+, muts and mut-. The mut+ phenotype refers to the ability of 
the strain to metabolise methanol at the same rate as the wild type (Cregg and Cregg 
2007). Pichia strains deficient in aox1 are termed muts (methanol utilization slow) 
strains whilst strains with the mut- (methanol utilization minus) phenotype such as 
MC100-3 are unable to grow on methanol (Inan and Meagher 2001; Cos, Serrano et al. 
2005). Although AOX is not actively secreted into the supernatant, but accumulates in 
the media due to leakage from the cells (Pickford and O'Leary 2004). 
 
3.2.2.3 Regulation of AOX 
 
Expression of AOX is strongly regulated and induced by methanol to high levels. AOX 
typically accounts for about 5% of total soluble protein in shake-flask culture, but can 
reach 30% in fermenter culture when fed with growth limited rates of methanol. The 
regulation of the aox1 in P. pastoris is similar to the regulation of the gal1 in 
Saccharomyces cerevisiae, using both repression/de-repression as well as an induction 
mechanism. The primary difference is that the de-repression mechanism does not 
induce significant transcription of the aox1 (Inan and Meagher 2001). In effect the aox1 
is not transcribed when in the absence of a repressing carbon source such as glucose, 
but can be transcribed up to 1000-fold in a methanol medium (Lin-Cereghino, Godfrey 
et al. 2006). This allows for protein production to be tightly controlled and expressed 
only in the presence of methanol. Glucose starvation can also result in the transcription 
of aox1.  
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3.2.3 Factors influencing expression levels 
 
The productivity of a P. pastoris expression system has been postulated to be influenced 
by a myriad of factors. Such factors can include the codon usage of the gene of interest, 
the number of gene copies integrated into the expression cassette, the choice of 
promoter, the processing and folding of the produced protein, the choice of secretion 
signal peptide and subsequent secretion of the produced protein and the extent of 
proteolysis upon secretion (Kowalski, Parekh et al. 1998; Curvers, Brixius et al. 2001; 
Koganesawa, Aizawa et al. 2001; Vassileva, Chugh et al. 2001; Agaphonov, Romanova 
et al. 2002; Outchkourov, Stiekema et al. 2002). These factors are interdependent and 
optimization of multiple factors is non-trivial. Optimization of single variable often 
results in diminished returns due to other variables becoming increasingly important in 
the production chain (Mattanovich, Gasser et al. 2004).  
 
Optimization of the P. pastoris expression system has focused upon improvements to 
the vector, host strain and fermentation process. However, recent developments in yeast 
systems biology has also allowed for process optimization via engineering of the yeast 
secretion system (Huang, Damasceno et al. 2011). Understanding of the physiological 
processes that lead to impaired expression levels can help identify areas of possible 
improvement in the overall process.  
 
3.2.3.1 Promoters for heterologous expression 
 
Various promoters have been used to drive expression of heterologous proteins in P. 
pastoris. Among the most commonly used promoters are inducible promoters such as 
pAOX, pFLD1, pDHAS and pPEX8 as well as constitutive promoters such as pGAP, 
pYPT1, pPGK1 and pTEF1. However, the majority of such promoters are not widely 
used due to their low expression levels and relative complexity as compared to pAOX 
(Logez, Alkhalfioui et al. 2012; Potvin, Ahmad et al. 2012).  
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3.2.3.1.1 pAOX1 
 
The most commonly used promoters are pAOX1-regulated systems due to the strength 
of the promoter. aox1 is upregulated in the presence of methanol and can result in 
significant levels of production even with a single copy of the target gene integrated 
into the expression cassette. In addition, pAOX-regulation allows for highly regulated 
inducible expression.  This ability allows for the production of toxic proteins in P. 
pastoris by allowing for the generation of biomass in the presence of a highly repressing 
catabolite followed by the production of the target protein once a suitable amount of 
biomass has been accumulated. Due to its track record of better protein production 
levels, pAOX1-regulation is the promoter of choice for most applications (Kim, Lee et 
al. 2009; Lei, Guan et al. 2012).  
 
The slower growth rates of the muts strains have been shown to be advantageous in the 
production of certain proteins such as the hepatitis B surface antigen where the 
production of proteins is limited by the rate of protein folding (Vassileva, Chugh et al. 
2001). This has been postulated to be due to the competition of the highly upregulated 
expression of AOX with the protein of interest for the limited available protein 
production machinery. Additionally, Muts strains exhibit a slower growth rate on 
methanol, a lower sensitivity to transient high methanol concentrations and this limits 
some sources of cellular stress due to high density cultivation such as oxygen-limited 
growth (Sreekrishna, Brankamp et al. 1997).  
 
Due to the varied conditions that could affect protein production levels, there is 
currently no consensus as to which of the two primary AOX genes give superior 
expression levels.  
 
Advances in the use and manipulation of pAOX have focussed upon the manipulation 
of positive and negative cis-acting regulatory elements within the promoter regions of 
the AOX genes (Ohi, Miura et al. 1994; Kuwae, Ohyama et al. 2005). A promoter 
library has also been produced by the deletion and duplication of putative transcription 
factor binding sites within the pAOX1. This has generated promoters with activity 
ranging from 6% to 160% of the original wild-type pAOX1 (Hartner, Ruth et al. 2008).  
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3.2.3.1.2 pGAP 
 
pAOX-regulated systems are methanol induced systems that can require large amounts 
of methanol that can cause control and safety issues during the induction phase. In 
addition the cytotoxicity of methanol means that methanol induction can cause 
additional considerations during downstream processing if the product will be used for 
therapeutic purposes.  
 
pGAP has been used as an alternative to pAOX. GAPDH was first isolated by the 
probing of a genomic library of P. pastoris using the GAPDH gene of saccharomyces 
cerevisae (Waterham, Digan et al. 1997). GAPDH is a key cytosolic enzyme in 
glycolysis and is stably and constitutively expressed at high levels in most cells. This 
allows for pGAP to be used to drive the constitutive expression of the desired 
recombinant protein without the need for induction or the use of methanol.  
 
pGAP-regulated genes have been well expressed when grown on various carbon-
sources such as methanol, glucose, glycerol or oleic acid (Cos, Ramon et al. 2006). The 
use of pGAP also has been shown to allow for stable, long-term (>30 days), continuous 
culture without the extensive control systems which accompany a methanol induction 
period (Goodrick, Xu et al. 2001). There has been conflicting reports as to the relative 
production levels of pAOX-regulation and pGAP-regulation (Waterham, Digan et al. 
1997; Vassileva, Chugh et al. 2001; Delroisse, Dannau et al. 2005; Kim, Lee et al. 
2009). However, there have been reports of improved protein production levels through 
the use of both pGAP and pAOX-regulation to drive the simultaneous constitutive and 
induced expression of the target protein (Wu, Lin et al. 2003; Zhang, Luo et al. 2009).  
3.2.3.1.3 Other Inductive Promoters 
 
Other promoters based on the methanol assimilatory (pDHAS) and dissimilatory 
(pFLD1) pathway have been proposed and used to drive production of heterologous 
proteins in P. pastoris.  Both FLD and DHAS are key enzymes during the utilization of 
methanol and are both upregulated during growth on methanol. Both of these proteins 
are controlled via methanol-induced promoters and can comprise up to 20% TCP 
(Tschopp, Brust et al. 1987; Gellissen 2000). pFLD1 is particularly interesting as it is 
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induced both in the presence of methanol as a carbon source and in the presence of 
methylamine as a nitrogen source (Shen, Sulter et al. 1998; Resina, Maurer et al. 2009). 
This makes it a perfect candidate for use in conjunction with pAOX1 for co-expression 
or for staggered expression of dependent proteins (Duan, Umar et al. 2011).  
 
3.2.3.1.4 Other Constitutive Promoters 
 
Although pGAP is undoubtedly the most popular of the constitutive promoters, other 
constitutive promoters have also been tested for use in P. pastoris. pYPT1 is a promoter 
derived from a secretory GTPase (Segev, Mulholland et al. 1988). However, pYPT1 
has been shown to have dramatically lower expression levels than either pGAP or 
pAOX1(Sears, O'Connor et al. 1998). Recently, pTEF1, a promoter for translation 
elongation factor 1-α (TEF-1)) has been shown to be able to achieve comparable 
expression levels to pGAP (Ahn, Hong et al. 2007). In addition, the promoter for the 
constitutively expressed glycolytic enzyme 3-phosphoglycerate kinase (pPGK1) has 
been used to drive the expression of Bacillus subtilis α-amylase when grown on 
glucose, glycerol or methanol (de Almeida, de Moraes et al. 2005).  
 
3.2.3.2 Stress 
 
A common strategy for the generation of high expressing cell lines is to increase gene 
dosage. This has been shown to be mostly effective; however, there have been cases 
where increased gene dosage has resulted in no improvement or even a decrease in 
production level (McGrew, Leiske et al. 1997; Vassileva, Chugh et al. 2001). This can 
be explained by a bottleneck within the processing machinery within the cell, such as 
within the membrane translocation, signal sequence processing or protein folding 
machinery (Hohenblum, Gasser et al. 2004).  
 
The overexpression of heterologous protein has been linked to increased flux through 
the tricarboxylic acid cycle, which can be attributed to an increase in energy demand 
(Dragosits, Stadlmann et al. 2009). This has been termed the metabolic burden and can 
result in the impairment of cell growth and protein yield (Ramon, Ferrer et al. 2007; 
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Baumann, Carnicer et al. 2010). The primary contributors to metabolic burden in yeasts 
are the protein degradation of misfolded or unfolded proteins in the endoplasmic 
reticulum (ER) via the unfolded protein response (UPR)/enhanced ER-associated 
degradation (ERAD) and the post-translational modifications of produced proteins 
(Gasser, Sauer et al. 2007).  
 
3.2.3.2.1The Unfolded Protein Response and ER-Associated Degradation 
 
One of the advantages of P. pastoris as an expression system is its ability for efficient 
folding of heterologous protein via the ER (Kjeldsen 2000). The environment within 
the ER is optimized for the accurate and efficient folding of polypeptides and enriched 
with chaperones, glycosylation enzymes and oxidoreductases (Gething and Sambrook 
1992). However, even with such a well-developed support mechanism, the folding 
process invariably fails on occasion. This results in the production of mis-folded or 
unfolded proteins which are recognized by the ER quality control and are subsequently 
eliminated via the unfolded protein response and the ER-associated degradation (Anelli 
and Sitia 2008; Hirsch, Gauss et al. 2009). The UPR and ERAD is can present a major 
bottleneck during P. pastoris heterologous protein production and understanding these 
mechanisms can offer additional insights into host cell optimization via rational 
engineering (Cudna and Dickson 2003).  
 
The UPR is a phylogenetically conserved signalling pathway that adjusts the abundance 
of the ER and ER-associated proteins in response to the presence and accumulation of 
unfolded proteins (Bernales, Papa et al. 2006) (Fig 3.2). Secretory expression starts with 
the translocation of the polypeptides into the ER lumen where they are folded, 
covalently modified and assembled into complexes when appropriate. During 
overexpression of heterologous protein, protein folding demand can exceed the folding 
capacity of the ER. The transmembrane kinase/endoribonuclease Ire1p acts as a 
detector of unfolded protein (Credle, Finer-Moore et al. 2005). Ire1p oligomerizes when 
BiP is released from it to bind misfolded protein (Shamu and Walter 1996). This 
activates the endoribonuclease activity of Ire1p to remove an 252 nucleotide long intron 
from hac1 mRNA (Whyteside, Nor et al. 2011). Religation of hac1 allows for the 
production of the transcription factor HAC1p which upregulates a large number of UPR 
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genes such as BiP and protein disulphide isomerase (PDI) by binding to an upstream 
sequence known as the unfolded protein response element (UPRE) (Kohno, 
Normington et al. 1993). Such UPR affected genes can comprise up to 5% of the yeast 
genome (Travers, Patil et al. 2000; Patil and Walter 2001).  
 
Induction of the UPR genes cause the upregulation of key proteins involved in the 
protein production process such as chaperones, foldases, transport factors and ERAD 
associated proteins thus increasing the capacity of the host cell to fold, process and 
secrete proteins (Ma and Hendershot 2004).  Continued ER-stress can also result in the 
activation of a variant of autophagy, termed as ER-phagy, where parts of the ER 
containing misfolded protein are transported to the vacuole for degradation (Bernales, 
Schuck et al. 2007). Activation of such autophagic responses have been triggered by 
the addition of reducing agents, tunicamycin and thapsigargin. (Bernales, McDonald et 
al. 2006; Ogata, Hino et al. 2006). Tunicamycin is regularly used for the inhibition of 
protein glycosylation in yeast, and as such the physiological impact of tunicamycin use 
can be important (Kuo and Lampen 1976). 
 
The ERAD is upregulated by the UPR. ERAD allows for the retro-translocation of 
unfolded protein from the ER into the cytosol for degradation via an ubiquitin- 
proteasome system (Hampton and Sommer 2012). Whereas other targets of the UPR 
improve protein folding capacity by increasing the availability of chaperones and 
protein-folding enzymes, the ERAD improves protein folding capacity by removing 
irreversibly misfolded protein from the ER.   
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Figure 3.2: The Unfolded Protein Response pathway of Pichia pastoris. Ire1p 
oligomerizes when BiP is released in the presence of unfolded protein (1). 
Oligomerization of Ire1p activates its endoribonuclease activity to allow for the 
removal of a 252 nt long intron from hac1 mRNA (2). This allows for the production 
of HAC1p (3). HAC1p binds to an upstream sequence known as the unfolded protein 
response element (UPRE) (4). This upregulates a large number of UPR genes such as 
BiP and protein disulphide isomerase (PDI) (5). 
  
 82 
 
3.2.3.2.2 Manipulation of the Pichia pastoris stress response 
 
Overexpression of BiP has resulted in increased protein yield in S. cerevisae possibly 
due to the increased folding capacity and improved secretion rates. However, 
overexpression of BiP has also resulted in lower expression levels in certain cases (van 
der Heide, Hollenberg et al. 2002). This has been postulated to be due to the attenuation 
of the UPR as well as the prolonged binding of BiP to the target proteins, which target 
the proteins for ERAD instead of the secretory pathway (Kauffman, Pridgen et al. 
2002).  
 
Other players within the UPR/ERAD pathways such as Hac1p and PDI have also been 
targets for overexpression but with varying success rates (Schroder 2008). However, 
modification of the folding and modification processes in the ER is non-trivial due to 
the complexity and interdependency in the system (Gasser, Saloheimo et al. 2008). The 
modification of one factor can lead to other limiting factors increasing in prominence. 
As such, modification effects are protein and host specific and should be tested on a 
case-by-case basis. Rather than genetic modification of the host cell, co-expression of 
chaperones and foldases along with the protein of interest could offer an alternative 
method of process optimization. This has been used with a degree of success with the 
introduction of S. cerevisiae chaperones like Kar2p, Ssa1p and PDI into P. pastoris 
(Zhang, Zhao et al. 2006).  
 
3.2.3.3 Proteolytic Degradation 
 
High-density culture in fermenters can cause significant stress upon the expression host 
cell. Environmental stress can cause the release of homologous proteases that cause the 
degradation of secreted protein and can impair protein yield (Sinha, Plantz et al. 2005). 
The activity of these extracellular proteases can be mediated by modifying various 
culture conditions and compositions. Lowering the culture pH and temperature and the 
addition of protease inhibitors such as phenylmethanesulfonylfluoride (PMSF) or 
additives such as casamino acids or peptone have been shown to be effective on a 
protein and host specific basis (Siegel and Brierley 1989; Jones 1991; Enfors 1992; 
Kang, Choi et al. 2000; Gonzalez-Lopez, Szabo et al. 2002). As such, engineering 
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protease-deficient strains might offer a better solution as to the problem of extracellular 
protease degradations.  
 
The major contributors to proteolytic degradation are PrA and PrB which are encoded 
by pep4 and prb1. These proteases are responsible for the maturation and activation of 
several proteases further downstream, as such, double knockouts of pep4 and prb1 in 
P. pastoris have resulted in protease deficient cell lines (Gleeson, White et al. 1998). 
Other protease genes that have been investigated are cpy1, yps1, kex2 and cym1 (Kang, 
Choi et al. 2000; Komeda, Sakai et al. 2002; Jonson, Rehfeld et al. 2004; Werten and 
de Wolf 2005). Recently, a multiprotease-deficient strain of the fission yeast 
Sacchromyces pombe has been developed which exhibited elevated secreted expression 
of human growth hormone (hGH) (Idiris, Tohda et al. 2010).  
 
3.2.4 A Comparison between Escherichia coli and Pichia pastoris 
 
This section aims to cover the relative strengths and weaknesses between the two 
expression systems. E. coli is a versatile expression system that is relatively 
straightforward to use. As such, for most novel proteins to be studied, it should be the 
first expression system to be used. If difficulties are encountered in production, the 
proteins characteristics and desired experimental parameters can then be used to select 
an alternative expression system.  
 
3.2.4.1 Limitations of Escherichia coli as an expression system 
 
E. coli is one of the oldest and best characterised expression systems for both research 
and industrial purposes. Due to the maturity of the expression system, the molecular 
genetics of E. coli is well studied and manipulation of the cellular machinery to optimise 
production is relatively straightforward. Expressing heterologous proteins in E. coli 
usually has a fast turnaround time with a comparatively low cost (Jana and Deb 2005).  
 
However, E. coli has some disadvantages as an expression system. Firstly, eukaryotic 
proteins can occasionally be produced in denatured and inactive forms sequestered in 
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inclusion bodies (Carrio and Villaverde 2001). This can be due to the overexpression 
or inherent properties of the protein of interest. Producing a viable sample would then 
involve non-trivial downstream processes to renature or refold the protein.  
 
Secondly, E. coli does not glycosylate heterologous proteins. This can negatively 
impact the stability and solubility of proteins and can influence reaction kinetics, 
activity, immunogenicity and receptor binding.  
 
3.2.4.2 Advantages of Pichia pastoris as an expression system 
 
There are several characteristics of P. pastoris that make it more suitable for certain 
proteins. Firstly, its similarity to S. cerevisiae and commonality in biological 
techniques, secondly, the presence eukaryotic protein processing mechanisms, and 
lastly, its suitability for fermentation and industrial processes. 
 
3.2.4.2.1 Similarity to Sacchromyces cerevisae 
 
S. cerevisiae is the model organism for yeast and its genetics and biology is a well-
studied subject (Botstein, Chervitz et al. 1997). The genome of S. cerevisiae was the 
first eukaryotic genome to be sequenced and an extensive library of deletion mutants 
have allowed for the regulation and mechanism of its biological processes to be 
relatively well understood (Goffeau, Barrell et al. 1996). Expression of heterologous 
protein has been attempted with S. cerevisiae, however expression levels were low 
compared to comparative expression levels in P. pastoris.  
 
Many of the biological techniques and facilities (e.g. cloning techniques, fermenter 
conditions) for S. cerevisiae can be easily adapted for use with P. pastoris, allowing for 
less complexity and initial outlay during laboratory setup and experimental design. The 
genetic similarity of the 2 with regards to various regulatory and secretion pathways 
such as the UPR/ERAD, tricarboxylic acid (TCA) cycle and amino acid synthesis also 
lends itself to the better understanding and subsequent engineering of the P. pastoris 
secretome (Baumann, Carnicer et al. 2010). However, caution has to be exercised as 
 85 
 
DNA microarray experiments have revealed some differences between the two such as 
the differential transcriptional regulation of cellular stress response as well as induction 
of the UPR (Gasser, Maurer et al. 2007; Graf, Gasser et al. 2008). 
 
3.2.4.2.2 Folding and post translational modifications 
 
P. pastoris can be considered to offer a middle ground between mammalian/baculovirus 
expression and E. coli expression. The expression of properly folded disulphide-rich 
proteins can be difficult in E. coli, however due to the eukaryotic nature of Pichia, there 
is a greater likelihood that heterologous proteins of interest would be expressed in a 
folded and functional form (Brondyk 2009; Cregg, Tolstorukov et al. 2009).  
 
Some proteins require post-translational modifications for them to adopt the proper 
structure and/or be functionally active. P. pastoris allows for a variety of 
posttranslational modifications such as both high mannose N- and O- linked 
glycosylation, phosphorylation, acetylation and acylation. In contrast to S. cerevisiae 
which tends to hyperglycosylate N-linked sugars, P. pastoris glycosylation tends to 
resemble higher eukaryotes with 8-14 mannose chains (Grinna and Tschopp 1989). In 
addition, recent advances have allowed for humanized glycosylation in P. pastoris 
(Jacobs, Geysens et al. 2009). However, unlike mammalian cell expression, P. pastoris 
is incapable of gamma-carboxylation (Fernandez and Hoeffler 1999). 
 
The advantages of P. pastoris over E. coli for production of glycosylated (human 
activin receptors) or eukaryotic proteins (human fetal brain expression library) have 
been demonstrated by studies conducted by Daly et al. and Lueking et al. (Lueking, 
Holz et al. 2000; Daly and Hearn 2006).  
 
3.2.4.2.3 Adaptations for fermenter culture/Industrialization 
 
Expression of the heterologous protein in P. pastoris can be achieved either by secretion 
into the medium or via intracellular expression. Secreted expression is typically 
achieved by either utilizing the native secretion signal present on natively secreted 
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proteins or by fusing the protein of interest to the secretion signal of the S. cerevisiae α 
factor prepro peptide.  
 
Cleavage of the α-factor takes place in 2 steps, preliminary cleavage by the KEX2 gene 
product between R and Q in the sequence QLRQAQA and subsequent cleavage of the 
QA residues pairs by STE13 gene product (Brake, Merryweather et al. 1984). There 
have been cases in which Ste13 cleavage of the QA repeats is not efficient and QA 
repeats can be left on the N-terminal on the expressed protein.  
 
P. pastoris secretes low levels of endogenous protein and the commonly used culture 
media does not contain added proteins. This allows for the secretion of the protein into 
the medium to serve as a first purification step and a dramatic simplification of 
downstream processes when conducted on an industrial scale.  
 
In addition, the preference of P. pastoris for respiratory over a fermentative mode of 
growth precludes the accumulation of ethanol and acetic acid metabolic by-products by 
cultures of other yeasts such as S. cerevisiae (Cereghino, Cereghino et al. 2002). This 
allows for P. pastoris to achieve higher cell densities than other similar yeasts such as 
S. cerevisiae. The production level of heterologous proteins has a direct correlation to 
the biomass used for production (Macauley-Patrick, Fazenda et al. 2005). This allows 
for a higher concentration of protein in the supernatant and a decreased cost of media 
and production space to produce similar amounts of protein.  
 
3.2.5 Isotopic labelling using the Pichia pastoris system  
 
Isotopic labelling is essential for structural determination. In NMR, 15N and 13C 
labelling is needed for triple resonance experiments and 2H labelling is used on 
occasions to improve spectral quality. In applications needing uniform labelling of the 
protein sample, adaptation of the expression strain to grow on isotopically enriched 
culture medium is typically sufficient. However, due to the high cost of said isotopes 
careful optimization of both the expression strain and downstream purification 
processes is required to reduce the final costs associated with protein production. In 
addition, even though fermentation generally tends to allow for higher cell densities 
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and greater control over pH, aeration and methanol feed rate, extended runs to 
accumulate isotopically enriched biomass can often result in uneconomical usage of 
labelled precursors such as 15N- ammonium sulphate and 13C methanol (Pickford and 
O'Leary 2004).  
 
Residue-selective labelling typically requires the use of auxotroph strains that require 
the supplementation of minimal media with the amino acid. Historically well studied 
expression systems such as E. coli and S. cerevisiae already have a myriad of amino 
acid biosynthetic mutants that are available for residue-specific labelling applications. 
However, there are currently only a few auxotrophic strains available for P. pastoris, 
these include histidine (his4), arginine (arg4), cysteine (cbs) and the aromatic acids 
(tyr1, aro7, aro1) (Crane and Gould 1994; Li, Ji et al. 2001; Lin Cereghino, Lin 
Cereghino et al. 2001; Whittaker and Whittaker 2005). With the recent sequencing of 
the genome of the GS115 strain of P. pastoris, further developments with regard to the 
availability of a larger variety of auxotrophic strains can be expected (Whittaker 2007; 
De Schutter, Lin et al. 2009).   
 
3.2.6 Summary 
 
Use of P. pastoris as an expression system is relatively new whereas e. coli has been 
the expression system of choice since Cohen and Boyer reported the transformation of 
E. coli with pSC101 in 1973 (Jackson, Symons et al. 1972; Cohen, Chang et al. 1973). 
The genome of E. coli was sequenced and made publicly available in 1997 and a 
veritable smorgasbord of specialised expression strains, vectors, tags and biological 
techniques have since been developed to coax the expression of soluble protein from e. 
coli.  
 
In contrast, the first complete sequence of P. pastoris has only been released in 2009 
(De Schutter, Lin et al. 2009). There are gaps in our understanding of the production 
and secretory mechanisms of P. pastoris and this has hitherto limited the development 
of engineered specialised host strains for specialised applications. Development of 
promoter libraries for the pAOX1, pGAP and other popular promoters should allow for 
fine-tuning of promoter strength to improve transcription rate or to decrease the 
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metabolic strain of overexpression in the future. Improvements in microfluidics have 
the potential to streamline the scanning of fermenter conditions and decrease process 
optimization time and expense.  
 
The cost of expression of heterologous protein in other eukaryotic systems such as 
mammalian cell culture and insect cell culture can be prohibitive due to the high prices 
of additives, transformation agents and media. In addition, the time needed to generate 
a stable well-expressing cell-line usually is longer than for P. pastoris. In addition, 
biological techniques for genomic manipulation and culture of P. pastoris are broadly 
similar to those for E. coli and as such, would simplify the process of switching 
expression systems.  
 
In summary, P. pastoris in its current state offers a credible and economically-viable 
alternative to E. coli and mammalian cell culture and due to the relative 
underdevelopment of its use as an expression system is an extremely scientifically 
interesting microorganism.  
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3.3 Materials and Methods 
 
3.3.1 Media 
 
All liquid media was autoclaved before use and stored at room temperature. Agar plates 
were stored at 4 °C. Antibiotics were added as needed to a final concentration of 50 
mg/ml (Carbenecillin), 15 mg/ml (Kanamycin), 12.5 mg/ml (Tetracycline). 
Concentrations for Zeocin™ and Geneticin® varied depending on the experimental 
parameters desired.  
 
BMGY media was made up of 100mM potassium phosphate, pH 6.0, 1.34% (w/v) 
YNB, 0.00004 % (w/v) biotin and 1% (v/v) glycerol. BMMY media was made up of 
100mM potassium phosphate, pH 6.0, 1.34% (w/v) YNB, 4 x 10-5 % (w/v) biotin and 
1% (v/v) methanol. YPD media was made up of 2% (w/v) tryptone, 1% (w/v) yeast 
extract, and 2% (w/v) dextrose in distilled water. YPD agar was made up of 2% (w/v) 
tryptone, 1% (w/v) yeast extract, 2% (w/v) dextrose and 2% agar in distilled water. 
YPDS agar was made up of 2% (w/v) tryptone, 1% (w/v) yeast extract, 2% (w/v) 
dextrose, 1M sorbitol and 2% agar in distilled water. YPDS media was made up of 2% 
(w/v) tryptone, 1% (w/v) yeast extract, 2% (w/v) dextrose and 1M sorbitol in distilled 
water 
 
Basal Salt Medium is the medium initially used for fermenter trials, it was made up of 
2.67% (v/v) 85% orthophosphoric acid, 0.093% (w/v) Calcium sulphate, 1.82% (w/v) 
Potassium sulphate, 1.49% (w/v) Magnesium sulphate heptahydrate, 0.413% (w/v) 
Potassium hydroxide and 2% (w/v) glycerol. 
 
FM21 was made up of 0.015% (w/v) calcium sulphate dihydrate, 0.065% potassium 
hydroxide, 0.195% (w/v) Magnesium sulphate heptahydrate, 0.24% (w/v) potassium 
sulphate, 0.35% (v/v) 85% orthophosphoric acid, 2% (w/v) glycerol and supplemented 
with 400 µg/L biotin and 1.45% (v/v) of either PTM1 or PTM4 trace salts solution.   
 
FM21LS (low salt media) was made up of 0.015% (w/v) calcium sulphate dihydrate, 
0.065% potassium hydroxide, 0.05 % (w/v) Magnesium sulphate heptahydrate, 0.24% 
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(w/v) potassium sulphate, 0.35% (v/v) 85% orthophosphoric acid, 2% (w/v) glycerol 
and supplemented with 400 µg/L biotin and 1.45% (v/v) of either PTM1 or PTM4 trace 
salts solution.   
 
FM22 was made up of 4.29% (w/v) potassium phosphate, 1.43% (w/v) potassium 
sulphate, 0.5% (w/v) ammonium sulphate, 1.17% (w/v) Magnesium sulphate 
heptahydrate, 0.1% (w/v) calcium sulphate dihydrate, 2% (w/v) glycerol and 
supplemented with 400 µg/L biotin and 1.45% (v/v) of either PTM1 or PTM4 trace 
salts solution.   
 
PTM1 trace salts solution contains 0.6% (w/v) copper sulphate pentahydrate, 0.008% 
(w/v) sodium iodide, 0.3% (w/v) manganese sulphate monohydrate, 0.02% (w/v) 
sodium molybdate dihydrate, 0.002% (w/v) boric acid, 0.05% (w/v) cobalt chloride, 
2.0% (w/v) zinc chloride, 6.5% (w/v) iron sulphate heptahydrate, 0.02% (w/v) biotin, 
0.5% (v/v) sulphuric acid. 
 
PMT4 trace elements solution 0.2% (w/v) copper sulphate pentahydrate, 0.008% (w/v) 
sodium iodide, 0.3% (w/v) manganese sulphate monohydrate, 0.02% (w/v) sodium 
molybdate dihydrate, 0.002% (w/v) boric acid, 0.05% (w/v) cobalt chloride, 0.65% 
(w/v) zinc chloride, 2.1% (w/v) iron sulphate heptahydrate, 0.02% (w/v) biotin, 0.1% 
(v/v) sulphuric acid. 
 
3.3.2 Strains Used 
 
3.3.2.1 Escherichia coli Strains 
 
The Origami (DE3) strain was used as the primary strain for the expression of all 
constructs.  The Origami (DE3) strain contains the genes trxB and gor, which causes 
mutations in thioredoxin reductase and glutathione reductase. This promotes the 
formation of disulphide bonds. Additionally, the strain also has dual antibiotic 
resistance against tetracycline and kanamycin. This allows for high selectivity for the 
host cells.  
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The Origami (DE3) strain also contains a λ prophage carrying the T7 RNA polymerase 
gene and lacIq. This allows for the repression of plasmid-carried T7 promoter driven 
expression until induction with IPTG.  
 
3.3.2.2 Pichia pastoris Strains 
 
P. pastoris is a methylotropic yeast that can utilize methanol as its sole carbon source. 
4 major strains of P. pastoris were used in the project, X-33, KM71H, GS115 and 
SMD1168. A more detailed analysis of the characteristics of each strain is given in 
section 3.4.2.1.  
 
5ml of YPD was first inoculated from a fresh commercial stab vial and incubated with 
gentle agitation (150 rpm) overnight at 30 °C. This was then used to inoculate 500 ml 
of YPD in an unbaffled 2L flask and incubated with gentle agitation at 30 °C until it 
reaches an OD600 of 0.6-0.8. The cells were pelleted via centrifugation at 2500 rpm 
(SLA-3000, Sorvall) for 5 minutes. The cells were then resuspended in 200 ml of YPDS 
and pelleted via centrifugation at 2500 rpm (SLA-3000, Sorvall) for 5 minutes. The 
supernatant was discarded and the cell pellet resuspended in 20 ml of storage media 
(2% (w/v) tryptone, 1% (w/v) yeast extract, 2% (w/v) dextrose, 30% (w/v) glycerol, 
1M sorbitol). The cell suspension was transferred into cryovials in 1 ml aliquots and 
flash frozen in a liquid nitrogen bath. The cryovials were then stored at -80 °C until 
needed.  
 
3.3.3 Protein expression 
 
3.3.3.1 Expression in Escherichia coli 
 
M9 medium containing 15NH4Cl (0.07%) and 
13C-glucose (0.2%) was used for isotopic 
enrichment of proteins with 15N and 13C. Unlabelled preparations were grown in LB 
media. A single colony from the plates containing transformed colonies containing the 
encoded target protein was then inoculated into 50 ml of LB media with appropriate 
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antibiotics. The cultures were then incubated overnight at 37 °C with constant agitation. 
25 ml of the overnight cultures were then used to inoculate 1L of LB and incubated at 
37 °C with constant agitation. 1 ml samples of the cultures were taken at regular 
intervals to determine the OD600 of the cultures. When the OD600 of the cultures reach 
0.4-0.8, the cultures were then induced with 1M IPTG to a final concentration of 1 mM 
IPTG. The induced cultures were then grown at 16 °C overnight with constant agitation.  
 
Cells were pelleted by centrifugation at 4500 rpm (SLA-3000, Sorvall) for 10 minutes 
and resuspended in 10 ml of lysis buffer (20 mM Tris-HCl, pH 7.9, 0.5M NaCl). 1tablet 
of EDTA-free protease inhibitor cocktail (Roche) per 50 ml of all buffers during 
purification to prevent proteolysis.  
 
3.3.3.2 Small Scale Selection and Expression in Pichia pastoris 
 
3.3.3.2.1 Small Scale Selection in Pichia pastoris 
 
A single colony from the plates containing transformed colonies were inoculated in 20 
ml of BMGY in a 100 ml flask and incubated at 30 °C with constant agitation 225 rpm 
for 16 hours. The cells were then harvested by centrifuging at 2500 rpm (SLA-3000, 
Sorvall) for 5 minutes. The supernatant was carefully decanted and the cell pellet 
resuspended in 50 ml of BMMY media. The resuspended pellet was then pelleted via 
centrifugation at 2500 rpm (SLA-3000, Sorvall) for 5 minutes and once again 
resuspended in 5 ml of BMMY media in a 100ml flask for an initial OD600 of 20-40. 
The culture was then incubated in a 28 °C incubator with constant agitation at 225 rpm. 
25 µl of 100% methanol was added to the culture every 24 hours. The culture was then 
grown for 24 hours.  
 
The highest expression clones were selected by Western blot for further study. In the 
case of time course experiments, the culture was grown for 5 days and samples were 
taken for analysis every 24 hours.  
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3.3.3.2.2 Dot-blot analysis 
 
2 µl drops of supernatant from small scale expression trials were applied slowly onto a 
nitrocellulose membrane in a grid pattern. Membrane was then allowed to air-dry for 
15 minutes in a covered container. The membrane was blocked with 50 ml of 10% (w/v) 
milk powder in TBS-T (20mM Tris-HCl, 150mM NaCl, pH7.5, 0.05% (v/v) Tween-
20) for 1 hour at room temperature with constant agitation. The membrane was then 
incubated with 0.5 mg/mL anti-His antibodies (Invitrogen) diluted 1:10000 in 50 ml of 
10% (w/v) milk powder in TBS-T for 1 hour at room temperature. The membrane was 
then washed three times with TBS-T for 10 minutes. The membrane was then incubated 
with secondary antibody conjugated with HRP diluted 1:10000 in TBS-T. Three further 
washes with TBS-T followed by one wash with TBS were conducted for 5 minutes each 
time with constant agitation. The signal was then detected using ECL western blotting 
substrate (Pierce) according to manufacturer’s instructions.  
 
3.3.3.2.3 Preservation of high expressing cell lines 
 
The highest expressing colonies from the plates as determined by Western blot analysis 
were inoculated into 10 ml of YPD media and incubated overnight at 30 °C. This 
overnight culture was then used to inoculate 1L of YPD in a 2L unbaffled flask and 
incubated at 30 °C with constant agitation at 225 rpm for 16 hours. The overnight 
culture was then pelleted via centrifugation at 2500 rpm (SLA-3000, Sorvall) for 5 
minutes and resuspended in YPD containing 30% glycerol at a final OD600 of 50–100. 
The vials were then frozen in a liquid nitrogen bath and stored at -80 °C.  
 
3.3.3.2.4 Small Scale Expression in Pichia pastoris 
 
A single colony from the plates containing transformed colonies were inoculated into 
10 ml of BMGY media and incubated overnight at 30 °C. This overnight culture was 
then used to inoculate 1L of BMGY in a 2L baffled flask and incubated at 30 °C with 
constant agitation at 225 rpm for 16 hours.  
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The cells were then harvested by centrifuging at 2500 rpm (SLA-3000, Sorvall) for 5 
minutes. The supernatant was carefully decanted and the cell pellet resuspended in 
200ml of BMMY media in a 2L baffled flask for an initial OD600 of 20-40. The culture 
was then incubated in a 28 °C incubator with vigorous shaking. 1 ml of 100% methanol 
was added to the culture every 24 hours to compensate for loss of methanol due to 
metabolism or evaporation. The culture was then grown for 1-5 days depending on the 
optimal period of expression based on previously conducted expression tests.  
 
Cells were pelleted by centrifugation at 5000 rpm (SLA-3000, Sorvall) for 30 minutes. 
The supernatant was then saved for further purification.  
 
3.3.3.3 Expression of 15N labeled protein in Pichia pastoris 
 
For isotopic enrichment of proteins in P. pastoris with 15N, minimal media such as 
FM22 containing 0.5% (w/v) (15NH4)2SO4 was used. Unlabelled preparations were 
grown in BMGY. A single colony from the plates containing transformed colonies 
containing the encoded target protein was inoculated into 20 ml of YPD media with 
either Geneticin®(G418) (Invitrogen) or Zeocin™ (Invitrogen) in a 100 ml flask. The 
cultures were then incubated overnight at 30 °C with constant agitation at 225 rpm. The 
overnight cultures were then pelleted by centrifugation at 2500 rpm (SLA-3000, 
Sorvall) for 5 minutes and the supernatant removed. The pellet was then resuspended 
in 50 ml of FM22. The cultures were then used to inoculate 1L of FM22 to an initial 
OD600 of 1.0 and incubated at 30°C with constant agitation at 225rpm for 24 hours. 
The culture was then pelleted via centrifugation at 2500 rpm for 5 minutes and 
resuspended in 200 ml of FM22 containing 0.5% (w/v) (15NH4)2SO4 in a 2L baffled 
flask. This should result in an initial OD600 of 20-40.  
 
The culture was then incubated at 30 °C with constant agitation at 225 rpm for 1 hour. 
In order as to transition the culture to growth on methanol, 5 ml of methanol was then 
added to the culture every hour for 2 hours. At the end of the 2 hours, 10 ml of methanol 
was then added to the culture.  20 ml of methanol was then added to the culture every 
24 hours of the induction stage (24 – 120 hours). pH of the media was monitored using 
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a pH probe (Thermo Scientific) and maintained at a constant value by the addition of 
1M NaOH.  
 
For the duration of the transitional stage and the induction stage, the culture was 
incubated at 22 °C with constant agitation at 225 rpm. The lower temperature was 
selected so as to counteract fluctuations in flask temperature which could have caused 
overheating in the culture. 1ml samples were taken every 24 hours to monitor protein 
production levels.  
 
At the end of the induction period, cells were pelleted by centrifugation at 5000 rpm 
(SLA-3000, Sorvall) for 20 minutes and the supernatant was reserved for further 
downstream processes.   
 
3.3.3.4 Bioreactor fermentation of Pichia pastoris  
 
A single vial of cells were thawed on ice and used to inoculate 10 ml of YPD media 
which was then incubated at 30 °C with constant agitation at 225 rpm for 16 hours. This 
was then in turn used to inoculate 500 ml of the same media that would be used in the 
subsequent fermentation in a 2L baffled flask. The culture was again incubated at 30 
°C with constant agitation at 225 rpm for 16 hours.  
 
The culture was then used to inoculate 4L of fermenter media in a 5L bioreactor vessel 
to an initial OD600 of 1.0. Cultures were grown in a 5L bioreactor vessel controlled by 
an ADI 1010 bio-controller connected to a PC running BioExpert software (Applikon 
Biotechnology). The pH was set and maintained at 5.0 by the addition of 28% 
ammonium hydroxide. Methanol levels were monitored and controlled using a 
methanol sensor (Raven Biotech). The internal regulation software of the sensor was 
used to control an external Watson-Marlow 101U/R peristaltic pump to regulate the 
methanol feed. The impeller was set at 1000 rpm with the top impeller 75mm above the 
bottom impeller, pH at 5.0, dO2 at 35% and a temperature of 30 °C throughout the run.  
Foam buildup was controlled by the addition of 1ml/L Acepol 83E to the media as well 
as the addition of 10% (v/v) Acepol 83E as needed over the course of the fermentation.  
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During the initial batch phase, the culture was allowed to consume the glycerol in the 
media. This phase of the fermentation usually lasts from 16 to 20 hours and results in a 
final OD600 of 50-60. The batch phase is then followed by a 4 hour fed-batch stage with 
50% (w/v) glycerol supplemented with 4 ml/L PTM4 fed into the fermenter at a 
constant rate. The Watson-Marlow 101U/R peristaltic pump 101 was set to a speed 
setting of 07 with L/S 14 (1.6 mm bore) tubing result in a constant flow rate of 0.45 
ml/min.    At the end of the fed-batch phase of the fermentation as indicated by a spike 
in dO2 levels, the final OD600 of the culture would be in the range of 100-150.  
 
After the fed-batch stage, the cells were then treated with a 0.1% v/v aliquot of 100% 
methanol supplemented with 4 ml/L PTM4 and 0.04% (w/v) histidine and the methanol 
sensor allowed to stabilize. The signal output was recorded as an mV value and used as 
the methanol feed set point. The culture was allowed to adapt to growth on 0.1% (v/v) 
methanol for 1 hour. During the transitional phase, the methanol feed was raised by 
0.1% every 2 hours until it reaches a final set point of 0.3%. The methanol level is then 
maintained at 0.3% throughout the induction phase. The induction phase lasts anywhere 
from 24-96 hours depending on the results of earlier time course experiments. At the 
end of the induction period, the culture was harvested and harvested by centrifugation 
at 5000rpm (SLA-3000, Sorvall) for 30 minutes.  
 
3.3.4 Protein purification 
 
3.3.4.1 Purification in Escherichia coli 
 
Cells were lysed either by French press (SLM instruments) or by sonication with 4 s 
pulses with 2 s intervals for 10 minutes at 50% power after preincubation with 1mg/ml 
of lysozyme. Cell debris and unlysed cells were then separated by centrifugation at 
15000 rpm (SS-34, Sorvall) for 30 minutes. 
 
Purification of target protein was achieved via IMAC binding using a gravity column. 
The cell lysate was then filtered through a 0.22 µm syringe filter (Minisart) and added 
to a 15 ml column containing 3 ml of Ni-NTA Agarose (Qiagen) which had been 
 97 
 
equilibrated with lysis buffer. The column was then sealed and incubated at room 
temperature for 1 hour with constant shaking to ensure efficient binding. The column 
was then washed with 3 column volumes of wash buffer (20 mM Tris-HCl pH 7.9, 40 
mM Imidazole, 0.5M NaCl) to remove nonspecifically bound material. The bound 
target protein was then eluted with elution buffer (20 mM Tris-HCl pH 7.9, 250 mM 
Imidazole, 0.5M NaCl) to yield purified protein. Samples from each step of purification 
were analyzed with SDS-PAGE.  
 
3.3.4.1 Soluble Protein Purification in Pichia pastoris 
 
P. pastoris cell strains typically secrete very low levels of homologous proteins, thus it 
is highly likely that the expressed target protein will form the majority of the proteins 
in the supernatant. Hence, secretion of the protein acts as a first step of purification.  
 
3.3.4.1.1 Anion-exchange chromatography 
 
The supernatant is brought to pH 8.0 for anion-exchange chromatography by the 
addition of 1M NH4OH. The supernatant is centrifuged at 5000 rpm (SLA-3000, 
Sorvall) for 30 minutes to pellet precipitates and the supernatant retained for 
downstream processes. The supernatant is then passed at 5 ml/min through a HiTrap Q 
HF Column (GE Healthcare) preequilibrated with equilibration buffer (50 mM HEPES, 
pH 8.0, 50 mM NaCl). The bound protein was then eluted with 100 ml of elution buffer 
(50 mM HEPES, pH 8.0, 1M NaCl). The eluted fraction was buffer exchanged into 
nickel-column binding buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl).  
 
3.3.4.1.2 Cation-exchange chromatography 
 
The supernatant is brought to pH 3.0 for cation-exchange chromatography by the 
addition of 1M HCl. The supernatant is centrifuged at 5000 rpm (SLA-3000, Sorvall) 
for 30 minutes to pellet precipitates and the supernatant retained for downstream 
processes. The supernatant is then passed at 5 ml/min through a HiTrap S HF Column 
(GE Healthcare) preequilibrated with equilibration buffer (50 mM sodium citrate, pH 
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3.0, 50 mM NaCl). The bound protein was then eluted with 100ml of elution buffer 
(50mM sodium citrate, pH 3.0, 1M NaCl). The eluted fraction was buffer exchanged 
into nickel-column binding buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl).  
 
3.3.4.1.3 Ni2+ affinity chromatography 
 
Further purification of target protein was achieved via nickel-column binding using a 
gravity column. 5 ml of Ni-NTA agarose slurry prequilibrated with nickel-column 
binding buffer (20 mM Tris-HCl, pH 8.0, 5 mM Imidazole, 0.5M NaCl) was mixed 
with the eluted fraction and incubated with gentle stirring for 1 hour at 4 °C. The 
supernatant was then applied to a gravity column and the flowthrough collected. The 
column was then washed with 3 column volumes of wash buffer (20 mM Tris-HCl, pH 
8.0, 40 mM Imidazole, 0.5M NaCl). The bound target protein was then eluted with 
elution buffer (20 mM Tris-HCl, pH 8.0, 250 mM Imidazole, 0.5M NaCl) to yield 
purified protein. Samples from each step of purification were analyzed with SDS-
PAGE. 
 
3.3.4.1.4 Gel filtration chromatography 
 
Gel filtration chromatography was performed using an AKTATM design System 
(Amersham Biosciences) in combination with a Superdex™ 75 or Superdex™ 200 
column. Samples were concentrated to a volume of 100 – 500 µl using the Vivaspin® 
(GE Healthcare) protein concentration system and buffer exchanged into a Tris-HCl 
buffer (20 mM Tris-HCl pH 8.0, 250 mM NaCl). Samples were injected onto the 
column at a flow rate of 1 ml/min and UV absorbance at 280 nm recorded.  
 
3.3.4.1.5 SEC-MALS 
 
SEC-MALS was performed using a Wyatt GPC/SEC Detection System (Wyatt 
Technology Europe) linked to a miniDAWN TREOS (Wyatt Technology Europe)  for 
light scattering and an Optilab rEX (Wyatt Technology Europe)  for refractive index 
measurement in combination with a WTC-MP030S5 column. Samples were 
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concentrated to a volume of 100 µl using the Vivaspin® (GE Healthcare) protein 
concentration system and buffer exchanged into a Tris-HCl buffer (20mM Tris-HCl pH 
8.0, 250mM NaCl). Samples were injected onto the column at a flow rate of 1 ml/min 
and results were analysed using ASTRA® 6 software (Wyatt Technology). 
 
3.3.5 Pull-down Assays 
 
Expressed TgM2AP was purified as per usual through metal-affinity chromatography. 
However, the purified TgM2AP was not cleaved with Factor Xa protease, thus leaving 
the 17 kDa polyhistidine and thioredoxin tag intact. This tagged TgM2AP was then 
subjected to size exclusion gel filtration to obtain a pure TgM2AP sample. This sample 
was then mixed with its putative binding partner and incubated for 15 minutes at room 
temperature. The mixture was then applied to 2 ml of Ni-NTA slurry preequilibrated 
with Factor Xa buffer. The column was then sealed and incubated at 22 °C for 1 hour 
with constant shaking to ensure efficient binding. The column was then washed with 3 
column volumes of wash buffer (20 mM Tris-HCl, pH 7.9, 40 mM Imidazole, 0.5M 
NaCl) to remove nonspecifically bound material. The bound complex was then eluted 
with elution buffer (20 mM Tris-HCl, pH 7.9, 250 mM Imidazole, 0.5M NaCl) to yield 
purified complex. Samples from each step of purification were analyzed with SDS-
PAGE. 
 
3.3.6 Polyacrylamide gel electrophoresis 
 
3.3.6.1 SDS- PAGE 
 
20 µl of protein sample was mixed with 10 µl of 3X gel loading buffer (50 mM Tris-
HCl pH 6.8, 1% (v/v) β-mercaptoethanol, 2% (w/v) SDS, 0.02% (v/v) bromophenol 
blue, 10% (w/v) glycerol) and heated at 95 °C for 4 minutes. 10 µl of prepared protein 
sample was loaded onto the gel with 5 µl Mark12™ Protein Standard (Invitrogen) as a 
molecular weight marker. The polyacrylamide gel was assembled in a 1.0 mm gel 
cassette (Invitrogen). Each gel consists of 4 ml of 12% acrylamide resolving gel (1.6 
ml distilled H2O, 1.2 ml 40% acrylamide/bis-acrylamide mix, 1.2 ml 1.25 M bis-Tris 
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(pH 6.8 with HCl), 25 μl 10% ammonium persulphate (w/v), 6 μl 
tetraethylmethyldiamine (TEMED)) and 2 ml stacking gel (1 ml distilled H2O, 0.4 ml 
40% acrylamide/bis-acrylamide mix, 0.6 ml 1.25 M bis-Tris (pH 6.8 with HCl), 25 μl 
10% ammonium persulphate, 6 μl TEMED). The gels were placed in an electrophoresis 
tank filled with running buffer (250 mM MES, 250 mM Tris, 5 mM EDTA, 0.5% (w/v) 
SDS). Electrophoresis was performed at 120 V for 75 minutes.  
 
Protein bands were visualized by staining with 50 ml of InstantBlue (Expedeon) with 
constant agitation for 30 minutes. The gel was then washed with 50 ml of water with 
constant agitation for three times for 5 minutes each time.  
 
3.3.6.2 Native-PAGE 
 
For Native-PAGE experiments ready-made 1.0 mm NativePAGE™ Novex® 4-16% 
Bis-Tris Gels (Invitrogen) were used in conjunction with the NativePAGE™ Gel 
Electrophoresis system (Invitrogen). The gels were placed in an electrophoresis tank 
filled with Dark Blue Cathode Buffer in the inner buffer chamber and Anode Buffer in 
the outer buffer chamber. All buffers and electrophoresis equipment were pre-chilled 
to 4 °C before commencement of the experiment. 15 µl of protein samples was mixed 
with 5 µl of 4X NativePAGE™ Sample Buffer and loaded onto the gel along with 5 µl 
of NativeMark™ Unstained Protein Standard (Invitrogen) as a molecular weight 
marker. The electrophoresis was carried out at 4 °C in the cold room at 150 V constant 
for 60 minutes, then 250 V constant for the remainder of the run until the dye front 
reaches the end of the gel cassette.   
 
3.3.6.3 Coomassie R-250 Staining  
 
Coomassie R-250 staining was used for visualization of protein bands on the 
NativePAGE gel.  After electrophoresis, the gel was placed in 100 ml fixing solution 
(40% (v/v) methanol, 10% (v/v) acetic acid), microwaved on high (1000 W) for 45 
seconds and agitated for 30 minutes. The fixing solution was decanted and replaced 
with 100 ml Coomassie R-250 stain (0.02% (w/v) Coomassie R-250, 30% (v/v) 
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methanol and 10% (v/v) acetic acid). This was then microwaved on high (1000 W) for 
45 seconds and agitated for 30 minutes. The stain was decanted and replaced with 100 
ml destaining solution (8% (v/v) acetic acid) and microwaved on high (1000 W) for 45 
seconds and agitated until the desired background was obtained.  
 
3.3.7 Digestion and purification 
 
Prior to Factor Xa cleavage or Enterokinase cleavage, the protein sample was buffer 
exchanged overnight at 4 °C into 5L of Cleavage buffer (20 mM Tris-HCl pH 8.0, 500 
mM NaCl, 2 mM CaCl2) to provide an optimal environment for factor Xa cleavage. 
SpectraPor® 10000 Dalton MWCO dialysis membrane (Spectrum) was used for 
dialysis.  
 
Quantification of the protein samples was achieved via Bradford assay. 2 µl of Factor 
Xa (Merck) or enterokinase (NEB) was then added to the sample and incubated 
overnight at 22 °C with constant shaking. The enzyme is irreversibly inhibited by the 
addition of PMSF to a final concentration of 1 mM. The protein sample is then passed 
through another metal affinity gravity column to remove the cleaved fusion partner and 
any uncleaved protein.  
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3.4 Results 
 
3.4.1 Expression in Escherichia coli 
 
Amplification and cloning of the constructs was conducted via protocols described in 
section 2.2. Samples were cloned into pET-32 Xa/LIC and transformed into XL1-Blue. 
Plasmids were verified via sequencing and used for the production of recombinant 
protein in Origami (DE3) cells. All proteins were purified via column affinity 
chromatography. Expression yield of the thioredoxin-fusion protein were around 10-20 
mg/L and were soluble. Removal of the thioredoxin tag was accomplished by the use 
of factor Xa and did not result in impairment to the solubility of the protein.  
Thioredoxin removal was problematic in the majority of constructs and was incomplete 
even after manipulating experimental variables such as temperature, digestion time, salt 
concentration and amount of enzyme added. In addition, even the application of size 
exclusion chromatography did not allow for the complete removal of thioredoxin from 
protein samples. This caused problems during the collection of spectral data, resulting 
in the presence of characteristic thioredoxin peaks within the 1D NMR spectra (Fig 
3.3). However, certain stringent experimental conditions (4 °C reaction temperature, 48 
hour reaction time with a 10:1 enzyme substrate ratio and 250 mM NaCl) followed by 
multiple rounds of affinity column purification and size exclusion gel filtration  would 
allow for a relatively pure sample to be obtained.  
 
The presence of thioredoxin (MW = 11kDa; pI = 4.82) even after extensive variation 
of experimental parameters indicated that successful cleavage was sequence dependent 
and that cleavage might have been sterically hindered by the presence of tertiary 
structures obscuring the Factor Xa cleavage site.   
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Figure 3.3: 1D (1H) NMR Spectrum of TSR5n. The 1D NMR spectrum of TSR5n shows extensive 
similarity to the 1D (1H) NMR spectra of thioredoxin as well as no additional structural peaks. Spectra 
was collected at 308 K 
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3.4.2 Expression in Pichia pastoris 
 
Despite our best efforts to generate a soluble and folded microneme protein samples in 
the current bacterial expression system, many of them have encountered problems 
during protein production. As a eukaryote, P. pastoris possesses a Golgi/ER mechanism 
which facilitates the proper folding of expressed proteins. P. pastoris was thus viewed 
as a possible expression system for proteins which hitherto have been unsuccessful in 
bacterial expression systems.  
 
Initial work on TgMIC2 and TgMIC3 was conducted in E. coli but have not produced 
a folded sample. Truncated domains of TgMIC4 have been expressed in E. coli and 
have resulted in structures of apple domains 1, 5 and 6. However, efforts to produce a 
folded sample for full length TgMIC4 have so far been unsuccessful. 
 
3.4.2.1 Choosing an Expression Strain 
 
The first step in the heterologous protein production in P. pastoris is the selection of a 
suitable expression strain. There are 4 major strains of P. pastoris cells used in this 
project, KM71H, X-33, GS115 and SMD1168. X-33 and GS115 are both mut+ strains 
and as such grow rapidly on methanol based media. KM71H has a disrupted AOX1 
gene and as such, is a muts strain that grows slowly on methanol based media. During 
integration of the target protein gene into the P. pastoris genome, the target gene could 
be integrated into the AOX1 gene, hence disrupting it. This would cause the formerly 
mut+ strain to present a muts phenotype. Hence, if using a mut+ strain for target protein 
expression, an additional verification step needs to be taken to verify the phenotype of 
the yeast strain.  
 
 X-33 is a wild-type P. pastoris strain that has a mut+ phenotype and exhibits good 
growth on both methanol and glycerol carbon sources. It does not require 
supplementation of minimal media with histidine.  
 
GS115 is a mut+ his- strain which exhibits good growth on both methanol and glycerol 
carbon sources. In addition, a disruption in the his4 gene causes an inability to 
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synthesize histidine and requires either the supplementation of minimal media with 
histidine or the incorporation of the his4 gene into its genome via transformation. This 
offers an additional method of selection for transformants. KM71H is a muts arg+ strain 
that is deficient in the AOX1 gene. This causes it to exhibit slower growth on methanol 
carbon sources.  
 
SMD1163H is a protease-deficient mut+ strain that exhibits good growth on both 
methanol and glycerol carbon sources. Protease-deficient strains may provide a more 
suitable environment for expression of certain heterologous proteins. pep4 prb1 double 
mutants show a substantial reduction or elimination in proteinase A, carboxypeptidase 
Y and proteinase B. Protease deficient strains can be an advantage when extracellular 
proteases can cause a decrease in yield such as during extended induction periods or 
when experimental conditions can cause decreased cell viability i.e. during culture in 
the presence of tunicamycin/DTT, high methanol concentrations or culture at extreme 
pH such as pH 3.0 or pH 7.0.  
 
Although theories have been put forward regarding the relative merits of mut+ or muts 
strains, the eventual expression success of a protein can only be evaluated on a case-
by-case basis and all expression strains should be considered and used. However, the 
expression strain used can affect the range of plasmids available and the optimal culture 
conditions further downstream. Over the course of this experiment all available P. 
pastoris strains were tested.  
 
3.4.2.2 Plasmids 
 
Plasmids used during this thesis were pPIC9k and pPICZα A; these make use of the 
AOX promoter which allows for induced expression. Other plasmids considered were 
the pGAPZα and pAO815 plasmids. The pGAPZα plasmid allows for the use of the 
GAP promoter which allows for high-level constitutive expression and the pAO815 
allows for the cloning of multiple gene copies into a single vector, this removing the 
requirement for screening for multi-copy integrants. Use of the GAP promoter was 
eventually disregarded as constitutive expression would not allow economic isotopic 
labelling of the protein. Use of pAO815 was disregarded due to the large potential size 
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of the final vector and the high possibility of rearrangement in E. coli. Integration of 
the plasmid into the yeast genome was verified via colony PCR (Fig 3.4A).  
 
3.4.2.3 Transformation 
 
As a first step for protein expression in yeast, we decided to use KM71H as our initial 
starting strain to simplify the initial screening process as it does not require the 
additional phenotype verification step. Constructs were cloned into both pPICZα A and 
pPIC9K. As a starting point an 80 µl aliquot of freshly prepared electrocompetent 
KM71H was then electroporated with 10 µg of purified plasmid linearized with SalI. 
Eventually all constructs were cloned into all 4 available expression strains.  
 
3.4.2.3.1 Gene dosage 
 
Initial transformation experiments used 2.5 µg to 5 µg of linearized plasmid DNA 
verified by agarose gel electrophoresis (Fig 3.4B). However, higher doses of linearized 
plasmid DNA resulted in larger numbers of colonies on high antibiotic concentration. 
However, doses over 15 µg generally did not give significantly larger numbers and 
occasionally caused problems during electroporation. The osmostability of competent 
cells after electroporation was is low and can result in low survival rates upon plating 
on low selection antibiotic concentration plates. The initial outgrowth step of 1 hour in 
1M sorbitol without agitation was deemed to be insufficient and was remedied by 
adding an additional 2 hour outgrowth step with rich media (YPD) supplemented with 
1M sorbitol without agitation before plating. Insufficient rounds of experiments were 
conducted to give a statistically significant result and as such this result is merely 
anecdotal and multiple rounds of experiments should be conducted in the future to 
confirm this result in a statistically relevant manner.  
 
Cell density upon plating can greatly affect the efficacy of the selection antibiotic, too 
high a cell density will result in inefficient selection and lowered copy numbers in 
transformants than expected. However, due to the highly random nature and scarcity of 
multi-copy integration events it can be beneficial to generate larger numbers of colonies 
for screening.  
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Figure 3.4: Agarose gels used for verification of the construct. A verifies the presence of the AOX1 
gene as well as the presence of the TgMIC3 insert via colony PCR. The PCR product used for cloning 
TgMIC3-CBL into pPICZα A was used as a positive control. B verifies the complete linearization of the 
plasmid after digestion with SacI and PmeI.  
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3.4.2.3.2 Cell viability post-electroporation 
 
Initial trial transformations had mixed results and transformants were only obtained at 
low selection antibiotic concentrations. This typically indicates a low copy number and 
consequently low expression levels. Initial trials were also hampered by low colony 
numbers (0-5 colonies per lowest Zeocin™ concentration plate). In order as to ensure 
maximum transformant viability after electroporation, an additional outgrowth step 
after electroporation in rich media (1M sorbitol supplemented with YPD media) was 
added and average colony numbers were improved to approximately 10-20 colonies per 
plate with the first colonies on high Zeocin™ concentration plates appearing (Fig 3.5).  
 
Colonies were selected from the highest Zeocin™ concentration plates. Small scale 
expression tests were conducted and the expression level of clones selected was tested 
using a dot blot. Multiple rounds of small expression trials indicated that none of the 
clones expressed to levels exceeding 1 mg/L.  
 
A second round of transformation was conducted to generate a greater variety of clones.  
Pichia strains X-33, GS115 and SMD1168 were used for this round of the 
transformation. Although research has indicated that the muts strain may be more 
amenable to the production of folded protein, mut+ strains have a higher growth rate on 
methanol and can result in a higher level of protein expression and accumulated 
biomass.  
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Figure 3.5: Agar plates showing the effects of antibiotic concentration and additional outgrowth 
step. Increasing the antibiotic (Zeocin™) concentration causes an observable decrease in the number of 
colonies on the plate. Adding an additional outgrowth step with YPD media rich media (1M sorbitol 
supplemented with YPD media) allows for increased numbers of colonies on the plate. 
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3.4.2.4 Screening  
 
One of the main goals of an expression system is to generate large quantities of suitable 
protein and the most important step in this endeavour is the screening process. Multi-
copy integration is a rare event that is estimated to happen in 1%-10% of cases, this 
means that hundreds of colonies might have to be screened before a suitable expression 
line can be isolated.  
 
Previous experiments have shown that high expressing clones do not solely arise from 
the clones with the highest antibiotic resistance. In addition, high-expressing strains are 
rare as they rely upon having multiple copies of the gene being inserted into the yeast 
genome. In addition, too high expression levels have been postulated to over-stress the 
eukaryotic folding mechanism and cause low or no expression. As a result of this, a 
variety of colonies across all antibiotic resistance levels were sampled and subjected to 
microscale screening.  
 
3.4.2.5 Microscale screening 
 
Originally screening was conducted ten at a time using 10 ml volumes, however this 
was slow and did not result in high expression level cell lines. There has been a move 
towards microscale screening for fermenter conditions in recent years and taking 
advantage of this movement would allow for faster condition screening in the future 
(Funke, Buchenauer et al. 2010). Microscale screening would also allow for larger 
numbers of colonies to be screened at a time and increase the chances of discovering a 
suitable cell line (Berrow, Bussow et al. 2006; Graslund, Sagemark et al. 2008).  
 
Microscale screening was carried out in 96-well microtiter plates in using 200 µl 
volumes. The major problem with microscale cultivation is the non-parallel and 
differing growth profiles of each clone. Induction at different culture phases can have 
far reaching impacts upon the expression profiles of the cell line and this can lead 
significant change in protein yield (Jenzsch, Gnoth et al. 2006). The easiest and most 
common method for equalising the starting conditions for the preculture is the 
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cultivation of the organisms until all the cultures are in the stationary growth phase 
(Studier 2005).  
 
This was achieved by a 48 hour batch phase with vigorous agitation (>275 rpm), with 
the removal of 150 µl of spent media and replacement with 150 µl of fresh media after 
24 hours. OD600 of all cultures remained constant at 12 ±2. The induction phase was 
carried out for 120 hours under aeration-limited conditions with the addition of 10ul of 
10% methanol every 24 hours.  The supernatant was then used for analysis via dot blot 
to identify possible high-expressing cell lines.   
 
5.3.4.1 Verification in larger volumes 
 
Research into the growth rates and expression levels of P. pastoris have shown that 
aeration is a significant factor in the production of heterologous recombinant proteins 
(Villatte, Hussein et al. 2001). Aeration is maximised by using 100 ml small glass flasks 
and limiting the culture volume to 20% of the vessel volume i.e 20 ml. However, this 
cannot replicate the conditions in large scale culture perfectly. Dissolved oxygen levels 
can reach much higher levels in 2L baffled flasks than in 100 ml small flasks, in 
addition, it is possible for rudimentary pH control with the addition of NaOH or HCl at 
12/24 hour intervals.  
 
With this in view, 5 colonies were selected and scaled up to 2L flask cultures to see if 
significant expression levels could be obtained in large scale culture. Aeration was 
maximised by the use of antifoam, a baffled flask and a high degree of agitation (>250 
rpm) and a degree of pH control was achieved by the periodic additions of dilute NaOH 
or HCl at 12/24 hour intervals. Initial biomass was also increased by using a 1L initial 
overnight seed culture concentrated five-fold by centrifugation and re-suspension in 
methanol media. This allowed for the verification of the results from dot-blot analysis 
via SDS-PAGE (Fig 3.6; Fig 3.7).  
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Figure 3.6: Dot blot of a single 96 well microtiter plate. This dot blot was generated by the method 
described in section 3.3.3.2.2. This shows one of the highest expressing clones in the project for TgMIC3-
EGF234 in well D4. This also illustrates the rarity of a multi-integrant (1-10% of all transformants). The 
image shown has been overlaid by a grid to assist in the identification of the clone in question.  
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Figure 3.7: SDS-PAGE of the highest expressing clones. These SDS-PAGE gels are of the highest 
expressing clones for TgMIC3 (right) and TgMIC4 (left) as identified via microscale screening. These 
clones were cultured in 200ml volumes to verify their expression levels. The relative purity of the protein 
of interest in the supernatant can be clearly identified. The band at 90kDa is AOX (expected MW = 
74kDa) which can be present in the supernatant due to leakage from the cells. The smeared band from 
28kDa to 35kDa is hyperglycosylated TgMIC3-EGF234 (expected MW = 15kDa).  
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3.4.2.6 Shake Flask Culture   
 
Shake flask culture was used for the production of isotopically labelled protein as well 
as to screen potential fermentation conditions.  
 
3.4.2.6.1 Screening of conditions for fermenter culture. 
 
The usefulness of screening for potential fermentation conditions such as media, pH, 
induction temperature and possible purification procedures can be limited as culture 
conditions during shake flask culture and fermentation culture can differ greatly. 
Fermenter culture conditions usually take place under substrate limited conditions, at 
high optical densities and at constant pH, shake flask cultures are generally aeration 
limited with moderate optical densities and where pH can fluctuate up to 2 pH units 
between pH equalization periods.  
 
These differences in culture conditions mean that proteolysis can be a major factor 
during shake flask culture due to the lowered cell viability and increased stress due to 
suboptimal culture conditions. In fermenter culture, more attention has to be paid to the 
purification processes as the accumulation of biological material can mean that 
extraneous binding of homologous P. pastoris proteins (AOX in particular) can cause 
problems with downstream purification processes. In addition, salts in the media can 
precipitate out during culture and purification and can decrease the efficiency of 
purification. Purification problems from fermentation culture will be covered in the 
section 3.4.2.7.1.  
 
Media compositions, induction temperature, induction time, pH and methanol 
concentrations were tested during the fermentation condition screening. Due to the 
differences in fermenter and shake flask culture, optimal conditions obtained by shake 
flask screening were only taken as a starting point for optimizing growth conditions in 
fermenter culture. BSM was chosen as the starting media for fermenter culture along 
with PTM1 as the supplemental trace mineral solution. Initial induction conditions were 
set at 30 °C for 100 hours and initial methanol concentration to be 1%.   
 
 115 
 
3.4.2.6.2 Isotopic Labelling 
 
Due to the high likelihood of proteolysis in shake flask culture, if initial expression 
levels are similar, expression cell lines arising from the protease-deficient strain 
SMD1168 were preferred for the production of labelled protein. Particular attention 
was paid to maintain the viability of the cells by increasing the frequency of addition 
of base to maintain pH.  
 
Initial screening of conditions used unlabelled media to decrease cost. The original 
expression line for TgMIC3-E234 originated from SMD1168 and was isolated from a 
colony resistant to 1 mg/ml Zeocin™ with an initial purified yield of 0.075 mg/L. The 
first step for isotopic enrichment is batch culture to build up biomass for protein 
production. This is carried out in unlabelled media with a repressing catabolite 
(glycerol) to ensure that the desired protein is only produced in the presence of labelled 
media.  
 
Inducing the culture immediately with 1% methanol can cause increased stress as well 
as increased protease activity due to sudden upregulation of AOX and subsequent 
production of hydrogen peroxide. Introducing a 4 hour period of methanol 
acclimatization increased purified protein yields from 0.075 mg/L to 0.12 mg/L. The 
optimal induction temperature and time was determined to be 22 °C for 72 hours. In 
general, parameters that favour a slower rate of protein production were found to be 
more successful during the production of isotopically enriched protein samples.  
 
3.4.2.7 Fermenter Culture 
 
Fermenter culture was primarily used for the bulk production of heterologous protein 
for use in crystallization trials and optimizations. Culture conditions during 
fermentation can vary drastically from shake flask culture and different factors have to 
be considered when optimising growth conditions. During shake flask culture, 
conditions were to be selected to minimise stress originating from the high variability 
of conditions. Fermenter culture allows for the tighter control of culture conditions and 
allows for culture at higher cell densities.  
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Fermentation was carried out with the accumulation of cell mass via a 20 hour glycerol 
batch phase, followed by a 4 hour glycerol fed-batch phase. OD600 typically reached 60 
at the end of the glycerol batch phase and usually exceeded 100 at the end of the 
glycerol fed-batch phase. The specific growth rate of the culture was used as an 
indicator as to the viability of the cell culture whilst the final yield of purified protein 
was used as an indicator as to the overall success of the protocol.  
 
Initial fermentation trials were conducted using BSM defined media supplemented with 
PTM1 at 30 °C with a 3 day induction period in the presence of 1% methanol. The 
induction period and culture temperatures were selected via condition screening in 2L 
shake flasks. An overly high concentration of methanol caused excessive oxygen 
demand and rapid depletion of dissolved oxygen in the culture medium. Reduction of 
methanol induction concentration from 1% to 0.2% allowed for substrate-limited 
growth and a consequent decreased oxygen demand.  
 
As with shake flask cultivation, inducing the culture immediately with 1% methanol 
was speculated to cause increased stress as well as increased protease activity due to 
sudden upregulation of AOX and subsequent production of hydrogen peroxide. This 
was mediated by introducing a 4 hour period of methanol acclimatization when 
methanol concentrations were increased by 0.1% every 2 hours until the final 
concentration of 0.3% methanol was reached.   
 
Use of BSM along with PTM1 also caused varying degrees of salt precipitation with 
the most extensive precipitation occurring during fermentation with pH ranges greater 
than pH 5.0. A large proportion of the precipitation was unable to be pelleted via 
centrifugation at 5000 rpm and necessitated centrifugation at 13000 rpm for complete 
clarification of the media. This was deemed unrealistic for processing of the quantities 
of supernatant produced via fermentation. Filtration via a variety of filter pore sizes 
such as 0.2 µm, 0.4 µm, 4.0 µm and 10 µm all failed due to extensive clogging of the 
filters.  
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3.4.2.7.1 Reformulation of fermenter media 
 
Pichia cultivation requires minerals such as potassium, magnesium and calcium. 
However, the mineral requirement of P. pastoris is still relatively unknown. In addition 
to the three cations, the culture of P. pastoris also requires a phosphate source which is 
provided by orthophosphoric acid. Salt precipitation in the media is caused by the 
formation of divalent and trivalent phosphates in the media at pH 5.0 and greater. This 
can cause problems during downstream purification. 3 different defined media 
compositions were trialled over the course of the experiment, FM21, FM22 as well as 
FM21LS. FM21 and FM22 are both reduced salt media with lowered levels of salts 
when compared to BSM. FM21 in particular contains roughly an eightfold decrease in 
salt concentrations.  
 
Trial fermentations were carried out with both media with either one of 2 alternative 
PTM formulations, PTM1 and PTM4. PTM4 contains an approximate threefold 
reduction of copper sulphate pentahydrate, zinc chloride, iron sulphate heptahydrate 
and sulphuric acid concentrations from PTM1. Usage of either FM21 or FM22 with 
either PTM1 or PTM4 did not significantly impact the growth profiles as compared to 
growth on BSM. Even though the level of precipitation was greatly reduced as 
compared to growth on BSM/PTM1 and did not cause membrane fouling, the 
supernatant remained opalescent at pH 6.0 and pH 7.0 even after extensive filtration 
and centrifugation. This fine particle build-up caused clogging of the columns during 
size-exclusion chromatography and anion exchange chromatography.  
 
FM21 was modified by reducing each of the components in turn by four-fold and 
examining the effects of the reduction on the extent of precipitation as well as the effects 
on the growth profile. Reduction of calcium sulphate dehydrate or phosphate levels 
decreased the growth rate of the culture and did not improve the extent of precipitation. 
Reduction of potassium salt levels did not impact the growth rate of the culture but also 
did not have an effect on precipitation. Decrease of the magnesium sulphate 
heptahydrate concentration resulted in little or no precipitation and had a limited effect 
on the growth rate of the culture and the maximum cell density that the culture was able 
to support. This formulation was termed FM21LS and used as the fermenter media of 
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choice for future protein production via fermentation. Trials with FM21LS used in 
combination with PTM4 indicated that the media stayed free of precipitation during 
culture at pH 3.0 -7.0 and supported growth up to an OD600 of 200.  
 
3.4.2.7.2 Optimization of purification protocol 
 
Isolation of purified protein from the crude supernatant involved a concentration step 
by passing the crude supernatant though an anion/cation exchange column. Due to the 
nature of high-density culture, large amounts of AOX1 are produced and can be present 
in the supernatant. During early attempts at purification, binding of AOX1 to the 
purification columns decreased the binding capacity of the column and severely 
decreased purified protein yield.  The presence of AOX1 can be easily recognized by 
the yellow-green colour it imparts to purification columns. AOX1 has a theoretical pI 
of 5.0 and the binding pH during anion/cation exchange was selected to specifically 
exclude AOX1 during crude purification. This allowed for the binding of the large 
majority of secreted protein in the supernatant and improved yield. After the 
purification via anion/cation exchange column the protein was then concentrated and 
purified using size exclusion chromatography (Fig 3.8).  
 
The shift from shake flask culture to fermenter culture resulted in the improvement of 
protein yields for all expression cell lines tested. Purified protein yields for TgMIC3-
CE2 increased from 0.02 mg/L to 0.08 mg/L, TgMIC3-EGF234 from 0.18 mg/L to 0.84 
mg/L and TgMIC3-FL from 0.12 mg/L to 0.30 mg/L and TgMIC4-FL from 0.05 mg/L 
to 0.7 mg/L. The use of the modified media and deliberate exclusion of AOX1 further 
improved yields.  
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Figure 3.8: Gel filtration elution profile of TgMIC4. Size exclusion chromatography was regularly used both as an analytical tool as well as for final purification. Fell length 
TgMIC3 was relatively pure after anion/cation exchange chromatography and the major peak from 55 to 65 ml was isolated and purified for further downstream processes. The 
estimated MW of the sample was 35 kDa which corresponded well to the estimate MW of the full length protein of 31kDa.
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3.4.2.7.3 Inhibition of glycosylation  
 
Hyper-glycosylation at N-glycosylation sites within the protein can cause problems 
during the gathering of structural data and purification.  Both TgMIC3-EGF234 and 
full length TgMIC3 were predicted using NetOGlyc 3.1 to contain an N-linked 
glycosylation site at N202. Removal of glycosylation can be accomplished 
enzymatically through the action of endoglycosidase (Endo) Hf and/or peptide: N-
glycosidase (PNGase F). Due to the tendency of P. pastoris for high mannose 
glycosylation at N-linked glycosylation sites, Endo Hf was used as the initial enzyme 
for deglycosylation. However, attempted deglycosylation of hyperglycosylated 
samples of TgMIC3-EGF234 and full length TgMIC3 was ultimately unsuccessful even 
after extended incubation periods (72hrs), a four-fold increase in enzyme and limited 
denaturation. Experiments utilizing the less specific PNGase F were also unsuccessful 
in complete deglycosylation of the protein sample.  
 
The alternative to enzymatic deglycosylation after protein production is the usage of an 
antibiotic, tunicamycin, to inhibit N-linked glycosylation (Fig 3.9). The initial 
concentration of 20 µg/ml of tunicamycin was insufficient for complete inhibition of 
glycosylation during fermenter culture and required a final concentration of 30 µg/ml 
of tunicamycin for complete inhibition. Inhibition of glycosylation during shake-flask 
culture required the addition of 20 µg/ml of tunicamycin. The OD600 of cultures with 
and without added tunicamycin were tracked over the 120 hour culture period and no 
significant deviations were observed.  
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Figure 3.9: SDS-PAGE showing the effect of tunicamycin. TgMIC3-EGF234 was predicted predicted 
using NetOGlyc 3.1 to contain an N-linked glycosylation site at N202. TgMIC3-EGF234 was confirmed 
to be hyperglycosylated post-expression using SDS-PAGE (gel on left) and glycoprotein staining. 
Culture in the presence of 30 µg/ml tunicamycin allowed for the reduced hyperglycosylation, resulting 
in a clear single band after purification (gel on right)  
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3.4.2.8 Expression of TgMIC2 clones in Pichia pastoris  
 
The successful expression and scale-up of full-length TgMIC3 and TgMIC4 indicated 
that a longer construct of full-length TgMIC2 might be more successful for expression 
in P. pastoris. In addition, additional methods for the optimisation of expression levels 
were also developed over the course of the expression of TgMIC3 and TgMIC4 
proteins. For this round of expression trials, six new constructs were generated and 
cloned into pPICZα A (for Zeocin™ resistance). These constructs included TSR12 for 
comparison with the existing model of TSR12 expressed in E. coli, TSR56_long (532-
698) which used the original TSP5 start point at residue 532 to the extended end point 
of TSP6 at residue 698, three analogues of the original E. coli constructs TSR 56, 
TSR56n and TSR12 as well as two constructs that included the TSR region, TgMIC2-
TR (271-698), TgMIC2-TR (271-658).  
 
These constructs were cloned into X-33, KM71H, GS115 and SMD1168 and subjected 
to the standard transformation protocol. The competent cells were dosed with 5, 10, 15 
and 20 µg of purified, linearized plasmid DNA over four rounds of transformations. 
Large 20mm petri dishes were used to allow for larger volumes of transformation mix 
to be plated. As in the experiments with TgMIC3 and TgMIC4, increasing the gene 
dosage to 15 mg increased the number of colonies on high selection antibiotic 
concentration plates.  
 
Taking this into account, large samples sizes were needed over a wide range of 
antibiotic resistance levels to ensure the greatest chance of success. Twelve colonies 
from each antibiotic resistance level were selected at random and cultured in 96-well 
microtiter plates to a uniform density. Of the transformants obtained from six new 
constructs, only one TSR56_long X-33 colony from the 1.0 mg/ml Zeocin™ 
concentration plate showed detectable expression.  
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Figure 3.10: SDS-PAGE of TSR56_long expression experiments. SDS-PAGE of the time course 
experiment (Top): L indicates the Mark12 protein standard markers. 0 indicates a sample taken from the 
initial culture. 1 indicates a sample taken after 1 day of culture. 3 indicates a sample taken after 3 days 
of culture whilst 5 indicates a sample taken after 5 days of culture. SDS-PAGE of the purification of 
TSR56_long (Bottom): L indicates the Mark12 protein standard markers. F indicates the flowthrough 
after passing supernatant through the Ni-NTA column. W indicates the fraction collected during the wash 
step and E indicates the eluted fraction from the column 
  
 124 
 
Expression and purification of TSR 56_long was achieved using the improved protocol 
and procedures from prior experiments with TgMIC3 and TgMIC4. Media used for the 
expression of TSR 56_long was FM22LS. FM22LS was chosen for its ease in transition 
to future fermentation experiments and its demonstrated ease for downstream 
purification.  
 
Time course experiments showed the optimal culture period for TSR56_long to be five 
days (120 hours) for 2L shake flask culture with 0.5% methanol (Fig 3.10). OD600 
remained stable over the expression period at 28. pH was maintained at a constant 
neutral pH 6.0 and proteolysis was limited by the incorporation of casamino acids into 
the media composition. This was conducted at a combination of three induction 
temperatures of 22 °C, 26 °C and 30 °C, and four methanol concentrations of 0.5%, 
1%, 2.5% and 5%. The optimal conditions for the shake-flask culture of TSR 56_long 
was determined to be an induction period of 120 hours at an induction temperature of 
22 °C at a methanol concentration of 0.5%. Methanol concentrations at or over 1% 
resulted in decreased cell growth and lowered purified protein yield.  
 
At the end of the culture period, the pH was adjusted to pH 3.0 prior to centrifugation 
and subsequent purification via cation exchange chromatography and IMAC. 
Purification was straightforward and clearing of the supernatant was achieved via 
centrifugation followed by vacuum filtration through a 4.0 µm filtration unit. Shake 
flask culture under experimentally determined optimal culture condition resulted in a 
purified protein yield of 1.2 mg/L as determined via use of a microvolume UV-Vis 
spectrophotometer (Thermo Scientific). Preliminary sparse matrix crystal screens at 4 
°C and 20 °C of two separate batches of the purified protein at pH 7.0 have not resulted 
in possible candidates for further optimization 
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3.5 Conclusion  
 
TgMIC2 is one of the key proteins involved in T. gondii host-cell invasion. The 
interaction between TgMIC2 and M2AP is relatively poorly characterized and it is 
unclear as to the location of the interaction in the TSP region and the ratio of the two 
molecules within the complex.  
The TSP12 pair has been shown to bind weakly to M2AP. The protein sample of 
TgMIC2-TSP56 expressed in E. coli was only partially folded at best. Modification of 
the domain boundaries of TgMIC2-TSP56 and expression in P. pastoris was intended 
to remedy this and allow for structural characterization of TgMIC2-TSP56.  
The longer construct (TgMIC2-TSP5n6n) allowed for the production of a partially 
folded sample that was subsequently shown to bind weakly to M2AP. TgMIC2-
TSP56_long expressed to a yield of 1.2 mg/L but did not result in any hits during sparse 
matrix crystal screens.  
Ideally, protein samples for initial crystallization trials and subsequent optimization 
should originate from a single production run to minimize batch-to-batch differences 
and allow for consistent results and rational optimization of crystals. Shake flask culture 
proved to be inadequate for these purposes as protein yield per batch were generally 
too low (0.05-0.18 mg) to run a complete crystal trial.  
 
Initial fermenter cultures had low yields as well as extensive precipitation and AOX1 
contamination causing low purification efficiencies. Common low-salt fermenter media 
such as FM21 and PTM4 did not reduce salt build-up as effectively as desired and a 
new media formulation (FM21LS) was used to produce all subsequent protein samples.  
 
The inhibition of glycosylation was achieved by culturing the expression cell lines in 
the presence of 30 µg/ml tunicamycin. Inhibition of glycosylation during labelled 
preparations required 20 µg/ml tunicamycin for complete inhibition.  
 
Use of FM21LS along with updated purification protocols allowed for improved protein 
yields that ranged from 0.8 mg to 18 mg per 4L fermentation run. This would be 
sufficient for the entirety of the crystallization process from screening to optimization. 
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However, fermentation requires a large amount of methanol (600 ml per 4L run) and 
would be uneconomical for production of isotopically labelled protein.  
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Chapter 4 
Structural studies of microneme 
proteins 
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4.1 General Principes of Structural Biology 
 
4.1.1 Introduction  
 
The foremost goal in structural biology is the determination of protein structures in 
order as to identify novel folds, new insights as to the biological function and 
mechanism of action of the protein as well as to identify possible sites for therapeutic 
action. The two major techniques in achieving this goal are X-Ray Crystallography and 
Nuclear Magnetic Resonance (NMR) spectroscopy.  
 
NMR spectroscopy is a spectrographic technique that uses the physical phenomenon 
known as NMR to generate data regarding the structure and dynamics of the protein in 
question. Although traditionally considered most useful in the investigation of small 
proteins (<35 kDa), advances have allowed for the resonance assignment and hence 
investigation of larger proteins.  
 
There has been a movement towards a greater integration and synergy of the two 
techniques to overcome the respective shortcomings of both (Szymczyna, Taurog et al. 
2009). NMR can provide information about the protein’s structure which can help with 
designing constructs that may prove to be more amenable for successful crystallization. 
Structural models obtained through NMR have also been useful as molecular 
replacement models for crystallography (Chen and Clore 2000; Chen, Dodson et al. 
2000).  
 
However, even though greater synergy between structural techniques can and will 
increase the quantity and quality of structural data available, there remains significant 
bottlenecks for both techniques. One of the most significant bottlenecks in the effort to 
obtain structural data is the need for purified high-quality protein samples. Both 
structural techniques require milligram amounts of purified, monodisperse, folded 
protein that remain soluble at high concentrations.  
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4.1.2 X-Ray Crystallography 
 
X-Ray Crystallography is a method widely used to determine structural information of 
proteins of an atomic level resolution. As of August 2012, 26860 out of 33444 (80%) 
of all structures in the Protein Data Bank (PDB) have been produced by way of X-Ray 
Crystallography. It is the leading method to obtain structural data at an atomic level 
resolution for large molecules (>35 kDa). 
 
X-Ray crystallography is based upon the diffraction of monochromatic X-rays by a 
three dimensional ordered array of atoms within a crystal. X-rays of varying 
wavelengths (between 0.5 Å – 2 Å) are used for the protein diffraction experiments and 
are scattered by the atoms’ electrons (Snell 2012). These short wavelength X-rays are 
usually produced via rotating anodes or synchrotron storage rings.  
 
Laboratory X-ray sources generate monochromatic X-rays by bombarding an angled 
anode metal (Cu or Mo) target with electrons. These electrons are produced by a heated 
cathode filament and accelerated using an electric field in the range of 20 – 60 kV. The 
collision of the electron with the anode target causes the ejection of an electron from 
the inner shells of the metal atom. This in turn causes an electron from a higher energy 
level to drop to a lower energy level causing the release of an X-ray photon that 
corresponds to the difference in energy between the two levels. The wavelength of the 
emitted x-rays will differ depending on the metal of the anode target. For example, for 
an electron that drops from the L energy level to the K energy level, the Kα wavelength 
of a copper anode is 1.54 Å whilst the Kα of a Molybdenum anode would be 0.71 Å.  
 
Electromagnetic radiation produced by synchrotron facilities were initially considered 
to be superfluous and at times a safety hazard. However, harnessing the unique 
properties of synchrotron radiation has allowed for decreased run times and the 
reduction of crystal sizes needed for data collection. Synchrotron facilities allow the 
circulation of charged particles such as electrons at close to the speed of light. When 
charged particles are accelerated, electromagnetic radiation is given off. The supply of 
electrons produced by an electron gun is accelerated by the linear accelerator into a 
series of dipole magnets arranged into a circle to form what is termed a booster ring. 
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This in turn feeds into a larger ring called the storage rings where the electrons are 
maintained in a high vaccum. Insertion devices such as wigglers and undulators are 
components inserted into straight sections of the storage ring to produce synchrotron 
radiation with varying beam widths and intensities (Dauter 2006). 
 
Data acquisition using a synchrotron offers many advantages such as increased beam 
intensity, higher collimation, wavelength tenability. In addition, more esoteric 
applications are available to make use of the continuous spectrum of emitted radiation 
and the flashing time structure of the X-ray beam (Dauter 2005; Holton 2009).  
 
4.1.2.1 General Principles of protein crystallization 
 
The successful structural determination of the protein of interest is dependent upon the 
quality of the crystal obtained from crystallization experiments. The greatest successes 
have been obtained with single crystals with a high degree of homogeneity, long-range 
order and a size between 10 µm3 and 1000 µm3 (Chayen 2003; Benvenuti and Mangani 
2007). 
 
 A protein will stay in solution only up to a certain concentration. Above this limiting 
concentration, the solution will no longer remain homogenous and the protein will fall 
out of solution in a variety of physical forms. Protein crystallization exploits this by 
varying the solution condition so as to obtain crystals as the solubility limit is exceeded. 
However, the actual process is seldom as straightforward as it seems. After varying the 
solution conditions, the solution might remain homogenous, the protein might fall out 
of solution as an aggregated form or undergo liquid-liquid phase separation instead of 
the desired crystalline form, or the protein might successfully crystallize but the crystals 
obtained are of poor quality and do no give suitable diffraction patterns (Asherie 2004). 
Even with extensive research into the process of protein crystallization, a generalized 
strategy for all proteins is still unavailable and problems are typically overcome via 
extensive trial and error using a sparse matrix crystallization screen (Cudney, Patel et 
al. 1994; Bergfors 2007; Larson, Day et al. 2007; McPherson, Nguyen et al. 2007; 
Caffrey, Li et al. 2012). 
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Crystallization is thought to occur in two steps, (i) nucleation and (ii) the growth of 
crystals from nuclei (McPherson, Kuznetsov et al. 2004). Nucleation represents a phase 
transition in which molecules move from a disordered to an ordered state, thus forming 
the smallest aggregate capable for spontaneous growth. The higher the concentration of 
the molecules, the higher the likelihood of collisions and the higher the chance of the 
formation of nuclei with a suitable size and orientation for crystallization (Malkin, 
Kuznetsov Yu et al. 1995; McPherson, Malkin et al. 1995; Drenth and Haas 1998).  
 
We can understand the process of protein crystallization by visualizing it in the form of 
a phase diagram, a diagram that shows the state of the material as a function of all the 
relevant variables in the system (Fig 4.1). If the concentration of the solution is so low 
as to be below the solubility curve, the protein will remain in solution. If the solution is 
overly supersaturated, undesirable disordered structures such as aggregates and 
precipitates will fall out of solution. At a lower level of saturation, termed the ‘labile’ 
or ‘crystallization’ zone, conditions will be favourable for observable spontaneous 
nucleation. If the supersaturation level is even lower, the nucleation rate will be too low 
for crystal formation in a reasonable timeframe. It has been experimentally determined 
that crystals will only form when the concentration exceeds the solubility by a factor of 
three in order as to overcome the activation energy barrier in forming the crystal 
(Chernov 1998). However, crystal growth generally occurs at solute concentrations 
below those needed for nucleation. When the protein concentration reaches the 
metastable zone, no additional nuclei are formed, but existing nuclei and crystals can 
grow. Crystal growth typically continues until the concentration the solution reaches 
equilibrium between the solid and solution phases. However the presence of impurities 
can cause disruptions in the crystal lattice of the growing protein and cause the 
termination of further crystal growth (Caylor, Dobrianov et al. 1999; Giege and Sauter 
2010; Candoni, Grossier et al. 2012). 
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Figure 4.1: Phase diagram demonstrating the general principle of crystallization. An oversaturated 
sample solution will cause the protein to fall out of solution in the form of aggregates, whilst an 
undersaturated solution will not crystallize. The protein and precipitant concentration in the samples is 
engineered to be within the labile zone. These conditions will be optimal for the formation of initial 
nuclei. Over the course of the crystal screening period, the protein sample will reach an equilibrium with 
the reservoir solution and cause the protein concentration to fall and enter the metastable zone where 
conditions for favourable for crystal growth.  
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4.1.2.2 X-Ray crystallography sample considerations 
 
The quality of the protein sample can be a major determining factor as to the eventual 
success or failure of crystallization. There are general guidelines that have been shown 
to be conducive for crystallization success. Firstly, the protein sample should be capable 
of being expressed in large milligram quantities in each batch. Protein conditions, 
purifications and procedures can vary and each protein batch should produce sufficient 
protein for the entire screening and crystallization process.  
 
The protein sample should be soluble at high concentrations and not aggregate at low 
concentrations. In addition, samples should be relatively thermostable and retain 
structural integrity over the length of the crystallization period. The protein should be 
purified to a high degree (at least 95-99% pure), however impurities have been known 
to act as nucleation centers that facilitate crystal growth.  
 
Homogeneity and monodispersity have also been shown to be important factors in 
determining possible crystallization. Impurities or heterogeneity in terms of sequence 
integrity, conformation or glycosylation can lead to crystallization failure, small crystal 
size or crystals that do no diffract to a high resolution or high intensity due to the 
inclusion of impurities in the crystal, causing lattice strain and decrease in crystal order.   
 
The protein can also be regarded as another variable to be considered when identifying 
possible crystallization conditions. In the context of this study, a high or heterogenous 
carbohydrate content due to glycosylation can lead to highly soluble proteins and can 
dramatically increase the amount of protein needed to achieve supersaturation. 
However, it has also been shown that glycosylation can often stimulate the adoption of 
the proper tertiary structure and hence improve the chances of successful crystallization 
(Chang, Crispin et al. 2007). There have been several descriptions of enzymatic 
removal of glycosylation and glycosylation inhibitors and such methods should be 
considered in the event of problems during crystallization trials (Baker, Day et al. 1994; 
Muto, Tsuchiya et al. 2009). 
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4.1.2.3 Crystallization techniques 
 
There has been a variety of crystallization techniques developed over the years. A 
selection of these include the batch method, vapour diffusion, dialysis, macroseeding, 
temperature crystallization and simple concentration (Weber 1997). Of the myriad of 
techniques, the three with the best track record are the batch method, vapour diffusion 
and dialysis (BMCD v4.03).  
 
The batch method is based upon spontaneous supersaturation (Fig 4.2A). The 
precipitant and the protein solutions are mixed and placed within a sealed container. In 
the microbatch method, droplets of the mixture as small as 1µl are immersed in an inert 
oil. In batch crystallization, high concentrations of the components come into contact 
within a short period of time. This can cause shock nucleation that can result in large 
numbers of small crystals or protein precipitation.  
 
The dialysis method (Fig 4.2B) uses the diffusion of low molecular weight components 
across a semi-permeable membrane. The protein is isolated within a container covered 
with a semi-permeable membrane and immersed within another container filled with 
precipitant solution. This allows the protein to be brought slowly towards its 
precipitation point by dialysis against a concentrated salt or organic solvent solution. 
Crystallization via dialysis tends to be useful to investigate the roles of discrete 
parameters due to the variation of only one parameter at a time.  
 
The vapour diffusion method (Fig 4.2C) is the most successful method for 
crystallization. There are three primary techniques in the vapour diffusion method, 
hanging drops, sitting drops and sandwich drops. A protein solution is mixed with the 
reservoir solution in a 1:1 ratio and placed in a sealed well with the reservoir solution 
in the bottom pool. This is then left at a constant temperature until the contents reach 
equilibrium.  
 
The vapour diffusion method achieves crystallization due to the gradual decrease of 
protein and precipitant concentrations through spontaneous vapour diffusion between 
the protein drop and the reservoir solution. This process proceeds until an equilibrium 
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point. Vapour diffusion methods are relatively straightforward to set up and automation 
has been developed to ease the screening process.  
 
In this study, a mosquito robot was used to set up initial sparse matrix crystallization 
screens via the sitting drop method whilst optimization of initial hits was achieved via 
the hanging drop method.  
 
4.1.2.4 Screening of protein crystallization conditions 
 
Due to the large number of variables that affect optimal crystal formation, protein 
crystallization is a non-linear iterative process with constant re-evaluations of the 
conditions chosen. This process can be broken down into two phases, the search phase 
and the optimization phase (Luft, Snell et al. 2011; Luft, Wolfley et al. 2011).  
 
The search phase is a process to identify the approximate conditions for crystal growth. 
The conditions for protein crystallization can influence varying factors including crystal 
packing, space group and symmetry which could all affect the ability of the crystal to 
diffract to a high resolution. As such, a diverse set of crystallization conditions should 
be identified so as to obtain the best quality crystals. In order as to ensure adequate 
coverage of the crystallization space, sparse matrix crystallization screens were 
developed. Such screens involve an intentional bias towards previously successful 
crystallization conditions whilst still maintaining a wide range of parameters.  
 
After the initial identification of promising conditions, the optimization phase is a 
process in which the parameters of the promising conditions are varied in gradual steps 
to improve the characteristics of the obtained crystals in an effort to produce diffraction 
quality samples. This can also involve the addition of specialised additives such as ions 
or detergents that could improve the packing of molecules within the crystal lattice. In 
addition, crystallization along with predicted ligands or binding partners could also be 
beneficial for crystal formation and could offer additional biological data.  
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Figure 4.2: The three major crystallization techniques. A: Batch and microbatch crystallization B: 
Dialysis crystallization C: Vapour diffusion crystallization. Batch crystallization relies upon spontaneous 
supersaturation upon mixing of the precipitant and the protein solutions. Crystallization via dialysis 
depends upon the protein solution approaching the optimal concentration as low molecular weight 
components diffuse across the semi-permeable membrane. In the vapour diffusion method, spontaneous 
vapour diffusion between the protein drop and the reservoir solution allows for the slow equilibration 
between the two and hopefully, subsequent crystallization.  
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4.1.2.5 Diffraction and diffraction data quality 
 
X-rays incident to the crystal are diffracted by the electrons within the protein 
molecules. The arrangement of the protein molecules within the crystal lattice allows 
for constructive interference and the subsequent reinforcement of X-ray scattering. X-
ray diffraction can be explained by the reflection of two X-ray beams by two equidistant 
planes (Bragg planes). The incident X-rays are reflected by both planes. If the X-rays 
are not absorbed by the crystal lattice or interfere with each other through destructive 
interference, diffraction is observed. Strong peaks of diffracted radiation are observed 
when the two reflected X-rays undergo constructive interference. The interference 
between the 2 beams is constructive when the path difference is an integer multiple of 
λ. This phenomenon of constructive interference from successive reflecting planes is 
characterised by Bragg’s Law (Drenth 1999)(Fig 4.3): 
 
𝑛𝜆 = 2𝑑 sin 𝜃 
 
In which λ is the wavelength of the X-ray, d is the distance between the Bragg planes 
and θ is the angle between the incident beam and the reflecting plane. In a typical 
protein crystal, there are multiple atomic planes interfering and the majority of reflected 
radiation undergoing destructive interference and results in sharp peaks of radiation 
against primarily empty background.   
 
When an X-ray beam is incident to a crystal, some of the Bragg planes are brought into 
the correct orientation to exhibit diffraction.  Rotation of the crystal allows for other 
crystal lattice planes to be brought into the correct orientation for diffraction and allows 
for a more complete data set to be collected.  
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Figure 4.3: Bragg’s Law. Incident beams are reflected by the electron clouds of the protein molecules 
within the parallel crystal lattice planes at an angle θ. The path difference between the incident X-ray 
beams is 2d sin θ. Constructive interference between the two incident beams is observed when the path 
difference (2d sin θ) is an integer multiple (n) of the wavelength (λ) of the incident radiation.  
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The highest data quality is achieved by measuring the intensities of as many radiation 
peaks (or diffraction spots) as possible. The theoretical higher limit of resolution from 
a data set corresponds to the minimal limit between the crystal lattice planes, deriving 
from the Bragg equation: 
 
𝑑𝑚𝑖𝑛 = λ/2 sin 𝜃𝑚𝑎𝑥 
 
Where, dmin corresponds to the minimal distance between the crystal planes. At the 
maximum angle of incidence (i.e. 90°), dmin is equivalent to half the wavelength of the 
incident radiation. This implies that the theoretical maximum resolution of a data set is 
related to the wavelength of the incident radiation, however, practically, the maximum 
resolution of a crystal is more often dependent on the quality of the crystal obtained 
(Dauter 1999).  
 
Experimentally derived crystals often do not have ideal crystal lattice arrangements. 
Protein molecules have areas within their structure that can exhibit various degrees of 
unfolded-ness and disorder such as loop regions. The internal structure of a crystal can 
be visualised as an arrangement of small perfect crystals (or unit cells). These unit cells 
have slightly different orientations with respect to each other due to problems during 
crystal growth. The extent to which these unit cells are misaligned with each other is 
known as mosaicity, with a higher mosaicity corresponding to a lower crystal quality, 
poorer datasets and consequently, lower resolutions (Drenth 1999). A high mosaicity 
causes smearing of the diffraction spots due to the crystal lattice planes giving rise to 
the diffraction spots remaining in the diffraction condition longer than those in a low 
mosaicity crystal. This will decrease the quality of the dataset obtained due to weak 
diffraction and possible overlapping of the diffraction spots.  
 
4.1.2.6 The phase problem 
 
Following data collection and processing, a contour map of the electron density 
surrounding the protein molecule is obtained. This electron density is represented by a 
wave equation which has frequency, amplitude and phase components. The frequency 
of the wave equation is directly derived from the frequency of the incident radiation 
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whilst the amplitude can be measured from the intensity of the radiation observed by 
the detector. However, the phase of the wave equation cannot be directly observed from 
the dataset obtained and has to be resolved through other means. This is commonly 
known as the phase problem (Taylor 2003). 
 
There are four primary methods for obtaining initial phase information, molecular 
replacement, isomorphous replacement, Multiple/Single Anomalous Dispersion 
(MAD/SAD) or through direct methods.  
 
4.1.2.6.1 Direct Methods 
 
Direct methods are typically used for small molecules with extremely high resolution 
data (<1.2 Å) (Karle 1989). However, it is an integral method for the identification of 
heavy atom sites in isomorphous replacement and Multiple/Single Anomalous 
Dispersion (MAD/SAD) methods.  
 
4.1.2.6.2 Molecular Replacement 
 
Molecular replacement refers to the technique where the phase information from a high-
resolution structure for a similar protein or protein domain as the protein in question is 
used to phase the target protein structure (Rossmann 1990). The similar protein or 
protein domain (or phasing model) is superimposed over the unit cell of the target 
protein, thus enabling an estimate of the initial phase to be obtained. Typically, the 
phasing protein is required to have a sequence similarity of >25% as well as a root mean 
square deviation of <2.0 Å between the backbone atoms of the two structures.  
 
4.1.2.6.3 Isomorphous Replacement 
 
Isomorphous replacement refers to the technique of introducing heavy atoms such as 
transitional or lanthanide series metals into the crystal lattice through either soaking or 
co-crystallization and using these heavy atoms to derive the phase of the crystal in 
question. Isomorphous replacement is dependent upon obtaining heavy-atom derivative 
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crystals isomorphous to the original native crystals. Datasets of both the native and their 
heavy-atom derivatives are collected and the positions of the heavy atoms within the 
crystal lattice located. The location of the heavy atom positions can be done through 
either direct methods or Patterson procedures. Direct methods are usually conducted 
through programs such as Shake-and-Bake (Hauptman 1997) or SHELX (Sheldrick 
2008). Patterson procedures make use of the differences between the Patterson maps 
(representations of the protein structure in vector space) of the native and heavy atom 
derivative crystals through programs such as SOLVE (Terwilliger and Berendzen 
1999).  
 
4.1.2.6.4 Multiple/Single Anomalous Dispersion (MAD/SAD) method 
 
Whereas isomorphous replacement requires both native and heavy atom derivative 
isomorphous crystals, MAD/SAD methods offer a substantial advantage over that of 
isomorphous replacement in that they allow all necessary datasets needed to be 
collected from a single crystal. MAD/SAD methods rely upon the presence of strong 
anomalously scattering atoms. Anomalous scattering occurs when the selected 
wavelength of the radiation is at the absorption edge of one of the constituent elements 
of the sample. Strong enough radiation will promote an electron from the inner shell to 
the outer shell of the atom and altering the scattering parameters of the atom, this is 
termed anomalous scattering. Anomalous scattering is detectable though changes in 
intensity and allows for phase information to be estimated from the dataset.  
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4.1.3 Nuclear Magnetic Resonance 
 
Nuclear Magnetic Resonance Spectroscopy is a method widely used to determine 
structural information of proteins of an atomic level resolution as well as interactions 
with binding partners, reaction kinetics and molecular dynamics (Montelione, Zheng et 
al. 2000; Cavanagh 2007; Kay 2011). As of August 2012, 6302 out of 33444 (18.8%) 
of all structures in the Protein Data Bank (PDB) have been produced by way of NMR.  
 
NMR spectroscopy exploits the physical phenomenon of nuclear magnetic resonance 
i.e. that the resonant frequency of a nucleus is influenced by its chemical environment 
and that one nucleus can influence other nuclei through chemical bonds. Since the first 
observation of NMR in solids and liquids in the 1940s, subsequent advances such as 
the pulse-FT approach, multipulse and multidimensional NMR techniques, high field 
spectrophotometers and TROSY experiments have greatly increased NMRs scope of 
applications (Kay, Clore et al. 1990; Pervushin, Riek et al. 1997; Tugarinov, Sprangers 
et al. 2004; Claridge 2009) 
  
4.1.3.1 General Principles 
 
NMR arises due to an intrinsic property of nuclei known as then nuclear spin angular 
momentum or ‘spin’, this can be described by the nuclear spin quantum number (I) and 
its magnetic quantum number (m). Nuclei with an even mass number and atomic 
number have zero spin (I = 0) and are deemed to be NMR inactive e.g 2H, 12C, 14N. The 
magnetic moment (m) of a positively charged nucleus can adopt 2I+1 possible 
orientations in the presence of an external magnetic field (B0). Hence, a proton, with I 
= ½, can adopt two possible energy states in the presence of an external magnetic field 
(B0) (Fig. 4.4).  
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Figure 4.4: Two possible orientations of the magnetic moment (µ) of a proton in the presence of an 
external magnetic field (B0). The two states are termed the α-state (m = + ½ ) and the β-state (m = -½) 
and correspond to nuclear spins which are parallel or antiparallel to B0 respectively. The α-state has a 
lower energy level than the β-state.  
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The two states are termed the α-state (m = + ½ ) and the β-state (m = -½) and correspond 
to nuclear spins which are parallel or antiparallel to B0 respectively. The α-state has a 
lower energy level than the β-state. Nuclei adopting such spins have a magnetic dipole 
and behave as bar magnets within a magnetic field.  
 
Application of electromagnetic radiation with an appropriate frequency will allow 
transition between the α- and β- states and is termed resonance. In the case of NMR, 
the appropriate frequency like in the radio frequency range (MHz)  
 
4.1.3.2.1 Lamor precession 
 
Nuclei with a non-zero spin have an associated magnetic moment and will experience 
torque in the presence of an external magnetic field. The resultant torque of the 
magnetic moment will cause it to precess about the field axis and a frequency known 
as the Lamor frequency which is directly proportional to the gyromagnetic ratio and 
external magnetic field strength (Fig 4.5). The transition between α- and β- states occurs 
at a frequency equal to the Lamor frequency.  
 
In summary, for a nucleus precessing in a magnetic field, the frequency of resonance is 
its Lamor frequency.  
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Figure 4.5: Lamor precession. Nuclei with a non-zero spin have an associated magnetic moment (µ) 
and will experience torque in the presence of an external magnetic field B0.  
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4.1.3.2.2 Boltzmann distribution 
 
At thermal equilibrium, a system of energy levels will have more particles adopting a 
lower energy level than higher energy levels. The population difference between the 
two possible energy levels can be described by the Boltzmann distribution: 
 
𝑁𝛽
𝑁𝛼
= 𝑒∆𝐸/𝑘𝑇 
Where N is the number of nuclei in each state, k is the Boltzmann constant and T is the 
temperature in K.  
 
Population differences under typical experimental conditions can be small (i.e 
approximately. 1 in 105 nuclei will realign upon application of the external magnetic 
field). This means that NMR spectroscopy can be a relatively insensitive technique. 
However, the slight differences in population results in a bulk magnetization along the 
z-axis and results in a net magnetization vector which can be visualized as the vector 
sum of all individual magnetic moments.  
 
4.1.3.2 Relaxation 
 
The process by which the bulk magnetization vector reaches its equilibrium level is 
known as relaxation. Relaxation typically takes place over a relatively long time-frame 
(0.001 – 1 second) and means that magnetization persists for a sufficiently long time to 
be manipulated and collected. However, this also imposes a time limit upon the 
acquisition of the signal. Relaxation occurs due to the presence of localised magnetic 
fields intrinsic to the sample oscillating at the appropriate Lamor frequency.  
 
Relaxation can be separated into two processes, longitudinal relaxation and transverse 
relaxation.  
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4.1.3.2.1 Longitudinal Relaxation (T1) 
 
Longitudinal (or spin-lattice) relaxation refers to the process by which the energy 
gained by the nuclei is lost to the lattice structure of the surroundings. Neighbouring 
spins have their own individual magnetic moments and tumble randomly due to thermal 
motion. The resultant transient magnetic fields at the Lamor precession frequency will 
cause the associated magnetic moment to precess. Effects from the neighbouring spins 
thus cause the z-component of the bulk magnetization vector to decay towards its 
equilibrium state and re-establish the normal Gaussian population distribution.  
 
Longitudinal relaxation is characterised by the time constant T1 according to the 
equation:  
 
𝑀𝑧,t = 𝑀z,𝑒𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑖𝑢𝑚(1 − 𝑒
−𝑡/𝑇1) 
 
Where t is the time after the Radiofrequency (RF) pulse and MZ is the z-component of 
the bulk magnetization vector. T1 is used to determine the relaxation delay in between 
acquisitions which is typically 5T1 for an accuracy of 1%.  
 
4.1.3.2.1 Transverse Relaxation (T2) 
 
Transverse (or spin-spin) relaxation refers to the process by which the nucleus loses 
phase coherence. The effect of local transient magnetic fields also serve to influence 
the transverse components of magnetic moments and in so doing, cause the bulk 
transverse magnetization vector to decay towards zero.  
 
Alternatively, as spins precess together, their magnetic fields interact additively to the 
external magnetic field, causing individual nuclei to precess at different rates. These 
effects are transient and random and causes the eventual dephasing of all spins and the 
reduction of the bulk transverse magnetization vector to zero.  
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The mechanism for transverse relaxation can be affected by molecular motion. When 
molecular motion is relatively fast, as is for smaller molecules or elevated temperatures, 
the local magnetic field experienced by all spins is relatively similar and results in a 
‘time-averaging’ of the local magnetic fields. This results in a longer T2 time constant 
and corresponds to improved signal-to-noise ratios and sharper linewidths. Conversely, 
larger molecules have slower motion in solution which results in a decreased T2 time 
constants, impaired signal-to-noise ratios and broader linewidths. The inverse 
relationship between molecule size and spectral quality is the reason for the relative 
difficulty of structural determination via NMR for molecules >50 kDa.  
 
Longitudinal relaxation is characterised by the time constant T1 according to the 
equation:  
 
𝑀xy,t = 𝑀xy,𝑒𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑖𝑢𝑚(𝑒
−𝑡/𝑇1) 
 
Where t is the time after the RF pulse and Mxy is the component of the bulk 
magnetization vector in the x-y plane. 
 
4.1.3.3 1D NMR 
 
A simple 1D NMR experiment can be described as follows. Firstly, the sample is at 
equilibrium. Secondly, a highly powered RF signal is applied to the sample with 
sufficient time and power to cause the rotation of the magnetic vector towards the 
transverse plane. Lastly, the vector is then allowed to precess about the magnetic field 
and is allowed to return to equilibrium on the z-axis. The precession of the magnetic 
vector results in an electrical current that is detected by a receiver mounted along the 
transverse plane. This signal decays exponentially over time and is known as the Free 
Induction Decay (FID). The acquisition of the FID takes anywhere from 50 ms to a few 
seconds and is then converted into an NMR spectrum by way of Fourier Transform. 
This process is termed a pulse sequence and is repeated several times to improve the 
signal-to-noise ratio. 1D NMR can serve as an extremely useful diagnostic tool in the 
early stages of protein sample screening to look for folded or partially folded samples 
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that would be suitable for isotopic labelling or crystallization trials (Page, Peti et al. 
2005). 
 
4.1.3.4 Multidimensional NMR 
 
The development of multidimensional NMR has allowed for the structural 
determination of biological macromolecules. Whereas 1D NMR contains information 
about one nucleus along one frequency axis, 2D and 3D NMR contains information 
regarding relationships between additional nuclei along multiple frequency axes. The 
available structural data is spread out along the additional axes and reduces the problem 
of signal overlap associated with 1D NMR.  
 
Multidimensional NMR is made possible by the use of scalar couplings and dipolar 
interactions in between nuclei. ‘Coupling’ is the term given to the splitting of resonance 
lines caused by a nucleus’s neighbouring nuclei. Scalar coupling or ‘J coupling’ is 
mediated via chemical bonds and can used for either short-range (2-3 chemical bonds) 
or long range (along the entire length of the amino acid side-chain) magnetization 
transfer. This serves as the basis for correlation spectroscopy (COSY) and long-range 
magnetization transfer is the basis for total correlation spectroscopy (TOCSY).  
 
4.1.3.4.1 2D Heteronuclear Single Quantum Coherence Spectroscopy (HSQC) 
 
The 2D HSQC experiment involves the transfer of magnetization on the proton to a 
heteronucleus, typically either 13C or 15N. Peaks on the spectra correspond to those on 
a 1D NMR experiment and the cross peaks would indicate couplings between pairs of 
nuclei. In the case of a 2D 1H/15N HSQC the resonance frequency of the amide proton 
is correlated with that of the attached nitrogen.  
 
The 1H/15N HSQC is particularly useful as it serves as a map of the amide backbone of 
the protein and the separation of the peaks in the spectrum can indicate the presence of 
tertiary structure. This can serve as a screen for possible candidates for 3D structure 
analysis through NMR. It has been proposed that a good quality HSQC spectra does 
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not correlate with crystallization success (Snyder, Chen et al. 2005; Yee, Savchenko et 
al. 2005), but it can serve as a guide for optimizing construct design.    
 
4.1.3.4.2 2D Nuclear Overhauser Effect Spectroscopy (NOESY) 
 
Nuclear Overhauser Effect Spectroscopy (NOESY) is a 2D experiment that utilises 
cross relaxation between proximal atoms (<5 Å) via direct dipolar couplings. This 
means in contrast to 2D HSQC, nuclei are correlated based on their spatial relationship 
rather than their chemical relationship. This allows for further restraints to be generated 
and forms the basis for tertiary structure determination.  
 
4.1.3.5 Three dimensional NMR Spectroscopy 
 
3D NMR experiments are typically performed upon doubly labelled protein samples, 
typically 15N and 13C. Their data is displayed across 3 frequency domains and most 
often are used to elucidate the secondary structure and assign sidechain resonances.  
 
4.1.3.5.1 Triple resonance experiments 
 
Triple resonance experiments are experiments that correlate 3 different nuclei (15N, 13C 
and 1H). These are used in conjunction with the 2D HSQC for resonance assignment of 
the backbone. Triple resonance experiments are typically analysed in pairs and are 
named according to the nuclei through with magnetization is transferred.  The 
HNCACB and CBCA(CO)NH experiments determine the Cα and Cβ frequencies of an 
amino acid residue and can be used to form amino acid connectivities. The HN(CA)CO 
and HNCO experiments are used to correlate carbonyl frequencies whilst the 
HBHA(CO)NH correlates the Hα and Hβ proton frequencies. Taken in conjunction, 
these experiments allow for the unambiguous assignment of protein backbone atoms.  
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4.1.3.5.2 Resonance assignments 
 
Crosspeaks on the 2D HSQC are picked in a semi-automated approach using 
NMRView and backbone assignments are assigned through the use of MARS (Jung 
and Zweckstetter 2004). HN(CA)CO and HNCO experiments are used to correlate 
carbonyl frequencies whilst the HBHA(CO)NH correlates the Hα and Hβ proton 
frequencies. Taken in conjunction, these experiments allow for the unambiguous 
assignment of protein backbone atoms.  
 
TOCSY experiments such as (H)CC(CO)NH–TOCSY, H(C)CH-TOCSY and(H)CCH-
TOCSY are used for side-chain assignments. The assignment of Hα, Cα and Cβ 
resonances allows for the calculation of a Chemical Shift Index (CSI) which can be 
used to predict secondary structure (Wishart and Sykes 1994).  
 
4.1.3.6 Structural Determination via NMR 
 
Structural data generated by NMR does not result in a unique three-dimensional 
structure of the protein. NMR data produces ranges of allowed values of different 
classes of restraints such as distances, angles or orientations rather than a single value. 
This reflects the fact that NMR probes proteins in solution, which are dynamic and 
hence give rise to variation in distances and conformations. Structure calculation using 
NMR data explores the conformational space defined by experimentally determined 
restraints and generates an ensemble of structural models over multiple iterations. 
 
4.1.3.7 Model generation  
 
A set of distance restraints for structure calculation is achieved through the acquisition 
and assignment of NOESY spectra. Manual assignment of NOESY spectra is typically 
difficult due to the absence of a three-dimensional model of the protein in question due 
to multiple possibilities giving rise to ambiguity in peak assignment. As such, 
assignment of NOESY spectra is usually achieved through automated means. ARIA 
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(ambiguous restraints for iterative assignment) is typically used for the automated 
assignment of NOESY spectra (Nilges 1997).  
 
ARIA assigns NOEs using multiple iterations of structure calculations. Each round of 
structure calculations comprises multiple steps, peak assignment, calibration, violation 
analysis and merging. An initial model family is generated based on any supplied 
manual assignments and any unambiguous NOEs and the lowest energy structures 
selected and used to calibrate NOESY spectra. Multiple rounds of iterative 
improvement to the models are conducted with increasingly stringent levels of tolerance 
used for NOE assignment until there are no significant violations greater than 0.5 Å.  
 
NOESY spectra provide distance restraints for structure calculations over a short 
distance. Structure calculations of proteins would require additional restraints to 
generate a viable three-dimensional structure. This is typically achieved by the 
gathering of dihedral angle restraints using chemical shift information and sequence 
similarity to predict phi (ϕ) and psi (ψ) angles for individual residues using programs 
such as TALOS (Cornilescu, Delaglio et al. 1999). 
 
In addition to distance and dihedral angle restraints, relative orientations between nuclei 
can also be used as a source of data for structure calculations. Residual dipolar coupling 
(RDC) data is typically used for this purpose as well as to measure dynamics within 
molecules. As RDCs are proportional to 1 𝑟3⁄  rather than 
1
𝑟6⁄  like for NOEs, RDCs 
allow for distance restraints over longer ranges to be gathered.   
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4.2 Materials and Methods 
 
4.2.1 NMR  
 
4.2.1.1 Sample preparation 
 
Cleaved protein was then buffer exchanged overnight at 4 °C into 5L of NMR buffer 
(0.6353% (w/v) NaH2PO4∙H2O, 0.1062% (w/v) Na2HPO4∙7H2O pH 7.0). The protein 
sample was filtered using a 0.22 µm syringe filter (Minisart) into a Vivaspin 20 spin 
concentrator with an appropriate molecular weight cutoff. The protein sample was then 
concentrated to 1.0 ml or less. Gel filtration was then used to further purify the protein 
sample. The Superdex 75 10/300 GL (GE Healthcare) column was equilibrated with 
degassed NMR buffer. The concentrated protein sample was then run using an Äkta 
FPLC (GE Healthcare) with a flow rate of 1.0 ml/min at 22 °C. The elution profile was 
then analyzed and the appropriate fractions were pooled and concentrated using a 
Vivaspin-20 spin concentrator with an appropriate molecular weight cutoff to have a 
volume of 1.0 ml or less.  
 
D2O was then added to the protein sample to result in a 10% volume of D2O to allow 
for the frequency lock of the spectrophotometer. 
 
4.2.1.2 NMR experiments 
 
All experiments were running at 35 °C for optimal spectral properties. The data were 
processed by NMR software NMRpipe (Delaglio, Grzesiek et al. 1995) and analyzed 
by NMRview (One Moon Scientific). 
 
One Dimensional Nuclear Magnetic Resonance (1D-NMR) was used as a first step to 
determine if the purified proteins were folded and suitable for further structural studies 
with labeled preparations. The Cross Faculty NMR Centre (Imperial College) provides 
both 600MHz and 800MHz (Bruker) NMR spectrophotometers for the structural 
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analysis of proteins. Data obtained was processed with NMRpipe and analyzed with 
NMRview (One Moon Scientific). 
 
4.2.2 Crystallization 
 
Crystallization screening kits and solutions were purchased from Hampton Research, 
Decode and Molecular Dimensions.  
 
Prior to initial crystallization trials, the protein was concentrated to 40mg/ml and buffer 
exchanged into 10 mM Tris-HCl pH 7.0.  
 
Initial crystallization trails were set up using a Mosquito robot with a volume of 0.1 µl 
of reservoir and 0.1 µl of protein solution. Multiple ICT1 plates were set up with 
different protein concentrations ranging from 5 to 40 mg/ml. An optimal protein 
concentration was selected and used to set up full crystallization trials at 4 °C and 20 
°C.  The plates were incubated for up to 30 days and regularly observed under a 
microscope.  
 
Optimization of the crystals was conducted using the hanging drop vapor diffusion 
method. Drops of 1 µl of protein solution mixed with 1 µl of reservoir solution were 
incubated with 800 µl of reservoir solution.  
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4.3 Results  
 
4.3.1 Structural Studies of TgMIC2 
 
4.3.1.1 NMR titration and chemical shift mapping 
 
In an NMR titration experiment, a 15N-labelled protein is gradually titrated with a 
unlabelled postulated binding partner. 2D (1H/15N) HSQC spectra are then gathered at 
different ratios of protein to ligand. The chemical shift changes of different peaks can 
then be observed by overlaying the different HSQC spectra over each other. The peak 
shifts of the backbone amides can then be mapped to particular residues involved in 
binding, hence allows the most perturbed residues to be identified.  
 
The chemical shift change that arises due to ligand binding can be attributed to 2 
different factors. Firstly, it arises due to the change in the local chemical environment 
of the residues due to the proximity of ligands atoms. Secondly, it can also come about 
due to structural changes in the 15N labelled protein due to the binding of the ligand.  
 
The binding of TgM2AP and TgMIC2 has been shown to be essential for the 
establishment of effective host-cell binding. in order as to identify the key residues 
involved in this interaction, we conducted 2 sets of experiments. First, we titrated 15N 
labelled TgM2AP and unlabelled TSR12 and TSR5n6n. Secondly, we did the reverse 
titration by titrating N-labelled TSR12 with unlabelled TgM2AP.  
 
For the titration of 15N-labelled TgM2AP with unlabelled TSR12 (Fig 4.6), unlabelled 
TSR12 was gradually added to 15N-labelled TgM2AP to achieve TgM2AP:TSR12 
ratios of 4:1, 2:1, 1:1, 1:2 and finally 1:4. Peak shifts were observable at 2:1 and no 
further peak shift was observed beyond an 1:1 ratio. The chemical shift changes 
involved were rather small and could indicate that the interaction between TgM2AP 
and TSR12 is weak and does not involve any aromatic residues.  
 
 156 
 
The titration of N-labelled TgM2AP with unlabelled TSR5n6n was performed similarly 
with the same ratios (Fig. 4.7). The primary residues (Δδ > 0.3) involved were Trp 21, 
Asp 33, Thr 42, Ser 58, Ile 66 and Ala 150. Yet again, the chemical shift changes 
involved were rather small. In addition, there was no transititory stage between 
unbound and bound spectra, this could indicate a slow exchange. 
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Figure 4.6: (1H/15N) HSQC spectrum of 15N-labelled TgM2AP titration with unlabelled TSR 12: 
Black: unbound N-labeled TgM2AP; Red: TgM2AP:TSR12 = 2:1; Blue: TgM2AP:TSR12 = 1: 1. 
Arrows indicate peaks shifts that imply binding of TSR12 to TgM2AP. Spectra were collected at 308 K.  
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Figure 4.7: (1H/15N) HSQC spectrum of 15N-labelled TgM2AP titration with unlabelled TSR 5n6n: 
Black; unbound N-labeled TgM2AP; Red: TgM2AP:TSR5n6n = 1:1. Some shift in peaks can be seen 
(arrowed), indicating a weak interaction between TSR5n6n and TgM2AP: Spectra were collected at 308 
K.  
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Figure 4.8: (1H/15N) HSQC spectrum of 15N-labelled TSR12 titration with unlabelled TgM2AP: 
Black; unbound N-labeled TSR 12; Red: TSR 12:TgM2AP = 1:1; Some shift in peaks can be seen 
(arrowed), indicating a weak interaction between TSR12 and TgM2AP Spectra were collected at 308 K.   
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Figure 4.9: Weighted-average chemical shift perturbation against residue number: (A) Weighted 
chemcial shift pertubation of TgM2AP due to TSR12 binding; (B) Weighted chemcial shift pertubation 
of TgM2AP due to TSR 56 binding.  
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Figure 4.10: Structure of TgM2AP with residues involved in binding of TSR12 highlighted. This 
figure shows the structure of M2AP. Primary residues (i.e. residues with Δδ > 0.3)  involved in binding 
of TgMIC2-TSR12 are highlighted in red, showing the binding surfaces on both β-sheet surfaces of 
TgM2AP. Structure was kindly provided by Bing Liu (Liu, Sawmynaden et al. 2009). Figures were 
generated with PyMOL (Schrodinger 2010).  
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4.3.1.2 Expanded domain clones  
 
The original clones for TSR34 and TSR56 resulted in unfolded proteins which were 
unsuitable for further structural experiments. In addition, previous testing of existing 
clones of TSR5 and TSR6 showed that they invariably were unfolded protein and hence 
were unsuitable for further structural studies.  
 
All constructs were cloned into the pET-32 Xa/LIC vector and expressed via typical 
protocols with no critical problems or issues. Slight precipitation along with loss of 
protein was observed during the expression and purification of TSR5n and TSR6n, 
however loss was not extensive and the protein sample was of sufficient concentration 
(>300 µM) for 1D (1H) NMR analysis.  
 
The most significant problem observed was the constant presence of thioredoxin in the 
protein sample even after gel filtration and metal affinity column purification. This 
caused difficulty in reading the spectra due to the intensity of the structured methyl 
peaks of thioredoxin. However, the spectra also indicated that the protein samples were 
primarily unfolded protein and thus unsuitable for further experiments. However, the 
spectra of TSR5n6n showed signs of being a partially folded protein (Fig. 4.11).  
 
Methyl groups resonate at around 0.9 ppm. In unfolded proteins, a sharp and intense 
peak can be observed around 0.8 - 1.0 ppm. On the other hand, in folded proteins, peaks 
corresponding residues within structured regions can be observed within the amide and 
methyl regions of the spectra. In the spectra of TSR 5n, 6n, 56_long and 5n6, around 
the 0.8 – 1 ppm region, a very sharp and intense peak can be observed, which indicates 
the presence of the methyl groups belonging to unstructured or flexible parts of the 
protein. In addition, there were no shifted methyl groups below 0.0 ppm which would 
indicate the presence of ring-current shifted methyl groups. Peaks in the amide region 
greater than 9 ppm would also indicate presence of a folded domain.  
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Figure 4.11: 1D (1H) NMR Spectrum of TSR5n6n. The spectrum shows some signs of structured 
peaks, indicating a potentially structured protein. Spectra was collected at 308 K 
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Figure 4.12: (1H/15N) HSQC spectrum of TSR5n6n. The HSQC spectrum has a large concentration of 
broad peaks between 8.5 and 8.0 ppm indicative of a protein with a large unstructured domain and few 
residues in a structured region. This could indicate that only a small region of TSR5n6n is structured or 
that TSR5n6n is an intrinsically unstructured protein which requires binding to its binding partner to 
adopt a structured conformation. Spectra was collected at 308 K with a field strength of 600MHz.  
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The construct TSR5n6n was deemed to be relatively promising and a labelled sample 
was generated. The spectra of the HSQC exhibited promising spectral properties, 
however, a large concentration of peaks were found around 8.3 ppm in the H dimension 
and 121 ppm in the N dimension (Fig.4.12). However, this confirmed that the sample 
was partially folded and suitable for use in pull-down assays with TgM2AP.  
 
In a further effort to isolate the primary domain(s) involved in binding with TgM2AP, 
we conducted pull-down assays. The pull-downs were conducted with TSR5n, TSR6n, 
TSR 56 and TSR 5n6n (Fig.4.13). The elution profile from size exclusion gel filtration 
indicated a good separation with a well-defined peak at the expected molecular weight. 
However, upon analysis of the fractions by SDS-PAGE, extraneous bands were 
detected at 20 kDa and 16 kDa, these could be remnants of the tag and the thioredoxin 
fusion protein that are interacting with TgM2AP.  
 
Analysis of the eluted fraction from the pull-downs shows that TgM2AP binds to 
TSR5n6n and TSR6n. Figure 7.9 shows that TSR5n6n is eluted with TgM2AP. The 
two extraneous bands at 20 kDa and 16 kDa were present in the gel filtration fraction. 
The band at 20 kDa was eluted with the flowthrough, this suggests that it does not 
possess a polyhistidine tag and could possibly be TgM2AP that has lost its fusion tag, 
which is about 16 kDa. This also offers an explanation for the presence of the 16 kDa 
band, which could possibly be the fusion tag with the polyhistidine tag and thioredoxin 
fusion partner. This would explain why it binds to the column and is eluted with elution 
buffer.  
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Figure 4.13: SDS-PAGE of pull-down experiments. SDS-PAGE of the pull-down of TSR6n with 
TgM2AP (Top): F indicates the flowthrough after passing the mixture of TgM2AP and TSR 5n/TSR 6n 
through the Ni-NTA column. L indicates the Mark12 protein standard markers. F indicates the fraction 
collected during the flowthrough step, W indicates the fraction collected during the wash step and E 
indicates the eluted protein(s) from the column. SDS-PAGE of the pull-down of TSR5n6n with TgM2AP 
(Bottom): L indicates the Mark12 protein standard markers. M indicates the gel filtration fraction of 
TgM2AP used for the pull-down. T indicates the gel filtration fraction of TSR 5n6n used for the pull 
down. F indicates the flowthrough. W indicates the wash and E indicates the elution.  
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Figure 4.14: Native-PAGE of the purified complex of TSR5n6n with TgM2AP. L indicates the 
NativeMark protein standard markers (Invitrogen). C indicates the complex. The complex formed has an 
approximate molecular weight of 80 kDa. The complex is postulated to be formed by one molecule of 
TgM2AP with two molecules of TSR5n6n 
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The eluted fraction of TgM2AP/TSR 5n6n was purified via size-exclusion gel filtration 
and analysed using Native-PAGE (Fig 4.14). The results showed that 
TgM2AP/TSR5n6n does indeed form a complex with an approximate molecular weight 
of 80 kDa. It is postulated that one molecule of TgM2AP associates with two molecules 
of TSR5n6n.  
  
4.3.2 Structural Studies of TgMIC3 and TgMIC4 
 
4.3.2.1 Analysis of protein samples using 1D (1H) NMR 
 
1D spectra of TgMIC3-EGF23 and TgMIC3-CE2 were collected from unlabelled 
shake-flask cultures of TgMIC3. TgMIC3-EGF234 originated from both SMD1168 and 
GS115 expression strains and were resistant up to 1.5 mg/ml Zeocin™ whilst TgMIC3-
CE2 originated from both SMD1168 and X33 expression strains and were resistant up 
to 0.5 mg/ml Zeocin™.  The protein samples were prepared using the method described 
in section 4.3.1.1.   
 
The 1D (1H) NMR spectra of TgMIC3-CE2 shows a strong methyl peak at -0.1 ppm 
(Fig 4.15). However, both the amide region and the region from 5 - 6 ppm have no 
obvious peaks. This could indicate that the TgMIC2-CE2 construct could be partially 
folded. 
 
The 1D (1H) NMR spectra of EGF234 shows no obvious peaks below 0 ppm (Fig 4.16), 
however this could be due to the lack of ring-shifted methyl groups in the structure. The 
presence of peaks in the amide region greater than 9 ppm indicates a folded domain. In 
addition, the peaks around 5 to 6 ppm arise due to Hα resonances in a β-sheet domain 
which provides further evidence of a folded domain.  
 
Both TgMIC3-EGF3 and TgMIC3-CE2 showed promising spectral characteristics that 
could signify that both constructs could potentially be candidates for structural 
determination via NMR.  
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Figure 4.15: 1D (1H) NMR Spectrum of TgMIC3-CE2. A is an expanded view of the methyl region; 
B is an expanded view of the amide region. There is a peak at -0.1ppm which is highly indicative of a 
folded domain. There are no obvious peaks in the amide region, which could indicate a partially folded 
domain. Spectra was collected at 308 K 
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Figure 4.16: 1D (1H) NMR Spectrum of TgMIC3-EGF234. A is an expanded view of the methyl 
region; B is an expanded view of the amide region. The absence of peaks below 0 ppm could be due to 
the lack of ring shifted methyl groups whilst the presence of peaks in the amide region indicate that there 
is a folded region. Spectra was collected at 308 K 
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4.3.2.2 Analysis of protein samples using 2D (1H/15N) NMR 
 
Labelled culture of TgMIC3 clones were produced using shake flask culture and 
according to the method described in section 4.13.1. TgMIC3-EGF234 originated from 
the SMD1168 expression strain and was resistant up to 1.5 mg/ml Zeocin™ whilst 
TgMIC3-CE2 originated from the SMD1168 expression strain and was resistant up to 
0.5 mg/ml Zeocin™.  TgMIC3-EGF234 had a purified protein yield of 0.12 mg/L whilst 
TgMIC3-CE2 had a purified protein yield of 0.02 mg/L.  
 
(1H/15N) HSQC spectra of TgMIC3-CE2 exhibited promising spectral properties (Fig 
4.17). However, some peak overlap was seen in the centre of the spectrum. This was 
speculated to be due to the presence of an unfolded domain within the protein. 
Similarly, the (1H/15N) HSQC spectra of TgMIC3-EGF234 also exhibited some 
promising spectral properties (Fig. 4.18). However, peaks were not as well dispersed as 
those in the TgMIC3-CE2 spectrum. 13C labelling via shake flask culture would require 
the use of an estimated 60-300 ml of 13C-methanol to produce a sufficiently 
concentrated sample for use in triple resonance experiments.  
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Figure 4.17: (1H/15N) HSQC Spectrum of TgMIC3-CE2. The peaks in the spectrum are generally well 
dispersed, which indicates that the protein was relatively well folded. Spectrum was collected at 308 K 
with a field strength of 600 MHz.  
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Figure 4.18: (1H/15N) HSQC Spectrum of TgMIC3-EGF234. The peaks in the spectrum seem to be 
gathered between 8.0 to 8.5 ppm, which could indicate the presence of a flexible region within the 
protein. Spectrum was collected at 308 K with a field strength of 600 MHz.  
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4.3.2.3 Crystallization of protein samples 
 
Crystallization trials of both TgMIC3-CE2 and TgMIC3-EGF234 were conducted. In 
addition, protein samples for full length constructs of TgMIC3 and TgMIC4 were also 
produced and used for crystallization trials. Crystallization trials and optimizations for 
TgMIC3-EGF234, full-length TgMIC3 and full-length TgMIC4 were conducted using 
a protein sample produced from a single production run. The protein yield from a single 
production run of TgMIC3-CE2 was too low and necessitated the use of multiple 
batches of protein for crystallization trials.  
 
All protein samples were confirmed to be homogenous and monodisperse via size 
exclusion chromatography - multi-angle light scattering (SEC-MALS) (Fig 4.19). All 
proteins were purified via gel filtration, concentrated to 40mg/ml and buffer exchanged 
into 10 mM Tris-HCl pH 7.0 immediately prior to initial crystallization trials. 
Crystallization trials were conducted at 4 °C and 20 °C.  
 
4.3.2.3.1 Domain constructs of TgMIC3 
 
The average yield for a single 4L fermentation run for TgMIC3-EGF234 was 3.5 mg. 
Crystallization trials for TgMIC3-EGF234 were conducted at 5, 10, 15 and 20 mg/ml 
protein concentrations but did not yield any hits. It was postulated that incomplete 
removal of sugar moieties might have precluded crystallization. Another batch of 
TgMIC3-EGF234 produced in the presence of tunicamycin to inhibit glycosylation was 
used for further crystallization trials but did not yield any hits.  
 
The average yield for a single 4L fermentation run for TgMIC3-CE2 was 0.32 mg. 
Crystallization trials for TgMIC3-CE2 were conducted at 5, 10, 20, 40 and 60 mg/ml. 
Crystals were obtained in one condition at 4 °C using a protein concentration of 40 
mg/ml. The initial crystallization condition was 0.1M NaCl, 0.1M HEPES pH7.5, 1.6M 
(NH4)2SO4.  
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Figure 4.19: SEC-MALS of TgMIC3 Full Length. Peak limits were defined as 1.255 - 1.433 ml. 
Results indicated that the sample was less than 1% polydisperse, an average molar mass moment of 
25000 Da and an average root mean squared radius moment of 5.9 nm.  
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Figure 4.20: Crystals of TgMIC4. A is a crystal of full length TgMIC4 which diffracted to 9Å. 
Conditions for crystal growth were 35% (v/v) 2-methyl-2,4-pentanediol, Na/K phosphate pH 6.2 with a 
protein concentration of 10 mg/ml (Wizard I - 43).  B is a crystal of full length TgMIC4 which diffracted 
to 8Å. Conditions for crystal growth were 35% (v/v) 2-methyl-2,4-pentanediol, Tris pH 7.0, 0.2M NaCl 
with a protein concentration of 10 mg/ml  (Wizard I – 24). C is a crystal of full length TgMIC4 which 
diffracted to 8Å. Conditions for crystal growth were 0.1 M Potassium chloride, 0.01 M Magnesium 
chloride hexahydrate, 0.05 M Tris-hydrochloride pH 8.5, 30% v/v Polyethylene glycol 400 with a protein 
concentration of 10 mg/ml (Natrix – 47). Crystals were obtained in 96 well plates.   
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4.3.2.3.2 Full length constructs of TgMIC3 and TgMIC4 
 
The average yield for a single 4L fermentation run for full length TgMIC3 was 1.2 mg. 
Crystallization trials for full length TgMIC3 were conducted at 5, 10, 15 and 20 mg/ml 
protein concentrations but did not yield any hits. It was postulated that similarly to 
TgMIC3-EGF234, incomplete removal of sugar moieties had precluded crystallization. 
However, SEC-MALS data indicated that the sample was less than 1% polydisperse. A 
batch of full length TgMIC3 was produced in the presence of tunicamycin was used for 
further crystallization trials but did not yield any hits.  
 
The average yield for a single 4L fermentation run for full length TgMIC4 was 2.8 mg. 
Crystallization trials for full length TgMIC4 were conducted at 5, 10, 15 and 20 mg/ml. 
Full details of all conditions tested can be found in the appendix Crystals were obtained 
in three conditions at 20 °C using a protein concentration of 10 mg/ml. Hits were 
obtained from formulation 43 from the Wizard I random sparse matrix crystallization 
screen (Emerald BioSystems), formulation 24 from the Wizard II random sparse matrix 
crystallization screen (Emerald BioSystems) and formulation 57 from the Natrix™ 
screen (Hampton Research) (Fig. 4.20). Optimization of crystals was attempted using 
vapour drop diffusion methods. Crystals were reproduced in similar conditions but did 
not exhibit any visible improvement in size. Crystals obtained diffracted to 8 Å 
resolution.  
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4.4 Conclusion 
 
Protein production using P. pastoris as an expression system was successful in 
producing homogenous, monodisperse protein samples for specific constructs such as 
Full length TgMIC3 and TgMIC4. However, for hyperglycosylated samples such as 
TgMIC3-EGF234, complete and uniform removal for sugar moieties proved difficult 
to achieve and further study is needed to develop a repeatable and effective protocol for 
uniform deglycosylation. Full length TgMIC4 was successfully crystallized and 
diffracted to a resolution of 8Å. TgMIC3-CE2 produced crystals but protein yields were 
insufficient for further investigation. 15N labeled protein samples were produced for 
TgMIC3-EGF234 and TgMIC3-CE2 and successfully used to gather 2D (1D/15N) 
HSQC spectra. However, the expected yield and suboptimal spectral qualities did not 
justify moving on to 13C labeling and subsequent triple resonance experiments.   
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Chapter 5 
Conclusions and Future perspectives 
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5.1 Biological Summary 
 
Toxoplasma gondii is an obligate protozoan parasite which is the etiological agent of 
Toxoplasmosis and a model organism for the Apicomplexan family which includes 
species such as the Neospora and Plasmodium spp. During the asexual phase of its life 
cycle, T. gondii exhibits a polyxenous nature, invading nearly all nucleated cell types 
via a unique form of gliding motility. Gliding motility is characterised by the sequential 
secretion of several discrete groups of adhesins and proteases to the parasite cell 
surface. Microneme proteins are one such group of proteins. Their pivotal role in host-
cell invasion as well as their immunogenic potential means that microneme proteins are 
important targets for further study.  
 
Apicomplexan microneme proteins have been extensively studied by this lab. In spite 
of the eukaryotic origin of the microneme proteins, structural data has been obtained 
for various microneme proteins such as the EGF3 domain from TgMIC6, M2AP and 
TgMIC1. However, data obtained from experiments with TgMIC3, TgMIC8 and 
TgMIC2 have indicated that the current prokaryotic expression system might be 
inadequate for the production of further folded microneme protein samples.  
 
5.2 Pichia pastoris: a viable alternative 
 
The origin of the project was due to the mounting difficulties in producing folded 
microneme protein samples of various microneme proteins using E. coli. Microneme 
proteins have higher proportions of cysteine residues that a typical protein and it is 
common practice to utilise a thioredoxin tag and E. coli expression strains that promote 
the formation of disulphide bridges. The Origami (DE3) expression cell strain has 
mutations in the thioredoxin reductase (trxB) and glutathione reductase (gor) genes. 
These mutations allow for the increased propensity of disulphide bridge formation. 
Thioredoxin enhances disulphide bridge formation by reducing proteins via a cysteine 
thiol-disulfide exchange. Thioredoxin has caused problems with purification of 
TgM2AP and TgMIC2 proteins whilst use of origami (DE3) has not resulted in soluble 
protein samples of TgMIC3 and TgMIC4.  
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The initial viability of cells transformed through electroporation was boosted by the 
addition of an outgrowth step in rich media whilst screening for high expression level 
cell lines was achieved by the use of microscale screening. This allowed for the 
generation of several high expression level cell lines from different expression cell 
strain origins and allowed for greater flexibility when selecting cell strains for 
fermentation.  
 
Labelled pure protein samples were successfully generated via shake flask culture and 
were verified to be fully labelled. The samples were subsequently used for analysis via 
2D HSQC. Protein yields for labelled protein were between 0.02 and 0.12 mg/L. 
Fermentation culture allowed for the generation of larger quantities of protein and 
protein yields were between 0.4 and 5 mg/L.  
 
Extensive precipitation was observed upon fermentation using protocol recommended 
BSM or FM21 along with PTM1. Neither centrifugation for filtration allowed for 
complete clearing of the supernatant and the supernatant remained opalescent. This 
caused clogging of purification column and a general decrease in binding capacity, 
purification efficiency and final protein yield. A reformulation of FM21 (FM21LS) was 
developed that when used in combination with PTM4 reduced precipitation to 
negligible amounts whilst still supporting high cell density culture. FM21LS was shown 
to support high density culture, however, detailed tests using growth curves of various 
P. pastoris strains growing on the various available strains would be able to further 
investigate the suitability of FM21LS as a growth media.  
 
There also remains certain ambiguities in the practical protocol such as the effect of 
gene dosage and the additional outgrowth step upon the observed colony number on 
antibiotic selection plates. Although an increase in colony number was observed by 
increasing gene dosage to 15 µg of linearized DNA as well as the addition of an 
additional outgrowth step, further rounds of experimentation is needed to generate 
statistically significant data.  
 
This work has demonstrated that P. pastoris offers a viable alternative to E. coli as an 
expression system for microneme proteins. Previously problematic proteins such as full 
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length TgMIC4 as well as truncated domain clones from TgMIC3 were expressed as 
soluble proteins in high quantities and were used in subsequent structural studies. 
However, the system is not a perfect system and proteins such as TgMIC2-TSP5n6n 
continue to be problematic.  
 
 
5.3 TgMIC2 
 
TgMIC2 is a key protein involved in invasion of the host cell. It has been shown that 
TgM2AP acts as an escorter for TgMIC2, however, the exact nature and location of the 
binding surface between the two proteins is as yet unclear. Through the results of the 
pull-downs and the NMR titrations we can see that TgM2AP interacts with both the 
TSR56 pair as well as the TSR12 pair. Via Native-PAGE, the approximate molecular 
weight of the complex has been determined to be approximately 80 kDa, and it is 
postulated that the ratio of TgM2AP to TgMIC2 in the complex is 1:2. In addition, the 
results of the pull-downs also point towards TSR6 as the primary domain involved in 
binding with TgM2AP.  
 
However, the NMR titration results are ambiguous and do not give a clear picture of 
the interaction between TgM2AP and TgMIC2 between TgM2AP and TgMIC2. In 
addition to being non-contiguous, the amino acid residues from both TgMIC2-TSR12 
and TgMIC2-TSR12 indicated to be involved in binding are similar. This could be due 
to a general interaction between TSR pairs and TgM2AP and would not be indicative 
of a true binding interaction. No additional peak shift was observed beyond a 1:1 ratio 
which is not indicative of a weak interaction whilst the magnitude of the peak shift is 
indicative of a weak interaction. This seemingly contradictory result deserves further 
scrutiny. 
 
In addition, efforts to produce a soluble and folded sample of TgMIC2-TSR34 have so 
far proven difficult and as such; the relative contribution of TgMIC2-TSR34 to the 
binding of TgM2AP is as yet unknown. Expression of TgMIC2-TSR56_long using P. 
pastoris was successful in producing a soluble homogenous protein sample. However, 
crystallization trials with the protein sample have not resulting in crystal hits.  
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Experiments with expressing TgMIC2-TSR56_long in mammalian cells have so far 
been unable to produce a well-folded protein sample.  
 
Further work for TgMIC2 will involve investigating the nature of the interaction though 
alternative means such as Isothermal Titration Calorimetry (ITC) to measure the 
thermodynamic properties of the interaction to quantify the strength of the interaction 
or via Surface Plasmon Resonance (SPR) which would allow for the quantification of 
the affinity and on-/off-rates of the protein interactions.  
 
Using the initial data generated by the CSI graph in conjunction with biochemical 
methods to investigate interaction kinetics, site-directed mutagenesis can be used to 
determine the relative contributions of individual residues to the overall interaction with 
TgM2AP.  
 
5.4 TgMIC3  
 
Domain clones of TgMIC3 were successfully expressed and labelled in shake flask 
culture. Both TgMIC3-CE2 and TgMIC3-EGF234 were partially folded when assessed 
via 1D NMR and resulted in reasonably well dispersed HSQC spectra. Although 
spectral quality and anaemic protein yield indicated that progress onto triple resonance 
experiments would be inadvisable, if a high expressing clone could be identified in the 
future it would allow for higher peak intensities and possibly resonance assignments.  
 
TgMIC3-CE2 successfully crystallized, albeit at an extremely high concentration of 60 
mg/ml. Protein yields for the expression cell strain were too low to run a complete 
sparse matrix crystallization trial and optimization. Once again, a higher expressing 
clone would allow for further investigation into this area. TgMIC3-EGF234 expressed 
at a much higher level but did not generate any hits. It was postulated that the 
incomplete removal of sugar moieties were responsible for increased flexibility and the 
subsequent decline in NMR spectral quality as well as the protein samples inability to 
crystallize. However, even when the glycosylation was completely inhibited through 
the use of 30 µg/ml tunicamycin, the protein sample did not result in any hits. The EGF1 
and EGF5 domains of TgMIC3 are degenerate and flank the central core of EGF234. 
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This blurring of protein domains might contribute to the difficulty of obtaining a folded 
protein sample. Additional domain scanning might remedy this in the future.  
 
Expression of a folded sample of full length TgMIC3 was thought to have the potential 
to eliminate the need to produce a sample for a truncated domain. Full length TgMIC3 
was successfully expressed and verified to be homogenous but did not result in any 
crystallization hits during screening.  
 
5.5 TgMIC4 
 
TgMIC1-4-6 is one of the key contributors to host-cell invasion by Toxoplasma gondii 
and has been the focus of extensive research into the mechanism of its function as well 
as its structural makeup. The N-terminal MAR-regions of TgMIC1 have been shown to 
bind to sialylated glycans on the host-cell surface (Garnett, Liu et al. 2009) as well as 
to TgMIC4-A12 (Reiss, Viebig et al. 2001; Saouros, Blumenschein et al. 2007). In 
addition, there has been some evidence that TgMIC4-A56 interacts in some way with 
the host-cell membrane. 
 
TgMIC4 comprises of six apple domains which form natural pairs, with only 3 residues 
between the two domains in each pair (i.e. A12, A34, A56). The solution structure of 
TgMIC4-A12 has been solved via solution state NMR and consists of two apple 
domains which closely adopt the typical structural features of previously determined 
apple domains (Marchant, Sawmynaden et al. 2008). Other apple domain pairs of 
TgMIC4 (A34, A56) have high sequence identities and structures of these domain pairs 
can be generated via homology modelling. Although the structures of individual apple 
domains have been solved, there has been a relative lack of information regarding the 
overall arrangement of the apple domains. The only structure in which the arrangement 
of tandem apple domain pairs has been elucidated is the structure of coagulation factor 
XI (Papagrigoriou, McEwan et al. 2006). This has been used as the basis for a proposed 
model of the arrangement of full length MIC4 (Figure 5.1) (Marchant, Cowper et al. 
2012) where the apple domains adopt a disc-like structure with TgMIC4-A56 more 
loosely associated.  
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Full length TgMIC4 was successfully expressed in fermenter culture with a purified 
protein yield of 0.7 mg/L. The protein sample was verified to be homogenous and 
crystallized at the concentration of 10 mg/ml. Crystals obtained diffracted to a 
resolution of 8 Å. However, the crystals were not large enough to allow for a complete 
dataset to be collected. Optimization of the crystal hits has so far failed to produce a 
crystal of higher quality. Efforts are ongoing to generate an outline structure of TgMIC4 
which would allow the spatial relationships between the apple domains within TgMIC4 
to be elucidated and the current proposed model to be confirmed or revised.  
  
 186 
 
 
 
 
 
 
 
Figure 5.1: A proposed model for the arrangement of full-length TgMIC4 and interactions with 
TgMIC1. The schematic (top) illustrates the interactions (dotted ovals) between TgMIC4 and TgMIC1. 
TgMIC4-A12 interacts with the MAR-regions of TgMIC1 whilst TgMIC4-A56 interacts with the host 
cell. A model for the arrangement of apple domains within TgMIC4 has been proposed (bottom) based 
upon the layout of coagulation factor XI where the fourth and sixth loops (L4 and L6) are at the interface 
between the A12 and A34 pairs and the A34 and A56 pairs are linked by an extended linker (dotted line).  
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5.6 Future perspectives  
 
The future direction of this project and potential areas for advancement are detailed 
below.  
 
5.6.1 Advances in Pichia pastoris as an expression system 
 
Advances in the use of P. pastoris as an expression system have been focused upon the 
modification of its genome to allow for upregulated expression of various proteins 
within the UPR/ERAD pathway.  Although the UPR/ERAD pathway in P. pastoris is 
relatively unstudied, the recent release of a complete genomic database of P. pastoris 
has allowed for the identification of several possible homologues of S. cerevisae 
UPR/ERAD pathway proteins. The identification and upregulation of selected 
homologues could allow for mutant expression strains that would have a higher folding 
capacity or an improved ability to endure environmental stress.  
 
5.6.2 The novel dimerization domain of TgMIC3 
 
Dimerization of TgMIC3 is essential to its function and the dimerization domain of 
TgMIC3 is postulated to have a novel dimerization mechanism. Previous expressions 
of domain clones containing the dimerization domain have been especially problematic 
either resulting in insoluble protein or precipitating during purification. This along with 
the novel nature of its dimerization mechanism could be indicative of an intrinsically 
disordered domain like the EGF2 domain from TgMIC6 (Sawmynaden, Saouros et al. 
2008). The dimerization domain might be stabilized by interaction with TgMIC8 and 
co-expression and co-crystallization could allow for crystals to be obtained for 
structural studies.  
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5.6.3 The arrangement of the apple domains within TgMIC4 
 
High resolution structures of several apple domains within TgMIC4 has been generated, 
however, the overall arrangement of these domains within TgMIC4 is still a mystery. 
If further optimizations fail to produce a crystal of diffraction quality, techniques such 
as small angle crystallography or electron microscopy can be employed to produce a 
low resolution structure to which the existing structures can be fitted into.  
 
5.6.4 Rhomboid proteins 
 
The rhomboid proteins are a group of membrane proteases that play a key role in the 
processing of microneme proteins during host-cell invasion. Structural data is absent 
for all known rhomboid proteins from toxoplasma gondii and would shed light upon 
their mechanism of action. Full length and truncated domain constructs have been 
cloned and the screening of transformants is being pursued.  
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A2: Pichia Troubleshooting and General Tips 
 
Issue Solution 
I’ve streaked out my expression cell 
strains but nothing has grown! 
Old (>3years) stocks from an old 
Invitrogen box can take up to 7 days to 
grow out. Wait.  
 
If they haven’t grown after a week, streak 
it out from a cryovial. Ask me where they 
are.  
My YPD smells delicious! It reminds me 
of brownies and cake.  
 
-or- 
 
My YPD looks different from yours! It’s 
more dark brown whilst yours is a golden 
yellow.   
You’ve just made caramel by autoclaving 
your dextrose (i.e. sugar) or by adding the 
filtered dextrose when your media is too 
hot.  
 
Filter (0.22µm) sterilize your dextrose. 
Always wait for your media to cool to 
room temperature before adding 
dextrose. I like to keep both in the 
incubator to equalise it to culture 
temperature before mixing.  
 
I tried filtering my methanol and it 
dissolved the filter! 
You’ve picked up one of the old 
nitrocellulose filters.  Use the PTFE ones 
instead when filtering methanol. 
Contamination! Pichia is much more sensitive to external 
bugs than E. coli as you don’t use 
antibiotics in many phases.   
 
Make sure you read up and practice your 
aseptic technique. I like to incubate 
freshly prepared media components at 
37°C for a few days just to identify 
 228 
 
contamination before they can cause 
problems further down the line.  
 
I also like to autoclave flasks, measuring 
cylinders and pipette tips, then squirrel 
them away in a fume cupboard to keep 
them sterile and untouched. Don’t use the 
same Gilsons for bacterial work and yeast 
work.  
My electroporation isn’t working and 
I’m getting no transformants on all 
plates! 
First, check that your electroporation 
parameters are set correctly and the time 
constant reads roughly close to the 
manufacturers’ instructions (8.0 if you’re 
using the bio-rad one in the lab). 
 
Remember to add the outgrowth step on 
YPDS. You’re basically torturing the 
cells into doing your bidding so they are 
pretty weak after. YPDS helps them to 
recover.  
 
Don’t directly plate transformants onto 
antibiotics. I’ve had better success 
growing colonies on plain YPDS plates, 
pooling then plating on selection media 
after.  
I’m getting no transformants on the 
highest antibiotic plates! My 
electroporation must have gone wrong! 
This is more common than you think. 
Multiple integrants are rare events and 
you should be patient and a couple more 
rounds. Use the 22cm plates if you have 
space.  
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Your electroporation is fine. It’s 
surprisingly hard to mess up 
electroporation.   
I’m getting hundreds of colonies on the 
highest antibiotic plates! Nobel prize 
here I come! 
More than 10 colonies on the highest 
plate usually means that the selection has 
failed in some way. Zeocin is sensitive to 
both heat and light so keep zeocin plates 
away from the light during storage and 
incubation.  
 
Plating too much cells can cause this as 
well. Keep to a maximum of 200µl for 
the small petri and 500µl for the large 
petri.  
 
In event of Nobel prize, bring back 
gravlax and meatballs.  
So many colonies… How do I choose? Pick every colony on the highest 2 
antibiotic selection plates. Pick at least 10 
from the lower 2 plates. There have been 
instances of high expression level clones 
from lower plates.  
 
I like to fill up at least one 96-microtiter 
well plate for each round of 
transformation along with 2 wells as 
controls.  
How do I shake 96-well plates? There is a high-rpm shaker for plates on 
the ground floor. Ask politely.  
My cells are growing irregularly in the 
plates.  
Passage(remove half of old media, add 
fresh media) the cells daily for 3 days 
before allowing them to grow to 
saturation and starting induction.  
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Is the dot-blot reliable?  Expression yields do vary between 
medium scale and microscale but in 
general, the highest expression clones in 
microscale usually turn out to be the 
highest expressing in large scale as well.  
 
However, I do like to choose at least 5 of 
the best clones and test them in shake 
flask as measurement of yield can be 
more reliable. Plus, time course 
experiments can be conducted at the 
same time.  
My cultures smell like bread/beer/feet. 
 
-or-  
 
My cultures smell like bread/beer/feet  
Congratulations, you have grown Pichia  
 
 
 
Congratulations, you  have grown 
something else  
 
To avoid situations like these, always 
check your cultures under a microscope 
regularly for signs of contamination and 
always remember aseptic technique.  
My minimal media (BSM, FM21, FM22) 
looks cloudy at fermentation pH.  
Phosphates should be prepared and filter 
sterilised if possible separately before 
mixing.  
 
Can you change your fermentation pH? 
pH <5.0 usually results in less 
precipitation .  
 
If its your first time, run the fermentation 
anyway as it might not cause a problem. 
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However, consult James Mansfield first 
as high levels of precipitation can block 
the air inlets and cause problems in the 
fermenter.  
 
If precipitation still causes problems, use 
FM21 with PTM1. Then FM21 with 
PTM4, then FM21LS with PTM1, then 
FM21LS with PTM4.  
I need the supernatant at X pH for 
procedures, how should I go about doing 
this? 
pHing the supernatant in the fermenter is 
the most convenient method. Precipitates 
can form during pHing and doing it in the 
fermenter allows you to clear the 
supernatant just by centrifuging.  
My culture doesn’t grow in minimal 
media! Its fine in rich media.  
Certain expression strains require 
supplementation. Refer to the strain 
guide for more information.  
My culture takes a long time to grow 
(doubling time >4 hours) in minimal 
media! 
Some cell lines do not take well to media 
changes. Culture the cell line in the media 
intended for and freeze and label 
accordingly for further use in the future.  
How do I pass the supernatant though 
a/an X column?  
Always make sure your supernatant is 
clear before passing it through a column.  
 
Whenever possible don’t use the AKTA 
to pump supernatant through a column, 
use the peristaltic pump instead. Ask me 
how to setup a leak proof system.  
 
If you must use the AKTA, ask a senior 
member of the lab to supervise, use a 
superloop and rinse the system 
thoroughly before and after usage.   
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Help! The columns turned purple/green 
and the column’s ruined! 
This is due to AOX leakage from the cell. 
Choose a condition that excludes AOX. 
pI of AOX is 6 and 500mM of NaCl 
usually limits binding to SEC columns.  
 
I’ve found that using 2 columns in series 
and eluting from the second column 
usually allows for better recovery if your 
proteins pI is similar to AOX.In the same 
vein, it usually takes 2 runs of SEC to 
purify a sample.  
 
To remove the contaminating protein 
from the column, pass 2M Urea through 
and leave it for 16-24 hours at 37°C 
sealed properly. Dissolve 1 tablet of 
trypsin in 10ml of water and inject it into 
the column, incubate it overnight at 37°C. 
Rinse afterwards according to protocols. 
Due to the high binding concentration, 
the first column is usually permanently 
impaired.  
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A3: Crystallization Conditions
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